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Chapter 1
Introduction

9Introduction
In a multicellular organism cells need to communicate with their environment and with one
another for many aspects of life. The mechanism by which cells communicate is signal
transduction. Defects in signal transducing molecules cause many diseases, including cancer,
and signal transduction has therefore been one of the most studied biological processes over
the past decades. The genetic model organism Caenorhabditis elegans shares many proteins
involved in signal transduction with vertebrates and is thus very well suited to study signal
transduction mechanisms in general.
The nematode Caenorhabditis elegans as a genetic model system
C. elegans is a simple and well-described organism
C. elegans is a small soil nematode that was chosen as a model organism to study animal
development and behaviour (BRENNER 1973). It has great potential for genetic analysis for
many reasons (reviewed in (BARGMANN and HODGKIN 2002; RIDDLE et al. 1997; WOOD
1988)). One of its most significant advantages is its simplicity, both in anatomy and in
genomic organization. In addition, C. elegans has a short life cycle of 3 days, is only 1 mm
long as an adult and is transparent throughout the life cycle, so that development can be easily
followed. Large populations can be grown on agar plates or in liquid using Escherichia coli as
the food source and strains can be kept as frozen stocks. Furthermore, the predominant sex in
a C. elegans population is the self-fertilizing hermaphrodite, but males, which arise
spontaneously at low frequency, exist as well and allow cross-fertilization. Finally, it is
extremely easy to make and identify mutants using for instance chemical mutagens.
In the past, several studies have been performed that are invaluable for C. elegans
geneticists nowadays. Studies on the cell lineage of C. elegans revealed that the pattern of cell
divisions is essentially invariant among individuals (SULSTON and HORVITZ 1977). The total
description of the invariant cell lineage from the single cell of the fertilized egg to the fully
differentiated cells of the adult was completed in 1983 (SULSTON et al. 1983). The adult
hermaphrodite has 959 somatic nuclei and fewer than two thousand germ cell nuclei. Adult
males contain 1031 somatic nuclei.
 The anatomy of C. elegans is also invariant among wild type individuals and has been
completely reconstructed by electron microscopy of serial sections (reviewed in (WHITE
1988)). Muscle cells, nerves, epithelia, intestinal cells and other cell types were identified and
revealed that the body plan is essentially the same as that of higher animals. The nervous
system of C. elegans consists of only 302 cells in the hermaphrodite and 381 cells in the male.
For all hermaphrodite neurons, the anatomy and connectivity has been elucidated (WHITE et
al. 1986). In addition, the number and positions of chemical synapses (5000), gap junctions
(600) and neuromuscular junctions (2000) that are made by these neurons were described. The
study revealed that the C. elegans nervous system is slightly different from the nervous
system of vertebrates: the synapses are simple and do not have complex postsynaptic
specializations. However, despite its simple nervous system, the nematode has genes for most
of the known molecular components of vertebrate brains, suggesting that the C. elegans
nervous system provides a valid minimal model for that in animals (BARGMANN 1998).
C. elegans is the first multicellular organism for which the complete genomic
sequence was reported ( C. ELEGANS SEQUENCING CONSORTIUM 1998). C.elegans has a small
genome, with a haploid DNA content of about 97 million base pairs, which is approximately
one-thirtieth of the number in the human genome (LANDER et al. 2001; VENTER et al. 2001).
It reveals more than 19,000 genes and over 40 percent of the predicted proteins have
significant homology with proteins in other organisms (C. ELEGANS SEQUENCING CONSORTIUM
Chapter 1
10
1998). The sequencing of the C. elegans genome was based on a clone-based physical map
(C. ELEGANS SEQUENCING CONSORTIUM 1998; WATERSTON and SULSTON 1995). This physical
map consists mainly of cosmids and YACs and has also been very useful to facilitate the
positional cloning of chosen loci. Besides the genomic sequencing, sequencing of expressed
sequence tags (EST) has been carried out, which was helpful in identifying and annotating
genes in the genomic sequence (C. ELEGANS SEQUENCING CONSORTIUM 1998). The completion
of the genome sequence made it possible to construct a gene expression map for all genes in
C. elegans (KIM et al. 2001). This gene expression map is based on micro-array data and
visualizes co-regulated genes. It can thus be used to identify genes that are regulated in a
similar manner to a gene or group of genes of interest.
Although the advantages of C. elegans are numerous, it also has drawbacks. Cell-
specific molecular studies are difficult to perform, because most somatic cells are small and
because the cuticle around the animal hinders access to these cells. For instance,
electrophysiological studies in C. elegans are technically extremely difficult. Patch clamp
methods have been developed to study ion channel activity in a few neurons and body-wall
muscles (GOODMAN et al. 1998; LOCKERY and GOODMAN 1998; PIERCE-SHIMOMURA et al.
2001; RICHMOND et al. 1999), but are not applicable to all muscles and neurons yet. In
addition, it is not possible to isolate sufficient amounts of protein from a certain tissue to
perform biochemical analyses. Another disadvantage is that, despite many attempts, no stable
C. elegans cell lines exist. Recently, a primary culture system that allows culture of C.
elegans embryonic cells has been described (CHRISTENSEN et al. 2002). These embryonic
cells differentiate into the various cell types that comprise the newly hatched larva. The
majority of cells differentiates into neuron or muscle cells, and these cells can be used for
electrophysiological studies (CHRISTENSEN et al. 2002). However, analysis on other cell types
remains difficult.
Forward genetics
One of the main advantages of C. elegans is that it is well suited to perform forward genetics:
mutants with interesting phenotypes can be easily collected and subsequently the mutated
gene can be identified by positional cloning. The spontaneous mutation rate is too low to be
useful, but a variety of mutagenic agents (such as ethyl methanesulfate (EMS)) and treatments
(such as ionizing radiation) can be used to obtain the desired mutations (reviewed in
(ANDERSON 1995; JOHNSEN and BAILLIE 1997)). In addition, mutations can be obtained by
insertional mutagenesis using transposons (GREENWALD 1985; MOERMAN et al. 1986).  The
wild type Bristol N2 strain cannot be used for transposon insertional mutagenesis, because
transposons are not active in the germ line of these animals. Some strains, so-called "mutator"
strains, do show germ line transposition, and it is these that are used for transposon insertional
mutagenesis. The advantage of this method is that it is relatively simple to clone the causal
insertion using a PCR-based method (WICKS et al. 2000).
Simple forward genetic screens
The first forward genetic screen performed in C. elegans was a simple F2 screen (BRENNER
1974). In this screen, a population of wild type hermaphrodites was exposed to a mutagen,
resulting in randomly mutated genes in the germ cells. The mutagenized worms were grown
for two generations to produce homozygous mutants (Figure 1A). In total 619 mutants with a
visible phenotype were identified in this way (BRENNER 1974). Over two-thirds of the found
mutants showed uncoordinated movement, indicating that the genes mutated in these
uncoordinated (unc) animals are potentially required for the proper development or function
of the nervous system. Indeed, cloning and molecular analysis of several of the unc genes
revealed factors important for neuronal differentiation, axon guidance and outgrowth, for
neurotransmitter synthesis and storage and for signal transduction (reviewed in (BARGMANN
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1998; CHALFIE and JORGENSEN 1998)). Besides the unc mutants, Brenner isolated mutants
with long, dumpy or small bodies, with blistered cuticle, twitching muscles or rolling
locomotion and with forked or bent heads (BRENNER 1974).
After this first forward genetic screen, innumerable "simple" screens have been
performed to find genes that function in a process of interest. For instance, to gain insight into
the process of vulva differentiation, screens have been performed to identify mutants that
either lack a vulva or have ectopic vulvae (FERGUSON and HORVITZ 1985; SULSTON and
HORVITZ 1981). Subsequent molecular analyses of these mutants revealed that LET-60, which
is a homologue of the well-known human oncogene RAS, is a key player in vulva
differentiation (HAN and STERNBERG 1990; WANG and STERNBERG 2001). Besides mutants
with clear visible phenotypes, more subtle mutants have been isolated as well that are affected
in processes like apoptosis, lifespan, chemosensation or thermotaxis (BARGMANN and MORI
1997; ELLIS and HORVITZ 1986; KENYON 1997).
Figure 1. Forward genetic screens. (A) A simple F2 screen to identify uncoordinated animals.
Wild type hermaphrodites (P0) are exposed to a mutagen. Consequently, genes are randomly mutated
in the germ cells. A certain sperm is mutated (indicated in grey), in this case in an unc gene.
Fertilization of an oocyte by this mutated sperm will result in a heterozygous F1 hermaphrodite. One-
quarter of its progeny will be homozygous for the mutation and have an uncoordinated phenotype.
Progeny of this uncoordinated animal should all have an uncoordinated phenotype, as can be examined
by transfer to a new plate. Adapted from (JORGENSEN and MANGO 2002). (B) A suppressor screen to
identify downstream targets of LET-60. In this screen, hermaphrodites that have a multivulva
phenotype caused by a dominant mutation in let-60 (let-60(gf); germ cells are indicated in grey) are
used for mutagenesis. A sperm that obtains a second mutation in a suppressor gene (dark grey) will
eventually result in animals with a wild type phenotype (i.e. one vulva) in the F2 generation.
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Complicated forward genetics screens
Not all genes show a visible phenotype in the F2 generation when mutated. Therefore, various
stategies have been used to increase the number of genes with a phenotype (reviewed in
(HODGKIN and HERMAN 1998; JORGENSEN and MANGO 2002)). Maternal-effect lethal screens
have been performed to identify genes that are essential for the earliest divisions of an
embryo. The earliest divisions are performed by maternally supplied mRNA and protein, and
animals mutated in these genes are therefore viable when derived from a heterozygous
mother, but embryonic lethal when born from a homozygous mother (reviewed in (KEMPHUES
and STROME 1997; SCHNABEL and PRIESS 1997)). The par genes, which are essential for
embryonic asymmetry, were identified in this way (KEMPHUES et al. 1988). In addition to the
maternal-effect lethal screens, maternal-effect viable screens were done to identify genes with
a non-essential function relatively early in development (HEKIMI et al. 1995). Examples of
such genes are the clk genes, which are involved in the temporal control of development and
behaviour, including life span (LAKOWSKI and HEKIMI 1996). clk-1 encodes for instance a
highly conserved mitochondrial protein involved in ubiquinone biosynthesis, providing a link
between the production of ubiquinone and aging (FELKAI et al. 1999; VAJO et al. 1999). To
identify genes that are required for the immortality of the germ line, a screen was performed
to isolate strains that become sterile after a couple of generations (AHMED and HODGKIN
2000). This screen identified a DNA-damage checkpoint protein, mrt-2, that is required to
prevent telomere shortening (AHMED and HODGKIN 2000). Park and Horvitz screened for
mutations that have dominant effects on the behaviour or morphology of C. elegans (PARK
and HORVITZ 1986). For about half of the genes that give a phenotype with a dominant
mutation loss of gene function did not result in a visible phenotype, indicating that loss-of-
function alleles of these genes would not have been found using a simple F2 screen (PARK and
HORVITZ 1986).
Suppressor screens
To identify genes involved in a particular process, a powerful method is to search for
extragenic modifiers (either enhancers or suppressors) of a mutation that affects this process
(reviewed in (HODGKIN and HERMAN 1998; JORGENSEN and MANGO 2002)). Suppressor
screens in particular have frequently been performed in C. elegans. To study signal
transduction, suppressor screens are very useful, because second-site mutations often identify
genes that are involved in the same genetic pathway as the gene that is disrupted in the
starting strain. For instance, to study RAS signalling, genetic screens for mutations that
suppress the multivulva phenotype of let-60 ras gain-of-function mutations have been done
(reviewed in (STERNBERG and HAN 1998); Figure 1B). Many genes that act downstream of
let-60 ras, including lin-45 (RAF), mek-2 (MAP kinase kinase), mpk-1 (MAP kinase) and sur-
2, have been identified in this screen (HAN et al. 1993; KORNFELD et al. 1995; SINGH and
HAN 1995; WU and HAN 1994). Subsequently, epistatic analyses determined the functional
order of action of these genes. In this way, a complete genetic pathway for RAS signalling has
been built (STERNBERG and HAN 1998). At the time of discovery of this RAS pathway in C.
elegans, several components of this pathway were not known to play a role in mammalian
RAS signalling. However, later studies in mammalian systems confirmed that they are also
involved in the mammalian RAS pathway. This shows that suppressor screens in C. elegans
are very potent in identifying (conserved) signal transduction pathways.
By screening for suppressors it should be kept in mind that not all mutants identified in
such screens are involved in the same process as the original mutant (reviewed in (PRELICH
1999)). An example is the class of informational suppressors that were identified in early
suppressor screens. These suppressors contained mutations in components of the translational
machinery and were called informational because they change the passage of information
from DNA to protein (reviewed in (MURGOLA 1990)). Most mutations altered tRNAs in such
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a way that an amino acid is incorporated at a stop codon, thus suppressing nonsense or
frameshift mutations. In C. elegans, several informational suppressors have been isolated and
cloned (BOLTEN et al. 1984; WATERSTON 1981; WATERSTON and BRENNER 1978). Although
these informational suppressors are useful to study the translational machinery, they do not
give information about the process that is disrupted in the original strain. Another class of
suppressors that frequently do not affect the process of interest alter the amount of mutant
protein. The primary mutation often results in increased or decreased activity or amount of the
protein, and second-site mutations that respectively decrease or increase the actual amount of
protein are expected to suppress the phenotype of the primary mutation. Either specific
regulators of the gene of interest or general components of gene expression pathways are
identified. A general gene expression pathway that can be mutated in C. elegans to suppress a
variety of phenotypes involves the smg genes (reviewed in (MANGO 2001)). These genes act
in nonsense-mediated mRNA decay, and suppression is probably caused by increased stability
of the mRNA encoded by the primary mutated gene (PULAK and ANDERSON 1993). Taken
together, careful analysis of the obtained suppressors is necessary to reveal whether they act
in the same or in an unrelated process as the original gene.
Caveats of forward genetics
Forward genetics cannot, unfortunately, unmask all components of a certain (signal
transduction) pathway. One problem is that if two genes functionally substitute each other (i.e.
they are functionally redundant), both genes have to be mutated to give a mutant phenotype.
Because the frequency of mutating two genes at the same time is very low, it is difficult to
identify redundant positions in a pathway. Another problem is that genes might be missed
because they function in more than one pathway. The phenotype of a mutant in that gene
might then be different from the specific phenotype that is being selected. An example is a
gene that has also a function that is essential for viability. A knockout of such a gene will not
be recovered from a forward genetic screen, because it is lethal. Finally, a gene can be
difficult to target by mutagenesis. For instance, the size of a gene might be so small that the
frequency with which it is mutated is too low to be isolated in a forward genetic screen.
Reverse genetics
With the completion of the sequencing project, reverse genetics has become more and more
important in C. elegans. Using reverse genetics, the function of a gene with known sequence
is determined (reviewed in (KUWABARA 1997; PLASTERK 1995)). It is even possible to study a
complete gene family or the complete genome (JANSEN et al. 1999; KAMATH et al. 2003). The
most common way to study a gene’s function is by inactivating that gene. However, a gene’s
function can also be determined by overexpression or expression pattern studies. Most
powerful is naturally a combination of these methods.
Stable gene knockouts
It is possible to obtain stable gene knockouts by several methods. Gene disruption by
homologous recombination with transgenic DNA is feasible (BROVERMAN et al. 1993; E.
Berezikov and R. Plasterk, personal communication), but is not yet used routinely. A standard
method to knockout genes is target-selected gene inactivation: animals are randomly
mutagenized and subsequently animals are searched that are mutated in the gene of interest.
The first reports of target-selected gene inactivation in C. elegans made use of transposon
insertional mutagenesis (RUSHFORTH et al. 1993; ZWAAL et al. 1993). Zwaal et al. constructed
a frozen library of nematodes mutagenized by transposon insertion, from which insertion
mutants in genes of interest can be found using PCR with one primer corresponding to the end
of the transposon and another corresponding to the gene of interest. Since most transposon
insertion do not (completely) knockout the gene of interest, because they are in an intron or
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spliced out of the exon (RUSHFORTH and ANDERSON 1996), a deletion derivative, which
occurs by imprecise excision, has to be obtained for a guaranteed null allele (ZWAAL et al.
1993).
A more direct approach for deleting a gene of interest makes use of a library of
chemically mutagenized nematodes (JANSEN  et al. 1997). A subset of the mutations
introduced by the chemical mutagen are random deletions that remove a significant amount of
DNA. A deletion in the gene of interest can be visualized with PCR. Recently, it has also
become possible to search for specific mutations in a gene of interest using a library of
chemically mutagenized nematodes (E. Cuppen and R. Plasterk, personal communication).
The mutations in the gene of interest are detected by resequencing that gene. This method has
already been used succesfully for knocking out genes in zebrafish (WIENHOLDS et al. 2002).
RNA interference
Another method to generate gene knockouts, although transient and not stable, uses RNA
interference (RNAi) (FIRE et al. 1998). RNAi is the targeted experimental silencing of genes
through the introduction of double-stranded RNA (dsRNA) of target genes. The dsRNA of the
target gene triggers the sequence specific degradation of the mRNA of that target gene
(reviewed in (GRISHOK and MELLO 2002; TIJSTERMAN et al. 2002)). RNAi was first described
in C. elegans, but also works in other systems, such as plants and human cells (ELBASHIR et
al. 2001; WATERHOUSE et al. 1998). In C. elegans, dsRNA of the gene of interest can be
introduced by injection into the gonad or other tissues (FIRE et al. 1998), but also via the
animal’s food, either by feeding the animals bacteria that produce the dsRNA (TIMMONS et al.
2001; TIMMONS and FIRE 1998) or by soaking them in a dsRNA solution (TABARA et al.
1998). RNAi is particularly useful in performing genome-wide screens (reviewed in
(BARSTEAD 2001)). Recently, a reusable library of bacterial clones that express double-
stranded RNA of almost all predicted genes of C. elegans has been constructed (FRASER et al.
2000; KAMATH et al. 2003). This library is fed to wild type Bristol N2 animals to assign
functions to as much genes as possible (KAMATH et al. 2003). To increase the number of
genes with an RNAi phenotype, rrf-3 mutants, which are hypersensitive to RNAi (SIMMER et
al. 2002), have been fed to this library as well (SIMMER et al. in preparation). Disadvantages
of RNAi are that the effect of RNAi is transient and variable, that a gene is often not
completely knocked out and that a fraction of genes cannot be targeted at all by this method
(FRASER et al. 2000).
Signal transduction pathways in C. elegans
The dissection of the RAS signalling pathway illustrates the usefulness of C. elegans genetics
in studying signal transduction. Other conserved signal transduction pathways have been
examined in C. elegans as well and these studies have provided new insights into the
molecular components and mechanisms of these pathways. A few examples of signal
transduction pathways extensively studied in C. elegans are given below.
Heterotrimeric G protein signalling
Heterotrimeric G proteins are signal-transducing molecules that are found in all eukaryotes.
They consist of a Ga-subunit, which contains a guanine nucleotide binding site and intrinsic
GTPase activity, and a tightly associated bg-subunit complex (reviewed in (RENS-DOMIANO
and HAMM 1995)). They act as molecular switches that alternate between active and inactive
forms. In the inactive state, the Ga-subunit is associated with a GDP molecule and is in
complex with the Gbg-subunit. Both the a- and the bg-subunit are anchored to the plasma
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membrane through lipid modifications (reviewed in (CHEN and MANNING 2001)). They
connect G protein-coupled receptors, which have seven transmembrane-spanning domains, to
intracellular signalling pathways. The seven-transmembrane receptors constitute the largest
and most ubiquitous family of membrane receptors, and recently it has become clear that,
besides coupling to the G proteins, they also couple to other signal transduction pathways
(reviewed in (PIERCE et al. 2002)).
Binding of a specific ligand, such as a hormone or neurotransmitter, to the G protein-
coupled receptor opens the guanine nucleotide-binding site of Ga and GDP is replaced by
GTP, which is present at much higher concentrations in the cell. Subsequently, the Ga and the
Gbg-subunit dissociate, and both have signalling functions and interact with specific
downstream targets in the cell. Examples of downstream effectors are adenylyl cyclases,
phospholipases, phosphodiesterases, tyrosine kinases and ion channels (reviewed in (NEVES et
al. 2002; RADHIKA and DHANASEKARAN 2001)). The activation or deactivation of these
downstream effectors results in alterations in the levels of intracellular second messengers,
such as cAMP, inositol trisphosphate (IP3), diacylglycerol (DAG) and Ca2+, which in their
turn transmit the signal by regulating the activities of other enzymes. The original signal is
often enormously amplified, because one G protein-coupled receptor can activate multiple G
proteins and every G protein can regulate several downstream effectors. In this way, many
biological processes, including embryonic development, cell growth and differentiation,
learning and memory, and neurotransmission, are being controlled (DHANASEKARAN et al.
1998; OFFERMANNS and SIMON 1998; RADHIKA and DHANASEKARAN 2001).
To end the activation state, the intrinsic GTPase activity of the Ga-subunit hydrolyses
the bound GTP back to GDP. Following, the Ga- and Gbg-subunit reassociate to the inactive
heterotrimeric complex. Regulators of G protein signalling (RGS) proteins facilitate the
inactivation of Ga-subunits by accelerating GTP hydrolysis, and probably provide an
additional mechanism by which cells can integrate multiple incoming signals (reviewed in
(ROSS and WILKIE 2000)). Signalling of the ligand-bound G protein-coupled receptor is
terminated  by phosphorylation and binding of arrestin (reviewed in (PIERCE and LEFKOWITZ
2001)).
In mammals, there are currently 20 Ga-, 6 Gb- and 11 Gg-subunits known (HAMM
1998). Based on sequence similarity, the Ga-subunits have been divided into four families,
Gas, Gai/o, Gaq/11 and Ga12/13. Ga-subunits within a class usually couple to similar receptors
and effectors. The Gas family of proteins signals via adenylyl cyclases, thereby producing the
second messenger cAMP. cAMP is known to activate several targets, including protein kinase
A (PKA), cyclic nucleotide-gated ion channels and the exchange factor for the small GTPase
Rap1 (EPAC) (reviewed in (CHIN et al. 2002)). Gaq/11 proteins activate phospholipase Cb to
produce IP3 and DAG (reviewed in (RHEE 2001)). IP3 is involved in the release of calcium
from intracellular stores and DAG activates protein kinase C (PKC) by recruiting it to the
membrane. In the Ga i/o pathway, both Ga and Gbg are known to signal to downstream
effectors (reviewed in (ALBERT and ROBILLARD 2002)). An important role of Ga i/o is to
inhibit adenylyl cyclase molecules. Recently, it has been demonstrated that Ga i/o is also
involved in the direct stimulation of certain tyrosine kinases (MA et al. 2000). The Ga12/13
pathway is the most poorly understood heterotrimeric G protein pathway. Some recent reports
revealed a number of direct downstream targets of Ga12/13, including a RasGAP, Bruton´s
tyrosine kinase and cadherins, but it is not known in which physiological response these
effectors are involved (JIANG et al. 1998; MEIGS et al. 2001).
In C. elegans, there are 21 Ga- (gpa-1–17, egl-30, goa-1, gsa-1, and odr-3), 2 Gb-
(gpb-1 and gpb-2) and 2Gg-subunit genes (gpc-1 and gpc-2) (C. ELEGANS SEQUENCING
CONSORTIUM 1998). Sequence alignment of the Ga-subunits showed that there is one clear
homologue for each of the four mammalian classes of Ga-subunits: goa-1 (Gai/o), gsa-1
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(Gas), egl-30 (Gaq/11) and gpa-12 (Ga12/13) (JANSEN et al. 1999). The other 17 Ga-subunits
cannot be classified in one of the mammalian classes and are considered to be an outgroup of
new Ga genes (JANSEN et al. 1999). The conserved Ga-subunits are broadly expressed and
are involved in multiple behaviours, whereas most new Ga-subunits are only expressed in a
few neurons in the head and specifically act in perception (reviewed in (WILKIE 1999). Below,
a detailed description of signalling via conserved and new Ga-subunits of C. elegans is given.
Gb and Gg signalling pathways are described as well.
The C. elegans homologue of Gas, GSA-1, signals via the adenylyl cyclases SGS-1 and ACY-2
The Gas gene of C. elegans, gsa-1, encodes a protein that is 66% identical to mammalian Gas
(PARK et al. 1997). Expression pattern studies revealed that gsa-1 is expressed throughout the
nervous system and in muscle cells (KORSWAGEN et al. 1997). Loss of gsa-1 results in
lethality at the first stage of larval development, showing that gsa-1 is an essential gene
(KORSWAGEN et al. 1997). The lethal phenotype of gsa-1 mutants is identical to the zygotic
null phenotype of the Gb-subunit gene gpb-1 and to the lethal phenotype of animals in which
the canal-associated neurons (CAN) have been cell-specifically ablated (ZWAAL et al. 1996; J.
Sulston, personal communication). This suggests that GSA-1 together with GPB-1 performs
an essential function in the CAN cells. Additional proof for this hypothesis came from studies
on the adenylyl cyclase gene acy-2. Adenylyl cyclases convert ATP into the second
messenger cAMP and are known to be downstream targets of Gas proteins in mammals and
several other organisms. acy-2 is specifically expressed in the CAN cells and loss of acy-2
results in an early larval lethal phenotype that is similar to the phenotype of gsa-1 and gpb-1
null mutants (KORSWAGEN et al. 1998). These results strongly suggest that the adenylyl
cyclase ACY-2 is a downstream target of GSA-1 in the CAN cells.
Another adenylyl cyclase protein that acts downstream of GSA-1 is SGS-1 (or ACY-
1). Like acy-2, sgs-1 is an essential gene (MOORMAN and PLASTERK 2002, Chapter 2 of this
thesis). However, the phenotype of sgs-1 null mutants, larval arrest, does not resemble the null
phenotype of gsa-1 or acy-2. sgs-1 is more broadly expressed than acy-2, with expression in
motor neurons, vulva muscle cells and body-wall muscle cells (KORSWAGEN et al. 1998).
Evidence for the activation of SGS-1 by GSA-1 came from studies using overexpression of
constitutively active GSA-1. This constitutively active GSA-1 was constructed by changing a
glutamine at position 208 (Q) to a leucine (L), a mutation that is analogous to the activating
Q227L mutation in human Gas, which is found in certain pituitary and thyroid malignancies
(LANDIS et al. 1989; LYONS et al. 1990) and endocrine disorders (IIRI et al. 1994; SHENKER et
al. 1993). The amino-acid change disrupts the GTPase activity of Gas and locks the protein in
the active GTP-bound state. Overexpression of constitutively active GSA-1 results in
hypercontraction of body-wall muscle cells and in swelling and vacuolization of ventral nerve
cord motoneurons and neurons located in head and tail ganglia (BERGER et al. 1998;
KORSWAGEN et al. 1997). Screens for suppressors of the activated GSA-1-induced neuronal
degeneration identified mutations in the adenylyl cyclase gene sgs-1, thereby establishing a
functional relationship between GSA-1 and SGS-1 (BERGER et al. 1998; KORSWAGEN et al.
1998). The mutations in sgs-1 isolated in the suppressor screens were all reduction-of-
function mutations; complete loss-of-function of sgs-1 results in larval arrest (MOORMAN and
PLASTERK 2002), and would therefore not be isolated in a suppressor screen. However, direct
testing of sgs-1 knockout animals revealed that these animals also suppress the neuronal
degeneration phenotype.
The neuronal degeneration induced by signalling of activated GSA-1 to SGS-1 is
morphologically distinct from programmed cell death and is not dependent on genes involved
in apoptosis (BERGER et al. 1998; KORSWAGEN et al. 1997). However, the neuronal
degeneration is similar to the necrotic cell death observed in deg-1, deg-3 and mec-4 ion
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channel mutants of C. elegans (CHALFIE and WOLINSKY 1990; DRISCOLL and CHALFIE 1991;
TREININ and CHALFIE 1995). The degenerins deg-1 and mec-4 encode proteins that are similar
to subunits of the amiloride-sensitive Na+ channel (HONG and DRISCOLL 1994; HUANG and
CHALFIE 1994). deg-3 encodes an acetylcholine receptor channel subunit (TREININ and
CHALFIE 1995). In the deg-1, deg-3 and mec-4 mutants, ion channels are thought to be
hyperactivated, causing excess ion influx that is ultimately toxic. In humans, a similar
mechanism is thought to be involved in the excitotoxic neuronal cell death observed in
neurodegenerative disorders and stroke: hyperactivation of glutamate-gated ion channels
results in increased ion influx and ultimately in cell death (COYLE and PUTTFARCKEN 1993).
This suggests that ion channels might also be hyperactivated in activated GSA-1 animals.
Recently, it has been shown that null mutations in calreticulin (CRT-1), which is a Ca2+
binding/storing protein predominantly found in the endoplasmic reticulum (ER), suppress the
necrotic cell death induced in deg-1 and mec-4, but not deg-3, mutants or by activated Gas
(XU et al. 2001). This suggests that DEG-1, MEC-4 and Gas signal directly or indirectly to
calreticulin to induce neuronal degeneration. In addition to calreticulin, three other genes
involved in regulation of intracellular Ca2+ levels, cnx-1, itr-1 and unc-68, are thought to
function in necrotic cell death (XU et al. 2001). itr-1 and unc-68 encode ER Ca2+ release
channels, and cnx-1 encodes an ER calcium binding chaperone calnexin homolog (DAL
SANTO et al. 1999; MARYON et al. 1996; XU et al. 2001). In deg-1 and mec-4 animals,
elevated Na+ concentrations caused by hyperactivation of Na+ channels probably signal to
calreticulin (XU et al. 2001). Possibly, GSA-1 also signals to calreticulin via hyperactivation
of Na+ channels, but GSA-1 might also activate calreticulin via a more direct mechanism.
SGS-1 is likely to be the first downstream target of GSA-1 in both cases. The suppression of
the activated Gas-induced neuronal degeneration by crt-1 null mutation is partial (XU et al.
2001), in contrast to the complete suppression by sgs-1 mutation (BERGER et al. 1998;
KORSWAGEN et al. 1997). Therefore, it is likely that signalling of GSA-1 to SGS-1 also
induces neuronal degeneration via other mechanisms.
Activation of calreticulin results in release of Ca2+ from the ER and thus in elevated
Ca2+ levels in the cell (XU et al. 2001). A recent report demonstrated that specific aspartyl and
calpain proteases are required for necrotic cell death in C. elegans (SYNTICHAKI et al. 2002).
At least two calpain proteases, CLP-1 and TRA-3, and two aspartyl proteases, ASP-3 and
ASP-4, are redundantly involved in the induction of neuronal degeneration caused by
activated Gas or mutations in deg-1, deg-3 and mec-4 (SYNTICHAKI et al. 2002). An increase
in Ca2+ concentration in the cell probably activates CLP-1 and TRA-3, which in turn activate
the aspartyl proteases ASP-3 and ASP-4 that execute cell death. Thus, an attractive model for
induction of neuronal degeneration is that elevated Ca2+ concentrations induced by calreticulin
in deg-1, mec-4 and activated Gas animals activate the calpain/aspartyl protease pathway to
destroy the cell (Figure 2). In deg-3 mutants, hyperactivation of the acetylcholine receptor
channel subunit DEG-3 probably directly increases the Ca2+ concentrations in the cell via
increased calcium influx (XU et al. 2001). In this way, the calpain/aspartyl protease pathway
is activated in deg-3 mutants as well.
Other components acting in the Ga s–induced neuronal degeneration could be
uncovered by cloning of additional suppressors of the neuronal degeneration phenotype.
Unfortunately, besides sgs-1, only one other locus, nxf-1 (or sgs-2), was found to suppress the
Gas–induced neuronal degeneration when mutated in our suppressor screens (Chapter 3 of
this thesis). nxf-1 encodes a nuclear export factor that is required for the nuclear export of
poly(A)-containing mRNAs (TAN et al. 2000). Mutations in nxf-1 probably affect the export
of activated Gas mRNA, and are therefore examples of suppressor mutations that alter the
amount of mutant protein, but do not affect the process of interest (i.e. Gas-induced
signalling).
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Overexpression of wild type GSA-1 results in hyperactive locomotion and egg-laying,
whereas partial (mosaic) loss of GSA-1 results in reduced locomotion and egg-laying
(KORSWAGEN et al. 1997). This indicates that Gas is involved in modulating these behaviours.
Loss or reduction of SGS-1 function also results in reduced locomotion, and it was shown that
Gas likely functions together with SGS-1 to regulate this behaviour (MOORMAN and
PLASTERK 2002). It is not known whether the Gas-SGS-1 pathway acts in motor neurons, in
body-wall muscle cells or in both.
Figure 2. Model for
induction of neuronal
degeneration in C. elegans.
Hyperactivation of MEC-
4, DEG-3 or GSA-1 results
in increase in intracellular
Ca2+ levels. In the case of
the hyperactivated DEG-3
(DEG-3(D)), Ca2+ levels
are increased via elevated
Ca2+ influx. In the case of
the hyperactivated MEC-4
(MEC-4(D)) influx of Na+
results in release of Ca2+
from stores in the
endoplasmic reticulum
(ER). Activated GSA-1
(GasQL) signals to SGS-1,
which may induce Ca2+ release from the ER via hyperactivation of ion channels or by a more direct
mechanism. The increase in intracellular Ca2+ levels is sensed by calpains, which activate a specific set
of aspartyl proteases to execute cell death. Adapted from (SYNTICHAKI et al. 2002; XU et al. 2001).
Heterotrimeric G proteins control positioning of the mitotic spindle in C. elegans
Asymmetric cell division, the process producing two different daughter cells, is critically
important in the generation of cell diversity (reviewed in (WODARZ 2002)). In this process, the
cell must first set up an axis of polarity. Second, cytoplasmic components are asymmetrically
distributed to one of the two poles. Finally, the mitotic spindle is oriented along the axis of
polarity. In C. elegans, cell division planes follow an invariant pattern, thereby resulting in the
fixed position of embryonic cells. One component that is involved in establishing different
patterns of cell division is the Gb-subunit GPB-1 (ZWAAL et al. 1996). As already notified
above, a gpb-1 knockout shows a larval lethal phenotype when maternal GPB-1 is present. In
embryos without maternally supplied GPB-1, which are obtained from transgenically rescued
homozygous mothers with little or no expression in the germline, spindle orientations in early
cell divisions are randomized. This results in abnormal cell positions in these embryos and in
embryonic lethality (ZWAAL et al. 1996). A practical method to study maternal genes is
RNAi, because this technique degrades both maternally and zygotically supplied mRNAs.
Indeed, in gpb-1(RNAi) embryos, spindle orientations are incorrect (GOTTA and AHRINGER
2001). It was shown that GPB-1 is important in regulating centrosome migration around the
nucleus and thus in orienting the mitotic spindle. GPB-1 is not required for embryonic
polarity of embryos. The Gg-subunit that acts together with GPB-1 in controlling spindle
orientation is GPC-2, because RNAi against GPC-2 but not GPC-1 results in spindle
orientation defects that are identical to those in gpb-1 mutants (GOTTA and AHRINGER 2001).
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None of the single Ga-subunit knockouts showed fully penetrant spindle orientation
defects (JANSEN et al. 1999), indicating that GPB-1 and GPC-2 might act together with
redundant Ga-subunits. Both goa-1, which encodes a homologue of human Gao (MENDEL et
al. 1995; SEGALAT et al. 1995), and gpa-16, which falls in the group of new Ga-subunits
(JANSEN et al. 1999), mutants show a low percentage of embryonic lethality, indicating that
these two Ga-subunits might have redundant functions (GOTTA and AHRINGER 2001; MILLER
et al. 2000). Indeed, a goa-1 gpa-16 double knockout shows 100% embryonic lethality and
incorrect spindle orientations. RNAi against both GOA-1 and GPA-16 resulted in 100%
embryonic lethality as well (GOTTA and AHRINGER 2001). This indicates that GOA-1 and
GPA-16 are the functionally redundant partners of GPB-1 and GPC-2.
Inactivation of GOA-1 and GPA-16 does not only lead to loss of Ga signalling, but
also to constitutive activation of Gbg. Comparison of goa-1(RNAi)  gpa-16(RNAi) embryos,
which have Gbg signalling, with goa-1(RNAi) gpa-16(RNAi) gpb-1(RNAi) embryos, which
have neither Ga nor Gbg signalling, revealed that Ga and Gbg are involved in separate
processes (GOTTA and AHRINGER 2001). Whereas the Gbg-subunit is involved in regulating
centrosome migration, GOA-1 and GPA-16 are required for correct behaviour and
morphology of the mitotic spindle in the one-cell embryo. Without the Ga-subunits, the
position of the mitotic spindle in the cell was symmetric instead of asymmetric (GOTTA and
AHRINGER 2001).
A component that probably plays a role in the GOA-1/GPA-16 pathway that controls
mitotic spindle orientation is the novel protein RIC-8 (MILLER and RAND 2000). RIC-8 is, like
GOA-1, involved in a signalling network that regulates neurotransmitter release in C. elegans
(MILLER et al. 2000). ric-8 reduction-of-function mutants exhibit a low percentage of
embryonic lethality that is dramatically increased in embryos derived from a goa-1/+; ric-
8/ric-8 parent (MILLER and RAND 2000). In these embryos, the position of the spindle was
often more symmetric than in wild type embryos, a phenotype that is associated with loss of
GOA-1/GPA-16 signalling.
What is the mechanism by which the heterotrimeric G proteins regulate spindle
orientation in C. elegans? Recent experiments in Drosophila and C. elegans start to give
insight in this process (SCHAEFER  et al. 2001; M. Gotta and J. Ahringer, personal
communication). Probably, the G proteins are activated by the PAR proteins, which are
asymmetrically distributed in the cell, via proteins with GoLoco domains (PINS in
Drosophila and AGS-3.2 and AGS-3.3 in C. elegans). Subsequently, the G proteins are
thought to translate cell polarity into spindle position. In mammals, heterotrimeric G proteins
are not known to be involved in asymmetric cell division yet, but a mammalian homologue of
PINS is required for mitotic spindle organization (DU et al. 2001), suggesting that the role of
heterotrimeric G proteins in asymmetric cell divisions is conserved.
A complex signalling network involving heterotrimeric G proteins controls locomotion in C.
elegans
Recent genetic experiments show that a complex signalling network is involved in regulating
the release of acetylcholine at the neuromuscular junction and thereby in modulating
behaviours in C. elegans (Figure 3). Two key components in this signalling network are the
homologue of mammalian Gao, goa-1, and the Ga q homologue of C. elegans, egl-30.
Activation of GOA-1 probably negatively regulates EGL-30 (HAJDU-CRONIN et al. 1999;
MILLER et al. 1999). Both forward and reverse genetics have been used to elucidate this
signalling network, as described below.
Animals lacking goa-1 show hyperactive movement, premature egg-laying, inadequate
male mating and hypersensitivity to the acetylcholinesterase inhibitor aldicarb (MENDEL et al.
1995; MILLER et al. 1999; SEGALAT et al. 1995). Aldicarb causes toxic accumulation of
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secreted acetylcholine at the neuromuscular junction. The hypersensitivity of goa-1 mutants to
aldicarb suggests that GOA-1 is normally involved in decreasing acetylcholine release at the
synapse, which is also consistent with the hyperactive locomotion of goa-1 mutants. GOA-1
is activated by serotonin, since loss-of-function mutations in goa-1 confer resistance to
serotonin-induced inhibition of locomotion (NURRISH et al. 1999; SEGALAT et al. 1995). In
addition, GOA-1 is thought to be activated by UNC-43, a Calcium/Calmodulin-dependent
protein kinase II (CaMKII). Possibly, UNC-43 directly regulates GOA-1 by phosporylation
(ROBATZEK and THOMAS 2000). A Calcium/Calmodulin-dependent protein phosphatase,
calcineurin, probably antagonizes UNC-43 signalling to GOA-1 (BANDYOPADHYAY et al.
2002). Overexpression or constitutive activation of GOA-1 results in paralysis and defective
egg-laying and feeding (MENDEL et al. 1995; SEGALAT et al. 1995). The expression pattern of
goa-1 is consistent with these phenotypes: goa-1 is expressed in most neurons and in the
muscles involved in egg-laying, pharyngeal pumping and male mating behaviour.
Mutations in egl-30 were first identified in a screen for egg-laying defective mutants
(TRENT et al. 1983). In addition to the egg-laying defect, egl-30 mutants show reduced
locomotion, decreased pharyngeal pumping rates and resistance to aldicarb (MILLER et al.
1996; TRENT et al. 1983). Brundage et al. showed that egl-30 mutants have mutations in the
Figure 3. Model for acetylcholine release at the neuromuscular junction of C. elegans by a
complex heterotrimeric G protein network. The molecules and steps in this signal transduction
network are discussed in the text. Calcineurin functions as a heterodimeric protein, consisting of CNA-
1 and CNB-1. Adapted from (VAN DER LINDEN et al. 2001).
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Gaq homologue of C. elegans (BRUNDAGE et al. 1996). Strong egl-30 alleles are lethal,
because of severly reduced muscle activity (BRUNDAGE et al. 1996). egl-30 is expressed in
both the nervous system and in muscle cells (LACKNER et al. 1999). Overexpression of EGL-
30 results in hyperactive locomotion and egg-laying (BRUNDAGE et al. 1996). Specific
overexpression of EGL-30 in the motor neurons is sufficient to induce hyperactive
locomotion, indicating that EGL-30 acts in motor neurons to regulate locomotion (LACKNER
et al. 1999). Because egl-30 mutants are resistant to aldicarb, EGL-30 is thought to increase
acetylcholine release at the synapse (MILLER et al. 1996). egl-30 mutations suppress
hypersensitivity to muscarinic agonists, indicating that EGL-30 is activated by muscarinic
agonists (BRUNDAGE et al. 1996). A forward genetic screen, which was performed to find
genes with phenotypes similar to reduction-of-function mutants in egl-30 when mutated,
identified, among others, egl-8 as a potential downstream target of egl-30 in acetylcholine
release (MILLER et al. 1999). egl-8 encodes a phospholipase Cb (PLCb) homologue.
Phospholipase Cb is a known direct target of mammalian Gaq, and thus it is likely that the C.
elegans Gaq EGL-30 directly activates EGL-8. This hypothesis is further supported by
biochemical experiments that showed that EGL-30 can activate phospholipase Cb in cultured
cells (BRUNDAGE et al. 1996). However, EGL-8 is probably not the only downstream target of
EGL-30, since egl-30 loss-of-function mutants have more severe defects than egl-8 loss-of-
function mutants (MILLER et al. 1999). Phospholipase Cb cleaves phosphatidylinositol 4,5-
biphospate (PIP2) into the signalling molecules diacylglycerol (DAG) and inositol 1,4,5-
triphsophate (IP3). Treatment of wild type animals with analogs of DAG, phorbol esters,
resulted in increased sensitivity to aldicarb, indicating that DAG positively regulates
acetylcholine release at the neuromuscular junction (LACKNER et al. 1999; MILLER et al.
1999). The regulation of acetylcholine release by DAG is in part mediated by the DAG-
binding protein UNC-13 (LACKNER et al. 1999; NURRISH et al. 1999). UNC-13 primes
synaptic vesicles for fusion at the neuromuscular junction by promoting the open form of the
SNARE complex protein syntaxin (RICHMOND et al. 2001). Thus, EGL-30 stimulates
acetylcholine release by activating EGL-8, which stimulates UNC-13 via production of DAG.
However, UNC-13 is probably not the only protein that is stimulated by EGL-30 to regulate
acetylcholine release at the synapse (LACKNER et al. 1999).
Mutations in egl-10 also confer phenotypes similar to egl-30 mutants (KOELLE and
HORVITZ 1996; MILLER et al. 1999). egl-10 encodes a regulator of G protein signalling (RGS)
protein (KOELLE and HORVITZ 1996). RGS proteins accelerate the slow intrinsic GTPase
activity of Ga-subunits and are therefore able to inhibit Ga signalling. Epistatic analysis
indicated that EGL-10 acts as a negative regulator of GOA-1 (KOELLE and HORVITZ 1996). In
total, 13 RGS proteins are found in C. elegans, and two other RGS proteins, RGS-1 and RGS-
2, act on GOA-1 (DONG et al. 2000). RGS-1 and RGS-2 appear to be redundantly involved in
egg-laying in response to food, but not in locomotion (DONG et al. 2000).
Another RGS protein that is involved in the signalling network regulating
acetylcholine release is EAT-16 (HAJDU-CRONIN et al. 1999). eat-16 was originally isolated
in a screen for defects in pharyngeal pumping (AVERY 1993). Screens for suppressors of the
paralysis induced by overexpression of constitutively active GOA-1 revealed that mutations in
eat-16 restore locomotion (HAJDU-CRONIN et al. 1999). Without expression of activated
GOA-1, eat-16 mutations give phenotypes similar to that of goa-1 loss-of-function mutations.
Because the constitutively active GOA-1 that is used in the suppressor screen is locked in the
GTP-bound state and thus insensitive to RGS proteins, it is not likely that GOA-1 is the target
of EAT-16. Indeed, further genetic and biochemical experiments showed that EAT-16 does
not regulate GOA-1, but rather acts downstream of GOA-1 and is involved in inhibiting the
Gaq homologue EGL-30 (HAJDU-CRONIN et al. 1999). This is consistent with the epistatic
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analysis of goa-1 egl-30 double mutants that showed that EGL-30 functions downstream of or
in parallel to GOA-1 (HAJDU-CRONIN et al. 1999; MILLER et al. 1999).
Both EGL-10 and EAT-16 have, besides an RGS domain, a Gg-like (GGL) domain
and a conserved N-terminal region. It was shown that a divergent Gb-subunit in mammals,
Gb5, can interact with GGL domains (SNOW et al. 1998). In C. elegans, GPB-2 is the closest
homologue of Gb5. Loss of gpb-2 results in animals that have delayed egg-laying and reduced
pharyngeal pumping (CHASE et al. 2001; ROBATZEK et al. 2001; VAN DER LINDEN et al. 2001).
This phenotype is similar to the phenotype of an egl-10 eat-16 double knockout, indicating
that GPB-2 may interact with both EAT-16 and EGL-10. Yeast-two hybrid analysis showed
that indeed GPB-2, like GPB-1, could physically interact with the GGL domain of both EGL-
10 and EAT-16 (VAN DER LINDEN et al. 2001). Recently, it has been proposed that GPB-2
cannot only bind to the GGL domain but also to the N-terminal region of EGL-10 and EAT-
16. GPB-2 thereby makes a noncovalent interaction between the N-terminal region and the
GGL/RGS domains of these RGS proteins (PATIKOGLOU and KOELLE 2002). The N-terminal
region is involved in Ga-binding specificity and may serve as a membrane anchor for EGL-
10 and EAT-16. Thus, GPB-2 directly interacts with the RGS proteins EGL-10 and EAT-16,
and is in this way able to inhibit both GOA-1 and EGL-30 signalling.
 Mutations in the diacylglycerol kinase dgk-1 (or sag-1) suppress the paralysis induced
by activated GOA-1, indicating that dgk-1 acts downstream of or in parallel to goa-1 (HAJDU-
CRONIN et al. 1999; NURRISH et al. 1999). Diacylglycerol (DAG) kinases phosphorylate DAG
to produce phosphatidic acid, thereby decreasing DAG levels. In a wild type background, dgk-
1 mutants show hyperactive locomotion, premature egg-laying and hypersensitivity to
aldicarb (MILLER et al. 1999; NURRISH et al. 1999). In addition, dgk-1 mutations suppress the
inhibition of locomotion induced by serotonin (NURRISH et al. 1999). These data suggest that
DGK-1 normally functions to decrease acetylcholine release at the synapse by reducing DAG
levels. A dgk-1 egl-30 double mutant exhibits phenotypes that were in between that of either
single mutant (MILLER et al. 1999). This is different from a goa-1 egl-30 double mutant that
showed an egl-30 phenotype (HAJDU-CRONIN et al. 1999; MILLER et al. 1999). Probably,
EGL-30 and DGK-1 do not act in a linear pathway, but rather antagonistically.
Another gene that is thought to be involved in regulating acetylcholine release is ric-8
(MILLER et al. 2000; MILLER et al. 1999). ric-8 mutants have phenotypes similar to egl-30
mutants. ric-8 encodes a novel conserved protein that acts upstream of EGL-30 or in a parallel
intersecting pathway (MILLER et al. 2000). However, it is not know what its exact function is
in regulating acetylcholine release. Screens to identify mutations that suppress the paralyzed
phenotype of ric-8 mutants revealed that dominant mutations in gsa-1 and sgs-1 strongly
suppress the ric-8 mutant phenotype (N. Reynolds and K. Miller, personal communication). In
addition, reduction-of-function mutations in a regulatory subunit of protein kinase A, kin-2,
were found. These mutations probably constitutively activate KIN-1, which is the catalytic
subunit of protein kinase A. In a wild type background, these mutations result in hyperactive
locomotion and hypersensitivity to aldicarb, suggesting that GSA-1, SGS-1 and KIN-1 act
presynaptically to increase acetylcholine release. Previously, it was already shown that Gas
regulates locomotion via signalling to the adenylyl cyclase SGS-1 (MOORMAN and PLASTERK
2002). An sgs-1 goa-1 double knockout mutant confers an sgs-1 mutant phenotype (i.e.
strongly reduced locomotion), indicating that the Gas-SGS-1 pathway acts downstream or in
parallel to the GOA-1 pathway (C. Moorman and R. Plasterk, unpublished observation).
Further analyses should reveal where GSA-1, SGS-1 and KIN-1 exactly function in the
acetylcholine release pathway.
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Heterotrimeric G proteins are involved in chemosensation and adaptation in C. elegans
C. elegans normally lives in the soil, where it has to seek food on the one hand and avoid
toxic compounds on the other hand. C. elegans receives most information about its
environment through detection of chemicals, so-called chemosensation (reviewed in
(BARGMANN and MORI 1997; MORI 1999)). C. elegans can detect both volatile chemicals and
water-soluble chemicals. Certain chemicals are attractive to C. elegans, resulting in
chemotaxis towards that chemical; other chemicals are repulsive, resulting in avoidance of
that chemical. Thus, chemosensation allows C. elegans to respond to its environment by
regulating its locomotory behaviour. Other behaviours that can be modulated via detection of
chemicals are egg-laying, feeding and male-mating. In addition, chemosensation is implicated
in the regulation of larval development. C. elegans can enter an alternative larval stage, the
dauer stage, that is specialized to survive severe environmental conditions (CASSADA and
RUSSELL 1975). High temperature, insufficient food and high nematode density are important
regulators of dauer formation. Animals determine nematode density in an early larval stage by
chemosensation of dauer-inducing pheromone, which is continuously excreted by nematodes,
and enter the dauer stage if pheromone levels are high. When dauer larvae are returned to
better circumstances, they can form normal fertile adults.
Chemosensory neurons are required to detect chemicals. In C. elegans, eleven classes
of neurons are predicted to be chemosensory, because their endings are exposed to the
environment through specialized sensory cilia. These chemosensory neurons are located in
two bilaterally symmetric sensory organs in the head, called the amphids, in six inner labial
sensory organs and in two bilaterally symmetric sensory organs in the tail, called the
phasmids. Specific killing of neurons with laser ablation revealed functions for 11 pairs of
sensory neurons in the amphids (reviewed in (TROEMEL 1999)). They are involved in
chemosensation of volatile attractants (AWA, AWC) and repellents (ASH, AWB, ADL),
water-soluble attractants (ASE, ADF, ASG, ASI, ASK) and repellents (ASH, ADL) and the
dauer-inducing pheromone (ADF, ASG, ASI, ASJ). The ASH neurons also detect high
osmolarity and nose touch. Recently, the phasmid neurons have been shown to function as
chemosensory neurons as well; they respond to repellents (HILLIARD et al. 2002). Besides the
chemosensory neurons, two neurons involved in thermosensation, the AFD neurons, are
identified in the amphids.
Binding of the chemical to a receptor on the chemosensory neuron is the first step in
chemosensation. Cloning of odr-10, which shows defective chemotaxis towards diacetyl but
not other odorants when mutated, revealed that G protein-coupled seven transmembrane
domain receptors are involved in chemosensation in C. elegans (SENGUPTA et al. 1996). In
mammals, G protein-coupled receptors are also involved in recognition and transduction of
chemicals (RESSLER et al. 1993). Only one or a few receptors are thought to be expressed in a
mammalian olfactory neuron (reviewed in (RONNETT and MOON 2002). In C. elegans, the
family of G protein-coupled receptors is the largest gene family (reviewed in (TROEMEL
1999)). In total, approximately a thousand genes encoding G protein-coupled receptors genes
have been predicted, thus comprising about 5% of all C. elegans genes (BARGMANN 1998).
They fall into four subfamilies based on sequence similarity: the odr-10-like, sra, sro and srg
family. The odr-10-like family is subdivided into str, stl, srd and srh classes and the sra
family into sra, srb and sre groups. Expression pattern studies on several G-protein coupled
receptors revealed that all four subfamilies contain receptors that are expressed in
chemosensory neurons (TROEMEL et al. 1995). They are localized to the ciliary endings of
these neurons, probably to facilitate detection of chemicals in the environment. Based on the
expression pattern studies, it is predicted that about half of the thousand G protein-coupled
receptors in C. elegans are involved in detecting chemicals (TROEMEL 1999). Another class of
candidate chemosensory receptors are the guanylyl cyclases (reviewed in (GIBSON and
GARBERS 2000)). A number of guanylyl cyclase is expressed in cilia of chemosensory
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neurons in C. elegans, and are thus potential chemoreceptors (YU et al. 1997). However, not
all will act as chemoreceptors, since guanylyl cyclases can also be involved in signal
transduction, as has been shown for ODR-1 (L'ETOILE and BARGMANN 2000). Given the
expression pattern studies and the large number of (putative) chemosensory receptors, it is
probable that, unlike in mammals, multiple receptors act in the same pair of neurons in C.
elegans, which is in agreement with the observation that multiple odorants can be sensed by
the same neuron in C. elegans.
After binding of the chemical to the G protein-coupled receptor, it is likely that
heterotrimeric G proteins are activated and signal to downstream effectors in the
chemosensory neuron. Indeed, several genetic and molecular analyses indicate that
heterotrimeric G protein signalling is involved in chemosensation in a wide variety of
organisms (KRIEGER et al. 1999; PRASAD and REED 1999; RONNETT and MOON 2002). In C.
elegans, the Ga-subunit ODR-3, which falls in the group of new Ga-subunits, was found in a
forward genetic screen for animals that fail to be attracted to the odorant benzaldehyde. In
fact, ODR-3 is essential for responses to all odorants sensed by the AWA and AWC neurons
(ROAYAIE et al. 1998). In addition, ODR-3 is required for responses to high osmolarity and
nose touch, which are sensed by ASH. ODR-3 is expressed in AWA, AWC and ASH, and
localizes to the ciliary endings. This suggests that ODR-3 acts directly downstream of
chemosensory receptors in these cells. In addition to its role in chemosensation, odr-3 is also
involved in AWC cilium development (ROAYAIE et al. 1998).
Besides odr-3, 13 of the other new Ga-subunits are almost exclusively expressed in
the (putative) chemosensory neurons: gpa-1–6; gpa-8–11; and gpa-13–15 (JANSEN et al.
1999; ZWAAL et al. 1997). In most chemosensory neurons, multiple Ga-subunit genes are
expressed. Loss-of-function alleles of five new Ga-subunits, gpa-2, gpa-3, gpa-5, gpa-6 and
gpa-7, show defects in chemosensation, indicating that they play a role in chemosensation. In
addition, overexpression of four new Ga genes, gpa-1, gpa-4, gpa-10 and gpa-11, resulted in
chemosensation defects, indicating that these genes may also function in chemosensation
(JANSEN et al. 1999). Other new Ga genes expressed in chemosensory neurons might be
functionally redundant or might have negative regulatory roles. Of course, it is also possible
that these Ga-subunits are defective in sensing chemicals that have not been tested. Thus,
besides multiple G protein-coupled receptors, C. elegans also uses multiple Ga-subunits in
chemosensation. The reason for this is probably that C. elegans needs to distinguish a large
number of chemicals with only a few chemosensory neurons. Recently, genetic experiments
showed that the new Ga -subunits can have both stimulatory and inhibitory functions,
depending on the chemical, thereby further increasing the ability to discriminate between
different chemicals (G. Jansen, personal communication). Taken together, these results
suggest that multiple and distinct G protein signalling cascades mediate the sensing of and the
discrimination between chemicals in C. elegans.
One other G protein subunit is exclusively expressed in chemosensory neurons, GPC-1
(JANSEN et al. 2002). Loss-of-function of this Gg-subunit did not result in altered sensation of
several chemicals tested nor in defects in the development of sensory neurons. In addition,
overexpression of gpc-1 had no effect on these processes. In mammals, it has been proposed
that Gbg-subunits are involved in adaptation or desensitization of the G protein-coupled
receptor to a stimulus (reviewed in (PITCHER et al. 1998). C. elegans shows adaptation to both
volatile and water-soluble compounds, and assays have been developed to detect adaptation
defects (COLBERT and BARGMANN 1995; JANSEN et al. 2002). These assays showed that loss
of gpc-1 results in defective adaptation to several water-soluble chemicals, but not to volatile
chemicals (JANSEN et al. 2002). Thus, while gpc-1 is not essential for sensing water-soluble
chemicals, gpc-1 is required for the subsequent desensitization of the signal transduction
pathway used to detect these water-soluble chemicals.
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Protein Kinase signalling
Protein phosphorylation is one of the most widely used mechanisms for signal transduction in
eukaryotic cells. It is important for basic functions, including gene transcription, protein
translation and DNA replication, but also for more advanced functions, such as cell
differentiation, cell-cell communication and synaptic transmission. Protein kinases conduct
phosporylation of proteins and thereby regulate the activity of these proteins. Some protein
kinases transfer phosphate to serine or threonine residues, others phosphorylate tyrosine
residues. About 1.7% of all human genes constitute protein kinases (MANNING et al. 2002b).
Most protein kinases belong to a single superfamily that share a conserved kinase catalytic
domain. This superfamily can be further classified in groups, families and subfamilies
(HANKS and HUNTER 1995; MANNING et al. 2002b). Protein phosphatases can reverse the
phosporylations performed by protein kinases.
C. elegans has 411 full length protein kinases and 21 partial kinase fragments
(reviewed in (PLOWMAN et al. 1999)). The protein kinase gene family is thereby the second
largest gene family of C. elegans, comprising 2-3% of all C. elegans genes. Like in humans,
the C. elegans kinases can be further divided in groups, families and subfamilies (PLOWMAN
et al. 1999). Most kinases have homologues in other organisms, although there are also some
worm-specific protein kinase subfamilies (MANNING et al. 2002a; PLOWMAN et al. 1999).
Below, two conserved kinase families of C. elegans, the PKC family and the DYRK family,
are discussed in more detail.
The PKC family of protein kinases in C. elegans
The protein kinase C (PKC) family can be categorized into three subfamilies on the basis of
structural similarities and cofactor requirements: conventional PKC (cPKC), novel PKC
(nPKC) and atypical PKC (aPKC) (reviewed in (NEWTON 2001)). The cPKCs are dependent
on Ca2+ for their activation. In addition, they need diacylglycerol (DAG) to be activated. The
nPKCs also need DAG to be activated, but are not dependent on Ca2+. The aPKCs are
dependent on neither Ca2+ nor DAG for their activation. When activated, PKCs catalyse the
phosporylation of effector proteins at specific serine or threonine residues, thereby regulating
their functions. In C. elegans, four pkc genes have been identified, tpa-1, pkc-1, pkc-2 and
pkc-3 (reviewed in (TABUSE 2002)). TPA-1 and PKC-1 belong to the nPKCs, PKC-2 is a
cPKC and PKC-3 is an aPKC.
TPA-1 was first identified as a target of the tumor-promoting phorbol ester PMA
(phorbol 12-myristate 13-actetate; also known as 12-O-tetradecanoylphorbol-13-acetate,
TPA) (TABUSE et al. 1989). In C. elegans, PMA induces a developmental growth arrest and
uncoordinated locomotion. The developmental growth arrest is probably caused by a feeding
defect (VAN DER LINDEN et al. 2003, Chapter 4 of this thesis). Mutations in tpa-1 suppress the
developmental growth arrest induced by PMA. tpa-1 encodes two PKC isoforms, TPA-1A
and TPA-1B, which are most similar to nPKCq and d subunits (SANO et al. 1995). Both TPA-
1 isoforms share the C-terminal region, which includes the pseudosubstrate region, two
cysteine-rich C1 domains and the kinase domain. However, TPA-1B lacks an N-terminal
extension of 137 amino acid residues. The expression of tpa-1A and tpa-1B is controlled by
different promoters. tpa-1A is expressed in vulval muscle and epidermal cells and in a variety
of neurons (VAN DER LINDEN et al. 2003; WAGGONER et al. 2000). tpa-1B is expressed in
hypodermal cells and pharyngeal muscles (TABUSE 2002; VAN DER LINDEN et al. 2003). TPA-
1A probably plays a role in long-term adaptation of the vulval cells to nicotine (WAGGONER et
al. 2000). In addition, TPA-1A is required for the uncoordinated locomotion induced by PMA
(A. van der Linden and R. Plasterk, personal communication). Both TPA-1A and TPA-1B are
thought to be involved in the developmental growth arrest induced by PMA (VAN DER LINDEN
et al. 2003). Interestingly, both TPA-1 isoforms are also involved in the developmental
growth arrest induced by constitutively activated GPA-12 (VAN DER LINDEN et al. 2003).
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GPA-12 is the C. elegans homologue of the Ga 12/13 class of heterotrimeric G proteins.
Constitutively active mutations in mammalian Ga12/13-subunits can lead to the oncogenic
transformation of human cells (JIANG et al. 1993; XU et al. 1994). The finding that mutations
in tpa-1 suppress both the activated Ga12- and PMA-induced growth arrest together with other
genetic experiments suggests that in C. elegans activated Ga12 signals through PKC to induce
a developmental growth arrest, and that induction of this signaling pathway by Ga12 can be
bypassed by PMA (VAN DER LINDEN et al. 2003).
 The pkc-1 gene encodes two PKC isoforms, PKC-1A and PKC-1B (LAND et al.
1994b). PKC-1A contains an N-terminal extension of 56 amino acids compared to PKC-1B.
The function of these PKC isoforms has not yet been elucidated, although the expression
pattern of pkc-1B suggests that it has a neuronal function (LAND et al. 1994a). The pkc-2 gene
is predicted to encode six PKC isoforms (ISLAS-TREJO et al. 1997). The different isoforms
probably perform distinct functions, since they have cell- and developmental-stage specific
expression patterns.
The atypical PKC-3 protein plays an essential role in early embryogenesis (TABUSE et
al. 1998; WU et al. 1998). PKC-3 interacts with one of the PAR proteins, PAR-3. The PAR
proteins are involved in asymmetric cell division by establishing the anterior-posterior
polarity of zygotes (KEMPHUES and STROME 1997), and it was shown that PKC-3 is required
for establishing asymmetry in early embryos as well (TABUSE et al. 1998). Subsequently,
studies in other systems showed that the role of atypical PKCs in asymmetric cell divisions is
evolutionarily conserved (reviewed in (KNOBLICH 2001)).  It is not yet known how atypical
PKCs establish asymmetry, but in Drosophila an atypical PKC is required for the asymmetric
localization of Inscuteable (Insc) (WODARZ et al. 2000). Insc can bind the GoLoco domain
protein PINS, which can activate the G protein subunit Gai (reviewed in (KNUST 2001)). This
suggests that in C. elegans PKC-3 might also be involved in activation of heterotrimeric G
proteins.
The DYRK family of protein kinases in C. elegans
The DYRK kinases are dual specificity protein kinases that catalyse autophosporylation on
tyrosine residues as well as serine/threonine phosphorylation in other proteins (reviewed in
(BECKER et al. 1998)). In Drosophila, a member of the DYRK family, minibrain, is involved
in the generation of a proper number of neuronal cells in the central brain and optical lobe
during postembryonic neurogenesis (TEJEDOR et al. 1995). The mammalian dual-specificity
protein kinase DYRK1A is implicated in the cognitive defects of Down syndrome. Down
syndrome is caused by trisomy of chromosome 21 and results in mental retardation. The
DYRK1A locus maps to the Down syndrome candidate region and introduction of a 180-kb
region of human chromosome 21, which contains the DYRK1A locus but probably no other
genes, is sufficient to produce defects in learning and memory in transgenic mice (SHINDOH et
al. 1996; SMITH et al. 1997).
In C. elegans, three DYRK family members have been described, mbk-1, mbk-2 and
hpk-1. MBK-1 is the orthologue of human DYRK1A and overexpression of this gene was
shown to interfere with the acute function of olfactory neurons but not with the formation or
differentiation of these neurons (RAICH et al. 2003, Chapter 5 of this thesis). This suggests
that increased gene dosage of human DYRK1A in Down syndrome might disrupt the acute
function of neurons as well. mbk-1 knockout animals are viable and do not exhibit obvious
morphological abnormalities. A similar result is found for hpk-1 knockout animals. However,
animals homozygous for an mbk-2 knockout display 100% penetrant maternal effect
embryonic lethality, indicating that mbk-2 is essential for viability (RAICH et al. 2003).
Further analysis of the DYRK family in C. elegans could provide additional insights into the
role of this family in mental retardation.
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ABSTRACT
The sgs-1 (suppressor of activated Gs) gene encodes one of the four adenylyl cyclases in the nematode
C. elegans and is most similar to mammalian adenylyl cyclase type IX. We isolated a complete loss-
of-function mutation in sgs-1 and found it to result in animals with retarded development that arrest in
variable larval stages. sgs-1 mutant animals exhibit lethargic movement and pharyngeal pumping and
(while not reaching adulthood) have a mean life span that is 50% extended compared to wild type. An
extensive set of reduction-of-function mutations in sgs-1 was isolated in a screen for suppressors of a
neuronal degeneration phenotype induced by the expression of a constitutively active version of the
heterotrimeric Gs subunit of C. elegans. Although most of these mutations change conserved residues
within the catalytic domains of sgs-1, mutations in the less-conserved transmembrane domains are also
found. The sgs-1 reduction-of-function mutants are viable and have reduced locomotion rates, but do not
show defects in pharyngeal pumping or life span.
ADENYLYL cyclases convert intracellular adenosine malignancies (Landis et al. 1989; Lyons et al. 1990) andtriphosphate (ATP) into cyclic adenosine mono- endocrine disorders (Shenker et al. 1993; Iiri et al.
phosphate (cAMP), a major second messenger in the 1994). SGS-1 has significant sequence similarity to mam-
cell that regulates many cellular processes. Mammalian malian membrane-bound adenylyl cyclases and is most
membrane-bound adenylyl cyclases consist of a short similar to the divergent type IX mammalian adenylyl
cytoplasmic N-terminal sequence, a six-transmembrane- cyclase. Human adenylyl cyclase type IX is predomi-
spanning region (M1), and a cytoplasmic catalytic domain nantly expressed in vital organs, including brain, heart,
(C1), followed by a second six-transmembrane-span- and pancreas (Paterson et al. 2000). The sgs-1 gene is
ning region (M2) and a second cytoplasmic catalytic ubiquitously expressed in the nervous system and mus-
domain (C2). The C1 and C2 domains together form cle cells of C. elegans (Berger et al. 1998; Korswagen
the catalytic core of the protein. The first 200–250 et al. 1998). A second adenylyl cyclase gene in C. elegans,
amino acids of each catalytic domain (the C1a and C2a acy-2, shows a more restricted expression pattern (Kors-
regions) are similar to each other and to the catalytic wagen et al. 1998). This gene is not involved in Gs-
domains of other adenylyl and guanylyl cyclases. In induced neuronal degeneration, but probably has an
mammals, nine different types of adenylyl cyclase genes essential function together withGs in the canal-associated
have been reported, all of which are directly activated by neurons of C. elegans (Korswagen et al. 1998).
the heterotrimeric G-protein -subunit Gs. In addition, Over the last decade, great effort has been undertaken
certain adenylyl cyclases can be regulated by Gi, G, to understand the catalytic mechanism of adenylyl cy-
calcineurin, calmodulin, protein kinase A, protein kinase clase and its regulation. Most studies have focused on
C, and forskolin (reviewed in Hurley 1999; Simonds the function of the highly conserved catalytic domains,
1999; Patel et al. 2001). and several residues that are important for catalytic activ-
We have previously reported that the Caenorhabditis ity (Tang et al. 1992, 1995; Liu et al. 1997; Yan et al.
elegans adenylyl cyclase SGS-1 (suppressor of activated 1997b; Zimmermann et al. 1998b), Gs binding (Yan
Gs) is a downstream target of the C. elegans Gs subunit et al. 1997a; Zimmermann et al. 1998a), Gi binding
in motoneurons (Korswagen et al. 1998): mutations in (Dessauer et al. 1998), forskolin stimulation (Yan et al.
SGS-1 suppress the neuronal degeneration induced by 1998), and ATP binding (Dessauer et al. 1997) have
a constitutively activating mutation in Gs (Berger et been determined, mainly through in vitro studies. In
al. 1998; Korswagen et al. 1998). In humans, activating addition, the determination of the crystal structure of
mutations in Gs are implicated in pituitary and thyroid the catalytic domains of adenylyl cyclase (Tesmer et al.
1997, 1999) has provided new insight into the catalytic
mechanism and the key residues for catalytic activity
1Corresponding author: Hubrecht Laboratory, Centre for Biomedical and binding of its regulators. The function of the twoGenetics, Uppsalalaan 8, 3584 CT, Utrecht, The Netherlands.
E-mail: plasterk@niob.knaw.nl transmembrane domains of adenylyl cyclase is less well
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concentration of 50 g/ml together with 100 g/ml pMH86understood. A recent study has now revealed that these
(Han and Sternberg 1991) in CB1282, and the transgenicdomains interact with each other persistently and that
array was crossed in NL3200 (sgs-1(pk1279)/ III; dpy-20
this interaction plays a critical role in the targeting and (e1282) IV). A rescuing strain, NL3212 (sgs-1(pk1279) III;
functional assembly of adenylyl cyclase (Gu et al. 2001); dpy-20(e1282) IV; pkEx1288[sgs-1() dpy-20()]), which does
not segregate viable Dpy-20 worms, was obtained. Single wormthus, these domains are very important for the proper
PCR confirmed homozygosity for the pk1279 allele (data notfunctioning of the protein.
shown).In this study, we show that sgs-1 is an essential gene
Isolation of suppressors of the activated Gs-induced neu-and that sgs-1 is involved in behaviors such as locomotion ronal degeneration: The screen that was used to identify sup-
and pharyngeal pumping. To identify new residues in pressors of the activated Gs phenotype was amodified version
of an earlier described screen (Korswagen et al. 1998). L4sgs-1 that are important for normal response to Gs,
NL545 animals were treated with 50 mm EMS in M9 buffer forwe performed a genetic screen for suppressors of the
4 hr, washed, and seeded at 40–60 animals per 9-cm nematodeactivated Gs-induced neuronal degeneration. In total, growth medium (NGM) agar plate. The F2 generation waswe identified 14 residues in sgs-1 that can be mutated synchronized usingNaOCl bleaching, and L1 larvae were heat-
to suppress the neuronal degeneration. Ten of these shocked for 2 hr at 33 to induce expression of pkIs296. The
animals that grew out to adults were again synchronized usingresidues are located in the catalytic domains of sgs-1,
NaOCl bleaching, and L1 larvae were heat-shocked for 2 hrbut fourmutations in the transmembrane domains were
at 33 to induce expression of pkIs296. Animals that did notalso found. Although none of the mutations are located
show neuronal degeneration were collected. sgs-1 alleles were
in the proposed active site of the protein, we show here identified by complementation testing.
that catalytic activity of sgs-1 is required for Gs-induced Activated Gs-induced neuronal degeneration: The acti-
vated Gs-induced pattern of neuronal cell death was mea-neuronal degeneration.
sured as described in Korswagen et al. (1997). Synchronized
L1-L2 larvae were heat-shocked for 2 hr at 33 and after 24
hr the neuronal degeneration pattern was examined in atMATERIALS AND METHODS least 20 animals using a high-powered dissection microscope
(Wild M3C). Animals that did not show 100% suppression ofNematode strains and culturing: All strains weremaintained
the neuronal degeneration were further examined using aas described by Lewis and Fleming (1995). DNA transforma-
Nomarski microscope (Zeiss Axioskop 2): the total numbertions by microinjection in C. elegans were as described by
of degenerated neurons was determined in 20 animals. TheMello and Fire (1995). Strains used in this study were Bristol
percentage suppression was calculated by comparing this num-N2, CB1282 (dpy-20(e1282) IV), NL545 (dpy-20(e1362) IV;
ber with the total number of degenerated neurons in NL545pkIs296[hsp::gsa-1QL dpy-20()] X) (Korswagen et al. 1997),
(dpy-20(e1362) IV; pkIs296[hsp::gsa-1QL dpy-20()] X) (100%NL585 (sgs-1(pk301) III, dpy-20(e1362) IV; pkIs296[hsp::gsa-1QL
degeneration) and NL586 (sgs-1(pk310) III; dpy-20(e1362) IV;dpy-20()] X) (Korswagen et al. 1998), NL586 (sgs-1(pk310)
pkIs296[hsp::gsa-1QL dpy-20()] X) (100% suppression). Sta-III, dpy-20(e1362) IV; pkIs296[hsp::gsa-1QL dpy-20()] X) (Kors-
tistics were calculated using directed Student’s t-tests.wagen et al. 1998), NL597 (sgs-1(pk384) III, dpy-20(e1362) IV;
sgs-1(pk1279) trans experiments: NL1999 sgs-1(pk1279)/pkIs296[hsp::gsa-1QL dpy-20()] X) (Korswagen et al. 1998),
dpy-17(e164) males were crossed with Bristol N2 hermaphro-NL1250 (mut-2(r459) I; sgs-1(pk450::Tc1) III) (Korswagen et
dites and with homozygous sgs-1mutants. 40 L1 progeny wereal. 1998), NL3200 (sgs-1(pk1279)/ III; dpy-20(e1282) IV), and
picked and their growth was followed. After 1-week of growthNL3224 (sgs-1(pk1279) dpy-17()/sgs-1() dpy-17(e164) III;
at 20, we checked for the presence of the sgs-1(pk1279) allelepkIs296[hsp::gsa-1QL dpy-20()] X). sgs-1 alleles pk484, pk487,
by PCR.pk862, pk866, pk867, pk871, pk875, pk880, pk884, pk886, pk904,
Construction and expression of a catalytically inactive sgs-1pk907, and pk927 were generated in an NL545 background
mutant: SGS-1 R1187A was constructed by PCR using primersin this study.
R1187-1 TGCTAGCGCAATGTACAGCAC and R1187-2 GCTGIsolation of an sgs-1 knockout animal: We used the out-
TACATTGCGCTAGCAATG containing the mutation. Theer primers delsgs1-9 GGCGGAAAAGTTGAAAATGA and
PCR fragment was cloned into a 15.6-kb NheI-BspEI fragmentdelsgs1-10 TGCAATGCTTCTCACCTGTC and the nested
of pRP1522 (Korswagen et al. 1998), giving rise to SGS-1primers delsgs1-11 CACGTGAAGGAGGTGGAAGT and del-
R1187A. The cloned PCR fragment was sequenced completelysgs1-12 CTGGTTTTTGTGCTGGGACT, spanning a genomic
and found to be free of errors. SGS-1 R1187A was injectedregion of 4.1 kb, to screen for deletion derivatives of pk450::Tc1
at the same concentration as the wild-type SGS-1 construct(Zwaal et al. 1993), a transposon insertion in the ninth exon
pRP1522 (50 g/ml; Korswagen et al. 1998) together withof sgs-1 (Korswagen et al. 1998). A 2.9-kb deletion derivative
the markers pRF6 (100 g/ml; Kramer et al. 1990) andof pk450::Tc1, sgs-1(pk1279), was isolated and could not be
pRP2017 (gpb-2::gfp; 50 g/ml; van der Linden et al. 2001)maintained as a homozygote. The sgs-1(pk1279) PCR product
in N2 animals. Three independent SGS-1 R1187 transgenicwas isolated fromgel and sequenced to determine the deletion
end points. The following sequence in capitals was found lines and two independent wild-type SGS-1 transgenic lines
were crossed in NL3224 and examined for their rescue of thearound the deletion site: (5-TGGAAGTAatacagat-gtgac
cacTATCTTTA-3). The pk1279 allele was backcrossed four larval lethality and suppression of the neuronal degeneration.
Behavioral assays: Life span was determined by transferringtimes to an N2 background and then crossed with CB164
(dpy-17(e164) III), resulting in strain NL1999 sgs-1(pk1279)/ L1-L2 larvae individually to plates 24 hr after synchronization
using NaOCl bleaching. The animals were incubated at 20dpy-17(e164). One-fourth of the progeny of NL1999 sgs-1
(pk1279)/dpy-17(e164) arrested in larval development, and we and monitored once daily until death. Day of synchronization
was used as the first time point. The animals were transferredconfirmed by PCR that these are homozygous for sgs-1(pk1279)
(data not shown). The homozygous pk1279 phenotype was to fresh plates once in 2 days while producing eggs to keep
them separate from their progeny. Animals were scored asrescued with a wild-type sgs-1 genomic construct, pRP1522
(Korswagen et al. 1998). This construct was injected at a dead when they stopped moving and no longer responded to
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Figure 1.—Phenotypes
of sgs-1(pk1279) animals.
(A) Genomic representa-
tion of the sgs-1 gene show-
ing the deleted region in
pk1279. GENEFINDER pre-
diction of the sgs-1 coding
sequence was confirmed by
sequencing of random and
oligo(dT) primed cDNA
amplified by reverse tran-
scriptase PCR (Korswagen
et al. 1998). (B) The devel-
opment of the sgs-1(pk1279)
animal (arrowhead) is com-
pared with similarly aged
Bristol N2 animal. (C)
Movement levels of N2, sgs-1
(pk1279) animals and sgs-1
(pk1279) pkEx1228[sgs-1()]
animals were assayed 96 hr
after synchronization. Each
bar represents the average of
10 animals. The error bars
represent the standard error
of the mean (SEM). Differ-
ences between N2 and sgs-
1(pk1279) were analyzed us-
ing Student’s t-test. sgs-1
(pk1279) animals are signifi-
cantly different for movement when compared with N2 animals (P 	 0.001). (D) Pharyngeal pumping levels of N2, sgs-1(pk1279)
animals and sgs-1(pk1279) pkEx1288[sgs-1()] animals were assayed 96 hr after synchronization. Each bar represents the average
of 20 determinations. The error bars represent the SEM. Differences between N2 and sgs-1(pk1279) were analyzed using Student’s
t-test. sgs-1(pk1279) animals are significantly different with respect to pharyngeal pumping when compared with N2 animals (P
	 0.001). (E) In many sgs-1(pk1279) animals, a cuticular plug is attached to the mouth opening. (F) The percentage of worms
alive on a given day after synchronization: N2, sgs-1(pk1279) animals and sgs-1(pk1279) pkEx1288[sgs-1()] animals. Mean life
spans
 SEM, with sample size in parentheses, are 18.0 
 0.8 (56), 27.9 
 2.8 (32), and 19.0
 1.0 (27), respectively. Significance
levels were calculated using Student’s t-test. sgs-1(pk1279) lived significantly longer than the wild-type strain (P 	 0.001), whereas
there was no significant difference between N2 and sgs-1(pk1279) pkEx1288[sgs-1()] animals (P  0.42).
prodding the head (Kenyon et al. 1993). Mean life spans kb of sgs-1 sequence is deleted in this allele, thereby
were compared by using Student’s t-test assuming unequal removing exon 8 up to exon 13. Nearly one-half of
variances.
the sgs-1 coding sequence is removed, including thePharyngeal pumping rates were determined by measuring
complete second transmembrane and second catalyticthe number of pumps per minute. Animals that had been
raised for 96 hr after synchronization using NaOCl bleaching domain. Therefore, it is highly likely that pk1279 is a
were placed on NGM agar plates seeded with OP50. Ten null allele. Animals homozygous for pk1279 undergo
animals for each genotype were scored for 2 min and each severely retarded development (Figure 1B). All animals
animal was scored twice. Statistics were calculated by using
passed the first larval stage, but arrested and died in onedirected Student’s t-tests.
of the later larval stages. The length of embryogenesisMovement levels were determined by measuring thrashing
levels. One thrash is defined as one change in direction of in pk1279 homozygotes was comparable to Bristol N2
bending at the mid-body (Miller et al. 1996). Animals were animals, and pk1279 homozygotes were morphologi-
synchronized using NaOCl bleaching and were raised at 20 cally normal at hatching (results not shown). The
for 96 hr after synchronization using NaOCl. An animal was pk1279 homozygotes showed reduced body-wall muscleplaced in microtiter plates with 50 l M9 and allowed to
activity (Figure 1C) and pharyngeal muscle activity (Fig-recover for 2 min. Subsequently, thrashes were counted for 2
ure 1D). We also observed difficulties with molting (Fig-min. Ten animals were examined for each genotype. Statistics
were calculated by using directed Student’s t-tests. ure 1E). In spite of these developmental abnormalities,
pk1279 animals had an extended life span: they lived
50% longer than the wild type (Figure 1F).
RESULTS
Rescue of the larval lethality was obtained with an
sgs-1 is essential for viability: A transposon-based extrachromosomal array containing pRP1522, a 14-kb
method (Zwaal et al. 1993) was used to isolate a deletion subclone containing the entire sgs-1 gene (Korswagen
et al. 1998). The rescued sgs-1(pk1279) transgenic ani-allele of sgs-1, sgs-1(pk1279). As shown in Figure 1A, 2.9
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mals were used to address whether maternally provided and pk866) or at the border of the second transmem-
brane domain and the nonconserved region of the sec-sgs-1 mRNA or protein is needed for development. Ex-
trachromosomal arrays are unstable and can be lost ond catalytic domain (pk907).
SGS-1 mutations are not located in the active site:during meiosis and mitosis (Stinchcomb et al. 1985;
Mello and Fire 1995). This results inmosaic expression The availability of the crystal structure of the catalytic
domains of adenylyl cyclase (Tesmer et al. 1997, 1999)of the transgene as it is lost in certain cells and cell
lineages. Rescued sgs-1(pk1279) transgenic animals that has made it possible to map the mutations in the cata-
lytic domains of sgs-1 to the crystal structure. This analy-lost the rescuing transgene in the germ line will have
progeny that lack both sgs-1 transgene expression and sis revealed that none of the 10 residues mutated in the
catalytic domains of sgs-1 was located in the proposedsgs-1 expression in the form of maternal inheritance of
sgs-1 mRNA or protein (Zwaal et al. 1996). Of the res- active site of the protein (Figure 2). Two of the mutated
amino acids (G1068 and R1074) were located at thecued pk1279 animals, 1–2% segregated only arrested
larvae that were identical to the arrested larvae segre- interaction interface with Gs. It has been shown for
mammalian adenylyl cyclases that mutations in thegated by heterozygous pk1279 animals. We did not ob-
serve any brood consisting of animals with a phenotype amino acid analogous to R1074 result in decreased bind-
ing toGs, with a consequent decrease in activation (Yanmore severe than that of the arrested larvae. This result
suggests that zygotic sgs-1 performs an essential function et al. 1997a;Zimmermann et al. 1998a). This suggests that
in the mutants G1068R and R1074K suppression of theduring development and that the ability to develop into
larva is not the result of the presence of maternal sgs-1 neuronal degeneration is the result of decreased bind-
ing to Gs. The remaining eight mutated amino acidsmRNA or protein.
sgs-1 mutants are suppressors of activated Gs-induced were distributed over the structure and were changed
to larger residues (L314F, L347F, A374V, H455Y, andneuronal degeneration: sgs-1 mutants were initially se-
lected as suppressors of activated Gs-induced neuronal S457F) or to residues that no longer make contact with
the backbone or side chain of other amino acids (M411I,degeneration (Berger et al. 1998; Korswagen et al.
1998). The neuronal degeneration phenotype is already S1109N, and R1216H). Biochemical analysis of mamma-
lian adenylyl cyclase type II with a mutation analogousvisible in the first larval stage, and it is therefore possible
to test the sgs-1 knockout animals for suppression of to R1216H has shown that mutation of this amino acid
does not result in gross structural alterations (Dessauerthis neuronal degeneration phenotype. Animals homo-
zygous for the null allele pk1279 that express the acti- et al. 1997). This suggests that R1216H has a specific
effect on adenylyl cyclase activity or regulation.vated Gs from a heat-shock promoter did not show
neuronal degeneration. Thus, sgs-1(pk1279) is a suppres- Catalytic activity of sgs-1 is necessary for induction of
neuronal degeneration: Induction of activated Gs insor of the activated Gs-induced neuronal degeneration
(Table 1). In screens for suppressors of the activated an sgs-1 null background did not result in neuronal
degeneration, showing that sgs-1 is essential for this pro-Gs phenotype, we have now obtained a set of 23 sgs-1
alleles (Table 1), of which 7 were described earlier (Kor- cess. Indeed, overexpression of the wild-type sgs-1 allele
in sgs-1(pk1279) animals both rescued the lethal pheno-swagen et al. 1998). The sgs-1 alleles were isolated with
a frequency of 1 in 50,000 mutagenized genomes; type and restored the neuronal degeneration pheno-
type upon induction of activated Gs (Figure 3A). Sincethey are all homozygous viable and recessive for the
suppression of the activated Gs phenotype. We con- none of the sgs-1 reduction-of-function mutations di-
rectly affected the active site of the SGS-1 protein, weclude from the viability of these sgs-1 alleles that they
are not complete loss-of-function alleles, but partial re- asked whether catalytic activity of SGS-1 is required for
the activated Gs-induced neuronal degeneration. Weduction-of-function alleles. All 23 sgs-1 alleles were se-
quenced and mutations were found in all alleles, except constructed a point mutation in the active site of SGS-1
(SGS-1 R1187A). R1187 is the residue analogous toallele pk310, which was not studied further (Table 1).
In three independent alleles (pk311, pk474, and pk871), R1029 of mammalian type II adenylyl cyclase. R1029
of type II adenylyl cyclase is an important residue foran identical splice donor site mutation in the first cata-
lytic domain was found. One allele (pk862) contained catalysis, and it was shown that changing this residue
into an alanine reduces catalysis by 30-fold, but doesa mutation 39 bp upstream of the ATG. In 18 indepen-
dent alleles, mutations were found that change 14 dis- not cause gross structural alterations (Yan et al. 1997b).
To our surprise, overexpression of the SGS-1 R1187tinct (mostly conserved) amino acids. Most mutations
that were found to suppress the activated Gs phenotype mutant into sgs-1(pk1279) animals rescued the lethality
of these animals, most probably due to residual catalyticwere located in one of the conserved regions of the
catalytic domains of sgs-1, suggesting that catalytic activ- activity (Yan et al. 1997b). However, we found that this
residual activity was not sufficient for the induction ofity of SGS-1 is needed for the activated Gs phenotype.
The mutations that did not map in the conserved re- neuronal degeneration, as these animals looked com-
pletely wild type upon induction of activated Gs expres-gions of the catalytic domains were located in the first
transmembrane domain (pk393, pk884, pk363, pk863, sion (Figure 3B). We conclude from this result that a
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TABLE 1
Properties of the sgs-1 mutants
Suppression
of neural Growth in trans
Allele Mutation Change Domain degeneration (%) to pk1279
pk862 caacgtc → caatgtc Upstream of ATG 100 
pk393a gga → aga G69R M1 100 ND
pk884 cca → tca P152A M1 72 
pk363a gga → gaa G181E M1 100 ND
pk863 gga → gaa G181E M1 ND ND
pk866 gga → gaa G181E M1 100 
pk487 ctc → ttc L314F C1a 100 
pk485 ctt → ttt L347F C1a ND ND
pk886 ctt → ttt L347F C1a 100 
pk880 gct → gtt A374V C1a 100 
pk867 atg → ata M411I C1a 87 
pk927 cac → tac H455Y C1a 100 
pk301a tcc → ttc S457F C1a 100 /
pk311a gtaactt → ataactt Splice donor, site C1a 100 ND
intron 7
pk474a gtaactt → ataactt Splice donor, site C1a 100 ND
intron 7
pk871 gtaactt → ataactt Splice donor, site C1a 100 
intron 7
pk907 gaa → aaa E992K M2-C2a 100 
pk384a ggg → agg G1068R C2a 93 
pk904 aga → aaa R1074K C2a 100 
pk484 agt → aat S1109N C2a 100 
pk874 agt → aat S1109N C2a ND ND
pk875 cgc → cac R1216H C2a 100 
pk310a Unknown 100 ND
pk1279 Deletion C1b-M2-C2 100 
pk1279/ Deletion/wild type 9 
Neuronal degeneration induced by activated Gs under heat-shock promoter control as described in materials and methods.
Phenotype was scored in at least 20 L1-L2 larvae for each genotype 24 hr after a 2-hr heat shock at 33. Mean total numbers of
degenerated neurons 
SEM, with sample size in parentheses, are 23.2 
 0.3 (60) for NL545 pkIs296[hsp::gsa-1QL]; 0.15 
 0.1
(20) for sgs-1(pk310) ; 21.1 
 0.4 (20) for sgs-1(pk1279)/; 1.9 
 0.4 (20) for sgs-1(pk384) ; 3.3 
 0.5 (40) for sgs-1(pk867); and
6.5 
 0.6 (60) for sgs-1(pk884). The mean total number of degenerated neurons was not determined for the other sgs-1 alleles,
but examination using a high-powered dissection microscope showed a level of neuronal degeneration comparable to sgs-1(pk310).
Differences between genotypes were calculated using Student’s t-test. There were significant differences between sgs-1(pk310)
and sgs-1(pk384) or sgs-1(pk867) or sgs-1(pk884) (for all P 	 0.001). There was also a significant difference between NL545 and
sgs-1(pk1279)/ (P 	 0.004). The growth in trans to pk1279 was determined as described in materials and methods. , none
of the animals tested has a growth delay; /, 80% of the animals have a growth delay, but all eventually become adults; ,
100% of the animals have a growth delay, and 50% are still in larval stage after 1 week of growth at 20; , all animals have
a growth delay, and none become adults. ND, not determined; C1b, nonconserved part of first catalytic domain.
a sgs-1 alleles that were identified in a previous study (Korswagen et al. 1998).
mutation in the active site suppresses the activated Gs- sion: a few neurons were degenerated in most animals
(Table 1). This suggests that the SGS-1 protein is lessinduced neuronal degeneration and that catalytic activ-
ity of sgs-1 is required for the neuronal degeneration disturbed in these alleles than in the other alleles. These
alleles had mutations in different domains of the SGS-1phenotype. Probably, mutations in the active site are
not found in our screen for suppressors of the neuronal protein, and thus there was no correlation between the
activity of the mutant proteins and the position of theirdegeneration because these mutations are lethal. How-
ever, we cannot exclude other explanations for the fact mutations. Animals heterozygous for pk1279 suppressed
the activated Gs-induced neuronal degenerationthat we have not found these mutations in our screen.
sgs-1 alleles form an allelic series: Most sgs-1 alleles, weakly: they showed a slight reduction in the number
of degenerated neurons induced by activated Gs ex-including the null allele pk1279, showed 100% suppres-
sion of the activated Gs-induced neuronal degenera- pression compared to homozygous sgs-1() animals (Ta-
ble 1). A possible explanation for this observation istion. However, three alleles, pk384 (G1068R), pk867
(M411I), and pk884 (P152S), showed 	100% suppres- that in these animals, sgs-1 activity is reduced due to the
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Figure 2.—Structural representation of the residues that
are changed in sgs-1 mutants. Complex of Gs (red) with the
catalytic domains of mammalian adenylyl (Tesmer et al. 1997, Figure 3.—Catalytically inactive SGS-1 does not rescue the
1999). Green, the C1a domain from adenylyl cyclase V; cyan, suppression of activated Gs-induced neuronal degeneration.the C2 domain from adenylyl cyclase II; yellow, the residues (A) sgs-1(pk1279) pkIs296[hsp::gsa-1QL] animal expressing
that are changed in sgs-1mutants mapped on their analogous pkEx1353[sgs-1()] shows neuronal degeneration (arrow-
residues in the crystal structure. Forskolin (FSK) and adeno- heads) after induction of activated Gs by 2 hr of heat shock atsine 5-( thio)-triphosphate (ATP) are located in the active 33. (B) sgs-1(pk1279) pkIs296[hsp::gsa-1QL] animal expressing
site of the enzyme. Modeling was done using RasMol. pkEx1348[sgs-1R1187A] does not show neuronal degeneration
after induction of activated Gs by 2 hr of heat shock at 33.
presence of only one functional copy and that in a small
percentage of neurons the sgs-1 activity is reduced to a sgs-1 reduction-of-function mutants have a normal life
span and pharyngeal pumping rates, but reduced loco-level that is too low to induce neuronal degeneration.
We were also able to detect variation in SGS-1 activity motion rates:Observation of the sgs-1(pk1279) allele sug-
gests that SGS-1 is involved in locomotion and pharyn-among the different sgs-1 alleles when we placed all
alleles in trans to pk1279 (Table 1). Most heterozygous geal pumping and life span determination. We measured
these three phenotypes in two additional sgs-1 reduc-animals grew normally. However, animals that had allele
pk301 (S457F), pk484 (S1109N), or pk907 (E992K) in tion-of-function alleles, one strong sgs-1 allele (pk484)
and one weak sgs-1 allele (pk867). We found that theretrans to pk1279 did not show normal growth: their phe-
notype was an intermediate form between wild-type and was no difference compared to the background strain
for either life span (Figure 4A) or pharyngeal pumpinghomozygous pk1279 animals. These results suggest that
the SGS-1 protein was more affected in pk301, pk484, (Figure 4B). This indicates that in these mutants the
remaining SGS-1 activity is sufficient for normal func-and pk907 than in the other alleles. The growth defect of
pk484/pk1279 and pk907/pk1279 animals is more severe tion in these processes. Since sgs-1(pk484) is the strong-
est sgs-1 reduction-of-function allele, it is not likely thatthan the growth defect in pk301/pk1279 animals, indi-
cating that pk484 and pk907 are the most severe alleles any of the other sgs-1 reduction-of-function alleles will
show effects on either life span or pharyngeal pumping.of sgs-1. Both these alleles have mutations in the part
of sgs-1 that is deleted in sgs-1(pk1279). We cannot ex- The locomotion rate, however, was reduced in the two
sgs-1 reduction-of-function mutants tested (Figure 4C),clude that certain alleles with a mutation in the part
of sgs-1 that is not deleted in sgs-1(pk1279) experience indicating that in these sgs-1 reduction-of-function mu-
tants, SGS-1 activity is not sufficient for wild-type locomo-intragenic complementation when placed in trans to
sgs-1(pk1279) and therefore have a less severe phenotype tion. The locomotion rate of sgs-1(pk484) was signifi-
cantly less than the locomotion rate of sgs-1(pk867). Thisthan pk484 and pk907. When we placed sgs-1(pk484)
(S1109N), which has a point mutation in the second confirms that the allelic series showed that sgs-1(pk484)
is a more severe allele than sgs-1(pk867). Since sgs-1catalytic domain, in trans to sgs-1(pk301) (S457F), sgs-1
(pk487) (L314F), sgs-1(pk867) (M411I), or sgs-1(pk880) (pk867) is one of the weakest alleles we have, probably
all sgs-1 reduction-of-function alleles will show reduced(A374V), which are all mutated in the first catalytic
domain, we did not observe an enhancement of the locomotion rates. Indeed, sgs-1(pk904) (R1074K) ani-
mals also showed significantly reduced locomotion ratesneuronal degeneration phenotype after expression of
the activated Gs from heat shock. This indicates that compared to the background strain (results not shown).
In mammalian adenylyl cyclases, mutation of the aminothere is no intragenic complementation between the
different sgs-1 reduction-of-function mutants. acid analogous to R1074 was shown to result in de-
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creased binding of Gs, but in normal regulation by Gi chemical evidence indicates that both catalytic domains
(C1 and C2) are essential for high enzymatic activityor the adenylyl cyclase activator forskolin (Yan et al.
(Tang andGilman 1995). In this study, we have isolated1997a; Zimmermann et al. 1998a). This suggests that the
a deletion allele of an adenylyl cyclase of C. elegans,reduced locomotion of sgs-1(pk904) animals is the result
sgs-1(pk1279), in which part of the nonconserved firstof decreased response toGs and thus that Gs functions
catalytic domain (C1b) and the complete second trans-together with SGS-1 in locomotion. We did not observe
membrane (M2) and second catalytic domain (C2) ofany other obvious defects in development or behavior
the SGS-1 protein are removed. Therefore, pk1279 isin the sgs-1 reduction-of-function alleles.
likely to be a null allele. Deletion of sgs-1 results in
retarded development and eventually in larval lethality.
This larval lethal phenotype is different from the larval
DISCUSSION lethal phenotype of knockout animals for gsa-1 (Kors-
wagen et al. 1997), the heterotrimeric Gs subunit thatsgs-1 is an essential gene: Adenylyl cyclases have com-
acts directly upstream of SGS-1 (Korswagen et al. 1998).plex functions and integrate and respond to diverse
This suggests that SGS-1 is not the only downstreamextracellular and intracellular signals. Genetic and bio-
target of Gs. Presumably, ACY-2, a second adenylyl cy-
clase protein in C. elegans that shows a more limited
expression pattern than sgs-1, is one of the other targets
of Gs (Korswagen et al. 1998), since acy-2 null mutant
animals have a larval lethal phenotype similar to gsa-1
null mutants. Two additional genes encode adenylyl
cyclases in the C. elegans genome, acy-3 (located on chro-
mosome V, our unpublished observation) and acy-4 (lo-
cated on chromosome III, C44F1.5; C. elegans Se-
quencing Consortium 1998). Little is known about
the role played by these molecules in Gs signaling.
sgs-1 is required for pharyngeal pumping and affects
life span: Pharyngeal pumping is disturbed in homozy-
gous sgs-1(pk1279) animals, indicating that SGS-1 is re-
quired for proper functioning of the pharynx. SGS-1 is
a downstream target of Gs, but it is not known whether
Figure 4.—Phenotypes of sgs-1 reduction-of-function ani-
mals. sgs-1(pk484) and sgs-1(pk867) were backcrossed two times
to NL545 (dpy-20(e1362) IV; pkIs296[hsp::gsa-1QL dpy-20
()]X), the background strain in which these alleles were
generated. (A) The percentage of worms alive on a given day
after synchronization: () NL545, () sgs-1(pk484) animals,
and (X) sgs-1(pk867) animals. Mean life spans 
 SEM, with
sample size in parentheses, are 17.1 
 0.7 (29), 17.0 
 0.6
(32), and 16.0 
 0.8 (29), respectively. Significance levels
were calculated using Student’s t-test. There was no significant
difference between NL545 and sgs-1(pk484) (P  0.91) or sgs-
1(pk867) (P  0.14). (B) Pharnygeal pumping levels of ()
NL545, () sgs-1 (pk484) animals, and ( ) sgs-1(pk867) animals
were assayed 96 hr after synchronization. Each bar represents
the average of 20 determinations. The error bars represent
the SEM. Significance levels were calculated using Student’s
t-test. There was no significant difference between NL545 and
sgs-1(pk484) (P 0.076) or sgs-1(pk867) (P  0.80). (C) Move-
ment levels of () NL545, () sgs-1(pk484) animals, and ( )
sgs-1(pk867) animals were assayed 96 hr after synchronization.
Each bar represents the average of 10 animals. The error
bars represent the SEM. Differences between the different
genotypes for the movement levels were analyzed using Stu-
dent’s t-test. NL545 animals are significantly different with
respect to movement levels when compared to sgs-1(pk484)
(P 	 0.001) or sgs-1(pk867) (P  0.048). In addition, sgs-
1(pk484) animals are significantly different with respect to
movement when compared to sgs-1(pk867) (P 	 0.001).
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Gs is also involved in pharyngeal pumping. It is there- junction regulated by EGL-30 and GOA-1 possibly re-
sults in regulation of Gs in muscle cells.fore possible that in the pharynx, SGS-1 is regulated by
a protein other than Gs. In several homozygous sgs-1 sgs-1 reduction-of-function mutants reveal important
residues in the adenylyl cyclase gene: Several studies(pk1279) animals the molting process was not com-
pleted, since a cuticular plug remains attached to the have been performed to identify residues that are in-
volved in the catalytic mechanism of adenylyl cyclasemouth opening. The pharynx plays an important role
in the molting process (Singh and Sulston 1978), sug- and its regulation. However, none of these studies was
performed in a complex organism, and in only onegesting that the pharyngeal defects seen in sgs-1 deletion
animals account for the incompletemolting. sgs-1 reduc- study, using the Dictyostelium discoideum adenylyl cyclase
ACA, were mutations in the transmembrane domainstion-of-function mutants do not have pharyngeal de-
fects, and we do not observe difficulties with molting in described (Parent and Devreotes 1995). Here, we
have used a genetic selection system in a complex organ-these mutants.
We observed that loss of sgs-1 significantly lengthens ism, C. elegans, that identified mutations in both the
catalytic and transmembrane domains of the adenylyllife span: sgs-1(pk1279) mutants live 50% longer than
wild-type animals. Lakowski and co-workers showed that cyclase gene. sgs-1 is an essential gene, and therefore
onlymutations that do not completely disrupt sgs-1 func-eatmutants, which have defects in pharyngeal function,
have significantly increased mean and maximum life tion were isolated. Out of the 14 residues that were
mutated, 10 residues were located in the catalytic do-span because of food restriction (Lakowski andHekimi
1998). Furthermore, it has been shown that signals from mains. All, except L314, are conserved residues between
different adenylyl cyclases. Only 2 of the conserved resi-the reproductive system influence the life span of an
animal (Hsin and Kenyon 1999). sgs-1 mutants have dues, R1074 and R1216H, were described in other stud-
ies, and there it was shown by biochemical analysis thatboth pharyngeal defects and a defective reproductive
system, and we therefore suggest that the extended life mutation of these residues does not result in gross struc-
tural alterations (Dessauer et al. 1997; Yan et al. 1997a;span is the result of these phenotypes. This is further
supported by the fact that sgs-1 reduction-of-function Zimmermann et al. 1998a). Further studies should reveal
whether, in the other sgs-1 reduction-of-function alleles,mutants do not show pharyngeal or reproductive system
defects and that their life span is comparable with the the reduced sgs-1 activity is the result of a defect in a
background strain. However, it is also possible that sgs- specific function of the protein or the result of improper
1 has a direct effect on life span. folding or instability of the protein.
SGS-1 and Gs function together in locomotion: Re- Four mutations revealed residues that are important
cent studies have shown that two G-protein -subunit for a normal response to Gs, but that are not located
genes in C. elegans, goa-1 (Go) and egl-30 (Gq), are in one of the catalytic domains. Three of these residues
involved in a complex signaling network that regulates (G68, P152, andG181) are located in the first transmem-
locomotion (Hajdu-Cronin et al. 1999; Lackner et al. brane domain, and one (E992) is located at the border
1999; Miller et al. 1999; Nurrish et al. 1999; Chase et of the second transmembrane domain and the noncon-
al. 2001; Robatzek et al. 2001; van der Linden et al. served part of the second catalytic domain. Recently, it
2001). Loss of function of goa-1 results in increased was shown that the transmembrane domains interact
locomotion rates (Mendel et al. 1995; Segalat et al. persistently and are involved in two important processes,
1995), whereas reduction of function of egl-30 results namely, the proper localization of the protein in the
in decreased locomotion rates (Brundage et al. 1996). membrane and functional assembly of the two catalytic
These G-protein pathways regulate diacylglycerol levels domains (Gu et al. 2001). It is possible that our trans-
in an antagonistic manner (Lackner et al. 1999;Miller membrane mutants are disturbed in the localization of
et al. 1999), either stimulating or inhibiting acetylcho- the adenylyl cyclase gene, as was shown for the Dictyo-
line release through the diacylglycerol-binding protein, stelium ACA mutants in the transmembrane domain
UNC-13. Our results show that there is yet another (Parent and Devreotes 1995), but it is also possible
G-protein signaling cascade involved in locomotion: Gs that in these mutants the two catalytic domains are not
signals to the adenylyl cyclase SGS-1 to regulate locomo- correctly assembled and therefore result in reduced ade-
tion. The GOA-1-GL-30 network is shown to act in ven- nylyl cyclase activity. Further studies should reveal, for
tral nerve cord motoneurons (Lackner et al. 1999; each of these transmembrane domain mutants, which
Miller et al. 1999). sgs-1 and gsa-1 (Gs) are both ex- of these two possibilities is correct. In summary, our
pressed in ventral nerve cord motor neurons and in study shows not only that C. elegans can be used to study
body-wall muscle cells. It is therefore possible that the gene function, but also that it can be a powerful tool
Gs–SGS-1 pathway acts in parallel to the GOA-1EGL- to study protein domain function.
30 network in motor neurons, but it is also possible that
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ABSTRACT
In the nucleus, newly synthesized precursor mRNAs undergo several processing steps, such
as 5' capping, splicing, polyadenylation and 3' end cleavage. They become associated with a
multitude of RNA binding proteins, resulting in the formation of an export-competent
ribonucleoprotein (mRNP) complex.  Transport of mRNP from the nucleus to the cytoplasm
occurs through the nuclear pore complex (NPC). Recent studies suggest that interactions
between mRNP and NPC are mediated by homologues of the NXF (nuclear export factor)
family of putative mRNA export receptors (reviewed in (CONTI and IZAURRALDE 2001; LEI
and SILVER 2002; ZENKLUSEN and STUTZ 2001)).
The first evidence for the highly conserved NXF protein family being involved in
mRNA export came from a study in Saccharomyces cerevisiae. A family member, Mex67,
was identified through its genetic interaction with the nuclear pore complex protein
nucleoporin Nup85 (SEGREF et al. 1997). In the temperature-sensitive mex67-5 mutant,
poly(A)+ RNA accumulates in the nucleus after shifting to the restrictive temperature (SEGREF
et al. 1997). Mex67 is a nucleocytoplasmic shuttling protein that forms a heterodimer with
another protein, Mtr2 (SANTOS-ROSA et al. 1998). The Mex67/Mtr2 mRNA export complex
can bind to RNA via Mex67 and interacts with NPC via Mtr2 (SANTOS-ROSA et al. 1998), and
it is thought that this complex drives the mRNP through the nuclear pore.
NXF1 (or TAP) is the human homologue of Mex67 and was first implicated in the
nuclear export of the unspliced genomic RNA of simian type D retroviruses (GRÜTER et al.
1998; KANG and CULLEN 1999). It was shown that NXF1 interacts directly with the cis-acting
constitutive transport element of this retrovirus. In addition to transporting viral RNAs,
human NXF1 is now also known to be involved in cellular mRNA export (BRAUN et al. 2001;
KATAHIRA et al. 1999). NXF1 needs to bind a 15 kDa protein (p15, also known as NXT1),
which has homology to the nuclear transport factor NTF2, for its activity (BRAUN et al. 2001;
GUZIK et al. 2001; KATAHIRA et al. 1999; LEVESQUE et al. 2001; WIEGAND et al. 2002). p15
performs a similar function to Mtr2 in yeast, although these proteins do not share significant
C. elegans NXF-1 is an essential protein that is required for the nuclear export of
poly(A)-containing mRNAs. In a screen for suppressors of the neuronal degeneration
induced by activated Gas under the control of a heat-shock promoter, two alleles of
nxf-1 were isolated. In addition to suppressing the heat-shock-induced activated Gas
phenotype, the nxf-1 mutations also suppressed other phenotypes under heat-shock
promoter control. nxf-1 tagged with green fluorescent protein (GFP) is found in the
nucleus of all cells of C. elegans. Mutant nxf-1 tagged with GFP shows a similar
expression pattern to wild type nxf-1 at 20°C, but is differently expressed at 33°C,
suggesting that the nxf-1 alleles are temperature-sensitive. We propose that mutant
NXF-1 is in an inactive conformation during heat-shock, and therefore not able to
transport the activated Gas mRNA (or more generally any mRNA) out of the nucleus,
resulting in absence of the activated Gas phenotype after heat-shock.
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sequence similarity. Besides NXF1, there are four other NXF proteins (NXF2-5) in humans,
and there is one homologue of p15 (NXT2) (HEROLD et al. 2000).
In Drosophila, four NXF1 members and one p15 homolog were identified (HEROLD et
al. 2000). NXF1 and p15 are required for mRNA export, whereas NXF2-NXF4 are probably
not (HEROLD et al. 2000; WILKIE et al. 2001). A temperature-sensitive allele of nxf1 (or small
bristles (sbr)) was identified in a screen for mutants defective in mRNA export (WILKIE et al.
2001). Furthermore, it was shown that NXF1 is required for the morphogenesis of several
tissues during development (KOREY et al. 2001).
In C. elegans, two NXF homologues were identified, NXF-1 and NXF-2 (HEROLD et
al. 2000; SEGREF et al. 1997). Using RNA interference experiments, it was shown that NXF-1
is an essential protein that is required for the nuclear export of mRNA in C. elegans, but that
NXF-2 is not involved in this process (TAN et al. 2000).  NXF-1 has 42% homology with
human NXF-1, and binds directly to RNA and nucleoporins. Furthermore, NXF-1 is able to
shuttle between the nucleus and the cytoplasm (TAN et al. 2000). Transient expression of
NXF-1 in human HeLa cells showed that this protein accumulates in the nucleoplasm and at
the nuclear rim (TAN et al. 2000). In C. elegans, one p15 homolog is identified, NXT-1, that
binds to NXF-1 (BLACK et al. 1999; HEROLD et al. 2000; WIEGAND et al. 2002). C. elegans
NXF-1 could only mediate mRNA export in human cells when C. elegans NXT-1 was also
expressed (WIEGAND et al. 2002).
In this study, we identified C. elegans NXF-1 mutants that suppress the phenotype
induced by expression of a constitutively active gsa-1 mutant from a heat-shock promoter.
gsa-1 encodes a heterotrimeric Gsa-subunit, and expression of the constitutively active form
of gsa-1 from its own or heat-shock promoter results in vacuolization and degeneration of
ventral nerve cord neurons (KORSWAGEN et al. 1997). We show that other phenotypes under
heat-shock promoter control are also suppressed by the mutations in nxf-1. A full length nxf-
1::gfp fusion that rescues the suppression of the neuronal degeneration is expressed in nuclei
of all cells in C. elegans, indicating that NXF-1 acts in all cells. Our results suggest that the
nxf-1 mutations are temperature-sensitive, thereby resulting in normal mRNA export at the
permissive temperature, but strongly reduced mRNA export at the restrictive temperature (so
during heat-shock).
MATERIALS AND METHODS
Nematode strains and culturing: General methods for culture, manipulation and
genetics of C. elegans were as described (LEWIS and FLEMING 1995). Strains were cultured at 20°C,
unless indicated otherwise. DNA transformations by microinjection in C. elegans were as described
(MELLO and FIRE 1995). Strains used in this study were Bristol N2, CB4856, CB1282 (dpy-20(e1282)
IV), NL545 (dpy-20(e1362) IV; pkIs296[hsp::gsa-1QL dpy-20(+)] X) (KORSWAGEN et al. 1997), and
NL3178 (pkIs1392[hsp::gfp rol-6(su1006)]). nxf-1(pk386) was generated in an NL545 background as
described (KORSWAGEN et al. 1998). nxf-1(pk864) was isolated in this study. Both nxf-1(pk386) and
nxf-1(pk864) were backcrossed twice to NL545, resulting in respectively NL4004 and NL4003. The
following strains were used for mapping: DR102 (dpy-5(e61) unc-29(e193) I), CB187 (rol-6(e187) II),
MT4306 (lin-39(n1190) unc-36(e251) III), MT2405 (ced-3(n17) unc-26(e205) IV), CB224 (dpy-
11(e224) V), NL1257 (dpy-11(e224) unc-42(e270); pkIs296[hsp::gsa-1QL dpy-20(+)] X) and NL1916
(rol-4(sc8) lin-25(n545) him-5(e1467) unc-76(e911) V; pkIs296[hsp::gsa-1QL dpy-20(+)] X).
Isolation of suppressors of the activated Gas-induced neuronal degeneration: The
screen that was used to identify suppressors of the activated Gas (GasQL) phenotype was as described
(MOORMAN and PLASTERK 2002). In short, L4 NL545 animals were treated with 50 mM EMS in M9
buffer for 4 hr, washed and seeded at 40-60 animals per 9-cm nematode growth medium (NGM) agar
plate. The F2 generation was synchronized, and L1 larvae were heat-shocked for 2 hours at 33°C to
induce expression of pkIs296[hsp::gsa-1QL].  The animals that grew out to adults were again
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synchronized, and heat-shocked for 2 hours at 33°C as L1 larvae. Animals that did not show neuronal
degeneration were collected. nxf-1(pk386) and nxf-1(pk864) were identified by complementation
testing.
Positional cloning of nxf-1(pk386): nxf-1(pk386) was mapped to linkage group V.
Using three-factor crosses with NL1257 (dpy-11(e224) unc-42(e270); pkIs296[hsp::gsa-1QL dpy-
20(+)] X), nxf-1(pk386)  was placed to the right of unc-42 (13/13 were Sgs(suppressor of activated
Gs)Dpy, 0/5 were SgsUnc). Crosses with NL1916 (rol-4(sc8) lin-25(n545) him-5(e1467) unc-
76(e911) V; pkIs296[hsp::gsa-1QL dpy-20(+)] X) placed nxf-1(pk386)  in between him-5(e1467) and
unc-76(e911) (20/20 were RolSgs and 4/18 were RolHimSgs). Subsequent crosses with NL1994
(pkIs296[hsp::gsa-1QL dpy-20(+)] X) that has CB4856 DNA between him-5(e1467) and unc-
76(e911) revealed that nxf-1(pk386)  is located right of the single nucleotide polymorphism (SNP)
pkP1538 at position 23,876 on cosmid F56A12 and left of SNP pkP1539 at position 13,555 on cosmid
F23B12. This region contains 13 predicted open reading frames (ORFs). Sequencing of these ORFs in
nxf-1(pk386)  and nxf-1(pk864)  revealed that both alleles have a mutation in the same ORF,
C15H11.3, which encodes NXF-1. The mutation in nxf-1(pk864)  destroys an AvaII restriction site,
and can therefore be visualized using restriction digestion: a PCR with primers SNPsgs-2a
TTCAGAGTAAGTTCCTGCGG and SNPsgs-2b AACCCACTCATTCTCTCTCG digested with
AvaII gives one band (~600 bp) when performed on nxf-1(pk864)  animals, but two bands (~140 bp
and ~460 bp) when performed on Bristol N2 wild type animals. Two nxf-1 genomic constructs,
pRP2110 and pRP2112, were able to rescue the suppression of the neuronal degeneration (Table 1).
pRP2110 contains a 6 kb XhoI/SstI fragment of C15H11 and was injected at 20 mg/ml together with
the markers pRF4 (100 mg/ml) (KRAMER et al. 1990) and pRP2017 (gpb-2::gfp; 50 mg/ml) (VAN DER
LINDEN et al. 2001) in NL4003 (nxf-1(pk864) V; pkIs296[hsp::gsa-1QL dpy-20(+)] X) animals,
resulting in NL4021 (nxf-1(pk864) V; pkIs296[hsp::gsa-1QL dpy-20(+)] X; pkEx1581[nxf-1(+) gpb-
2::gfp rol-6(su1006)]). pRP2112, a full length GFP construct (see below), was injected in the same
strain at the same concentration (20 mg/ml) together with pRF4 (150 mg/ml), resulting in NL4020 (nxf-
1(pk864) V; pkIs296[hsp::gsa-1QL dpy-20(+)] X; pkEx1638[nxf-1::gfp rol-6(su1006)]).
Activated Gas-induced neuronal degeneration: The activated Gas-induced pattern
of neuronal cell death was measured as described in Korswagen et al. (1997). Synchronized L1-L2
larvae were heat-shocked for 2 hours at 33°C and after 24 hours the neuronal degeneration pattern was
examined in at least 20 animals using a Nomarski microscope (Zeiss Axioskop 2). The percentage
neuronal degeneration was calculated by comparing this number with the total number of degenerated
neurons in NL545 (dpy-20(e1362) IV; pkIs296[hsp::gsa-1QL dpy-20(+)] X).
Construction and expression of wild type and mutant full length nxf-1::gfp: A 3.9
kb XhoI/MscI fragment from C15H11 was cloned in SalI and SmaI sites of pPD95.77 (A. Fire,
personal communication), resulting in pRP2111. A full length GFP fusion (pRP2112) was constructed
by cloning a B g l I I /S m a I PCR fragment, generated using primers sgs-2gfp2
AAGTTGATGCCAAGTGGCTG and sgs-2gfp1a CTCCCCCGGGCATGAGCAAACGCTTCTG
CTG (SmaI site in bold), into BglII-MscI fragment of pRP2111. The cloned PCR fragment was
sequenced completely and found to be free of errors. pRP2112 (20 mg/ml) was injected together with
pMH86 (150 mg/ml) (HAN and STERNBERG 1991) in CB1282 (dpy-20(e1282) IV) animals, resulting in
two independent transgenic lines, NL4007 (dpy-20(e1282) IV; pkEx1578[nxf-1::gfp; dpy-20(+)]) and
NL4008 (dpy-20(e1282) IV; pkEx1579[nxf-1::gfp; dpy-20(+)]). Animals expressing GFP were
examined using a Nomarski microscope (Zeiss Axioskop 2). A full length GFP fusion containing the
mutation present in pk864 (pRP2113) or pk386 (pRP2114) was constructed by cloning a BglII-MscI
PCR fragment, generated using primers seqsgs-2a CAATCGCATCCGTCATTTGG and snpsgs-2b
AACCCACTCATTCTCTCTCG on respectively nxf-1(pk864)  and nxf-1(pk386)  animals, into BglII-
MscI fragment of pRP2112. The cloned PCR fragments were sequenced completely and found to be
free of errors. pRP2113 and pRP2114 were injected at the same concentration as pRP2112 (20 mg/ml)
together with pMH86 (150 mg/ml) (HAN and STERNBERG 1991) in CB1282 (dpy-20(e1282) IV)
animals, resulting in respectively NL4025(dpy-20(e1282) IV; pkEx1583[nxf-1(pk864) ::gfp; dpy-
20(+)]) and NL4034 (dpy-20(e1282) IV; pkEx1639[nxf-1(pk386) ::gfp; dpy-20(+)]).
Temperature-sensitivity experiments: Temperature-sensitivity of nxf-1(pk386)  and
nxf-1(pk864)  animals at 25°C and 27°C was determined as follows. nxf-1(pk386) pkIs296[hsp::gsa-
1QL dpy-20(+)] and nxf-1(pk864) pkIs296[hsp::gsa-1QL dpy-20(+)] animals were crossed
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respectively 2 and 4 times to wild type Bristol N2 animals. Animals without the pkIs296[hsp::gsa-1QL
dpy-20(+)] transgene were selected, resulting in NL3223 (nxf-1(pk386) V) and NL4005 (nxf-1(pk864)
V). L1 larvae of these two strains were placed at 25°C or 27°C, and were followed for phenotypes.
The temperature-sensitivity assay using mutant and wild type full length GFP
constructs was done as follows. NL4008 (dpy-20(e1282) IV; pkEx1579[nxf-1::gfp; dpy-20(+)]),
NL4034 (dpy-20(e1282) IV; pkEx1639[pk386::gfp; dpy-20(+)]) and NL4025 (dpy-20(e1282) IV;
pkEx1583[nxf-1(pk864)::gfp; dpy-20(+)]) L4 animals were picked and examined using a confocal
microscope (Leica TCS NT).  Subsequently, the animals were heat-shocked for 2 hr at 33°C and
examined immediately with a confocal microscope.
RESULTS
nxf-1(pk386) and nxf-1(pk864) suppress heat-shock promoter-induced phenotypes
Expression of a constitutively active gsa-1 mutant from its own or heat-shock promoter
results in vacuolization and degeneration of ventral nerve cord neurons (KORSWAGEN et al.
1997). gsa-1 encodes a heterotrimeric Gsa-subunit, and previously it was shown that
mutations in an adenylyl cyclase gene, sgs-1, suppress the neuronal degeneration phenotype
(KORSWAGEN et al. 1998). One other locus (previously called sgs-2 (KORSWAGEN et al.
1998)) was identified that can be mutated to suppress the neuronal degeneration phenotype
induced from heat-shock promoter. The two alleles that have mutations in this locus, pk386
and pk864, were isolated at a very low frequency of ~1 in 500,000 mutagenized genomes, and
both alleles are recessive for the suppression of the activated Gas phenotype. The mutant
animals are homozygous viable and do not show obvious defects in behavior or development.
In addition to suppressing the heat-shock promoter-induced activated Gas phenotype (Figure
1A and B), the alleles also suppress heat-shock promoter-induced GFP expression (Figure 1C
and D) and partially suppress the lethargic movement induced by expression of activated Gao
from a heat-shock promoter (results not shown) (MENDEL et al. 1995). This suggests that this
locus is not a specific downstream target of Gas, but rather a general suppressor of heat-shock
promoter-induced phenotypes.
Figure 1.     p k 8 6 4
animals suppress heat-
shock promoter-induced
phenotypes. (A) pkIs296
[hsp::gsa-1QL] animal
shows neuronal degen-
eration (arrowheads) after
induction of activated
Gas by 2 hours heat-
shock at 33°C. (B) pk864
pkIs296 [hsp::gsa-1QL]
animal does not show
neuronal degeneration
after 2 hours heat-shock
at 33°C. (C) pkIs1392
[hsp::gfp] animal shows
strong GFP expression
directly after a 2 hr heat-
shock at 33°C. (D) pk864 pkIs1392[hsp::gfp] animal shows hardly any GFP expression directly after a
2 hr heat-shock at 33°C. Picture C and D are taken with 2300 millisecond (ms) exposure time.
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The mutation in pk386 was mapped to chromosome V, and placed between markers
him-5 and unc-76 (Figure 2A). Further fine-mapping was performed by using the
polymorphic strain CB4856, placing the mutation right of the single nucleotide polymorphism
(SNP) pkP1538 at position 23,876 on cosmid F56A12 and left of SNP pkP1539 at position
13,555 on cosmid F23B12. Sequencing of all 13 ORFs in this region revealed that both pk386
and pk864 contained a mutation in the same gene, nxf-1. nxf-1 belongs to a family of nuclear
export factors that are involved in mRNA transport out of the nucleus (HEROLD et al. 2000;
SEGREF et al. 1997; TAN et al. 2000). Two genomic subclones, pRP2110 and pRP2112,
containing wild type nxf-1 (Fig. 2B), were able to rescue nxf-1(pk864) (Table 1). This
indicates that indeed the nxf-1 mutations are responsible for the suppression of the heat-shock
promoter-induced neuronal degeneration.
NXF-1 is a 628 amino acid protein, that has a ribonucleoprotein (RNP) domain, two
leucine-rich repeats (LRR), an NTF2-like domain and a nuclear pore complex (NPC) binding
domain (Figure 2C). In nxf-1(pk386), a conserved glutamic acid at position 287 is changed to
lysine. This amino acid is located in the second LRR of NXF-1 (Figure 2C). In nxf-1(pk864),
a nonconserved glycine at position 379 is changed to arginine. This amino acid is located in
the NTF2-like domain of NXF-1 (Figure 2C). Since NXF-1 is known to be involved in
mRNA transport out of the nucleus (TAN et al. 2000; WIEGAND et al. 2002), it is likely that
the nxf-1 mutant animals are disturbed in this process. Thus, nxf-1 animals probably do not
show heat-shock promoter-induced phenotypes because mRNAs produced during heat-shock
are not (or less efficiently) transported out of the nucleus.
Figure 2. pk386 and pk864 have mutations in nxf-1. (A) Genetic map of linkage group V,
showing the location of pk386 and nxf-1 and the markers used to map. (B) Structure of nxf-1 gene.
Arrows show the location of the mutated bases found in nxf-1(pk386) and nxf-1(pk864). Two rescuing
constructs, pRP2110 and pRP2112, are indicated. X, XhoI; S, SstI; GFP, Green Fluorescent Protein. (C)
Structure of NXF-1 protein. The leucine rich repeats (LRR), the NTF2-like domain and the nuclear
pore complex (NPC) binding domain are shown. Arrows indicate the location of the changed amino
acids in the alleles nxf-1(pk386) and nxf-1(pk864).
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TABLE 1
nxf-1 mutations suppress activated Gas-induced neural degeneration
genotype transgene mutation neural degeneration (%)
N2 (wild type) - 0
pkIs296[hsp-gsa1QL] - 100
nxf-1(pk386); pkIs296[hsp-gsa1QL] - E287K 14
nxf-1(pk864); pkIs296[hsp-gsa1QL] - G379R 15
nxf-1(pk864); pkIs296[hsp-gsa1QL] pkEx1581[nxf-1(+)] 94
nxf-1(pk864); pkIs296[hsp-gsa1QL] pkEx1638[nxf-1::gfp] 96
Neuronal degeneration induced by activated Gas under heat-shock promoter control as described in
Material and Methods. Phenotype was scored in 20 L1-L2 larvae for each genotype 24 hr after a 2 hr
heat-shock at 33°C. Mean total numbers of degenerated neurons ± SEM, with sample size in
parentheses, are 23.2 ± 0.7 (20) for NL545 pkIs296[hsp::gsa-1QL]; 3.4 ± 0.5 (20) for nxf-1(pk386);
3.5 ± 0.6 (20) for nxf-1(pk864); 21.8 ± 0.7 (20) for nxf-1(pk864) pkEx1581[nxf-1(+)]; and 22.3 ± 1.0
(20) for nxf-1(pk864) pkEx1638[nxf-1::gfp].
nxf-1 shows a ubiquitous and nuclear expression pattern
A fusion of full length nxf-1, including 1.6 kb promoter sequence, with GFP was constructed
to analyze nxf-1 expression (Figure 2B). Because this full length GFP fusion is able to rescue
the suppression of the neuronal degeneration (Table 1), it is likely that the observed
expression pattern reflects the expression of the endogenous nxf-1 gene.  Animals transgenic
for this nxf-1::gfp fusion showed GFP expression in virtually every cell and tissue of C.
elegans (Figure 3A). Expression begins during embryogenesis (Figure 3B), and continues
during all larval stages and adulthood. As is shown in Figure 3C, nxf-1 is expressed in ventral
nerve cord neurons, which are susceptible to the activated Gas-induced degeneration.
Furthermore, we always observe high expression in intestinal cells (Figure 3C). The intestinal
cells undergo endoreduplication during larval growth to reach a DNA content of 32n and they
are responsible for the production of all yolk protein (HEDGECOCK and WHITE 1985; KIMBLE
and SHARROCK 1983; WOOD et al. 1985). Consequently, a high amount of mRNA has to be
transported out of the nucleus in these cells, which may explain the high levels of NXF-1.
Previously, transient expression of an nxf-1 full length GFP fusion in human HeLa cells
showed that NXF-1 was found predominantly in the nucleus, where it accumulated in the
nucleoplasm but not in the nucleoli (TAN et al. 2000). In addition, Tan et al. observed that
NXF-1 was localized at the nuclear rim. In C. elegans, NXF-1 accumulates in the nucleus as
well (Figure 3), and we also observed localization at the nuclear rim. This nuclear rim
expression is most clear in the large intestinal nuclei (Figure 3D and 4A), but is also seen in
nuclei of other tissue. We did not observe exclusion of NXF-1 from the nucleolus (Figure
3D). However, we cannot exclude that the nucleolar localization is the result of
overexpression of the NXF-1::GFP fusion protein.
nxf-1 mutations are temperature-sensitive
Previously, it was shown that functional knockdown of nxf-1 by using RNAi was lethal for
both embryos and adult animals (TAN et al. 2000). pk386 and pk864 animals are viable and do
not show any obvious defects in development or morphogenesis. This strongly suggests that
the mutations in pk386 and pk864 are not complete loss-of-function mutations. So, what is the
nature of these mutations? One possibility is that the mutations are reduction-of-function
mutations, thereby reducing (but not abolishing) the total level of exported mRNAs in these
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Figure 3.      Expression pattern of nxf-
1 as analyzed using a full length GFP
gene fusion. (A) Overview of nxf-1
expression in an L2 larva. nxf-1 shows
nuclear expression in all cells and
tissues of C. elegans. Similar
expression is seen in other stages. (B)
nxf-1 is expressed in the early embryo.
(C) Expression of nxf-1 in ventral
nerve cord (VNC) neurons (arrows
show group of VNC neurons), and
intestinal cells (IC). (D) NXF-1
accumulates in the nucleus, and is also
located at the nuclear rim. Shown is a
Nomarski image (upper panel) and
fluorescence image (lower panel) of the same intestinal cell. Other cell types show similar localization.
animals. It is also possible that the mutations only affect export of heat-shock mRNAs.
However, the fact that the two mutations are located in different domains of the protein makes
this latter possibility less likely. Another possibility is that pk386 and pk864 are temperature-
sensitive alleles, so that during the heat-shock at 33°C (the restrictive temperature) the NXF-1
protein is in an inactive conformation, and cannot export mRNAs (including the newly
produced heat-shock promoter mRNAs). In both S. cerevisiae and D. melanogaster,
temperature-sensitive alleles of nxf homologues were identified (SEGREF et al. 1997; WILKIE
et al. 2001).
One method to test whether the nxf-1 mutants are temperature-sensitive is to raise
these mutants at the restrictive temperature and examine whether their phenotype is different
from wild type animals raised at the restrictive temperature and/or from nxf-1 mutant animals
raised at normal temperature (20°C). Unfortunately, it is not possible to grow C. elegans at
33°C, the temperature that is used for heat-shock and that is expected to be the restrictive
temperature, for longer periods of time. Therefore, we cannot directly test temperature-
sensitivity at 33°C. When raised at 25°C, nxf-1(pk386) and nxf-1(pk864) animals did not show
a temperature-sensitive phenotype. nxf-1(pk386) and nxf-1(pk864) animals that were placed at
27°C as L1 larvae showed a temperature-sensitive phenotype: they became completely sterile,
whereas wild type Bristol N2 animals still produced progeny at that temperature (data not
shown). However, we were not able to rescue this phenotype by introduction of wild type nxf-
1, and thus cannot exclude that this phenotype is caused by other (linked) mutations.
Figure 4.     Localization of mutant and wild
type NXF-1 at different temperatures. (A)
Wild type nxf-1 shows a general nuclear
expression pattern at 20°C. (B) nxf-
1(pk386)::gfp and (C) nxf-1(pk864)::gfp are
similarly expressed to wild type nxf-1::gfp
at 20°C. (D) Wild type nxf-1 is similarly
expressed after 2 hr at 33°C compared to at
20°C. (E) nxf-1(pk386)::gfp shows
predominantly expression at the nuclear rim
after 2 hr heat-shock at 33°C. (F) nxf-
1(pk864)::gfp shows a similar expression
pattern at 33°C to wild type nxf-1 at 33°C.
All pictures show intestinal cells, but other
cell types show similar expression.
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Segref et al. showed that a temperature-sensitive mutation in the yeast homologue of
NXF-1, Mex67, results in misexpression of this protein at the restrictive temperature, but not
at the permissive temperature (SEGREF et al. 1997). To address the possible temperature-
sensitivity of nxf-1(pk386) and nxf-1(pk864), we constructed fusions of full length nxf-1
containing the pk386  or pk864  mutation with GFP. Animals that overexpress nxf-
1(pk386)::gfp show a similar expression pattern to wild type nxf-1::gfp at 20°C (Figure 4A
and B). However, directly after a 2 hr heat-shock at 33°C, nxf-1(pk386)::gfp shows a different
expression pattern than wild type nxf-1::gfp: all nxf-1(pk386)::gfp is localized at the nuclear
rim, whereas wild type nxf-1::gfp is localized at the nuclear rim, in the nucleoplasm and
around the nucleolus, as at 20°C (Figure 4D and E). This result suggests that the mutant NXF-
1 protein is temperature-sensitive and has a different (inactive) conformation to wild type
NXF-1 at 33°C. nxf-1(pk864)::gfp shows a similar expression pattern to wild type nxf-1::gfp
at 20°C and 33°C (Figure 4E and F), although the expression at the nuclear rim might be
slightly reduced at 33°C. Since nxf-1(pk386) and nxf-1(pk864) are similar with respect to the
suppression of the neuronal degeneration induced by activated Gas, it is likely that nxf-
1(pk864)  is also a temperature-sensitive allele. We propose that mRNAs that are produced
during heat-shock are not exported out of the nucleus in nxf-1(pk386) and nxf-1(pk864)
animals due to a conformational change in the mutant NXF-1.
DISCUSSION
In this study we report the identification of two mutations in the nuclear export factor NXF-1
of C. elegans. The first mutation changes a conserved glutamic acid at position 287 in the
Leucine-rich repeat (LRR) into a lysine. LRR domains are short sequence motifs that are
thought to be involved in protein-protein interactions (KOBE and DEISENHOFER 1994). The
LRR domain of human NXF1 is essential for binding the CTE viral RNA, but not for general
RNA binding affinity, binding to nucleoporins and localization to the nuclear rim (BRAUN et
al. 2001; BRAUN et al. 1999; HO et al. 2002). Deletion of the LRR domain completely
abolishes mRNA export, suggesting that this domain binds to one or more (unidentified)
cellular proteins, and that this binding is essential for export of cellular mRNA (BRAUN et al.
2001). Recently, it has been shown that NXF members interact with several proteins,
including REF/Aly and Y14, that are part of a complex that is deposited by the spliceosome at
exon-exon junctions (KATAOKA et al. 2000; RODRIGUES et al. 2001; STRASSER and HURT
2000, STUTZ et al. 2000). It is thought that these proteins recruit NXF to cellular mRNA and
that this is mediated by the N-terminal domain of NXF including the LRR domain (STRASSER
and HURT 2000, STUTZ et al. 2000). In C. elegans, homologues of the REF family are present
(STUTZ et al. 2000), and these might mediate binding to mRNA via the N-terminal domain of
NXF-1 as well. This raises the possibility that the mutation in the LRR of C. elegans NXF-1
interferes with recruitment to cellular mRNA by these C. elegans homologues. The
observation that the C. elegans NXF-1 E287K is predominantly localized at the nuclear rim at
the restrictive temperature, whereas wild type NXF-1 is not, is in agreement with this
hypothesis. The NXF-1 E287K protein is expected to bind normally to NPC components,
since the LRR is not important for this process, but, when bound, may no longer be able to be
released. This would result in localization of the mutant protein at the nuclear rim and in a
strong reduction in mRNA export.
The second mutation in NXF-1 changes glycine 379 to an arginine. Glycine 379 is
located in the NTF2-like domain of NXF-1. The NTF2-like domain in NXF proteins is known
to mediate heterodimerization with NXTs and is essential for the export of cellular mRNA
(BACHI et al. 2000; SUYAMA et al. 2000). Recently, it has been demonstrated that this
heterodimer has a single nucleoporin-binding site located at the NXF side of the heterodimer
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(FRIBOURG et al. 2001) and that the sole function of this heterodimer is to bind to
nucleoporins (BRAUN et al. 2002). Probably, the temperature-sensitive mutation in the NTF2-
like domain results in decreased affinity of NXF-1 for NXT-1 at the restrictive temperature,
and thereby in strongly reduced binding to nucleoporins and diminished mRNA export. This
hypothesis is in agreement with the observation that NXF-1 G379R might have reduced
localization at the nuclear rim at the restrictive temperature. C. elegans NXT-1 is, like NXF-1,
an essential protein, since RNAi against NXT-1 results in 100% embryonic lethality (FRASER
et al. 2000). It is therefore not possible to test whether NXT-1 knockdown is able to suppress
the activated Gas-induced neuronal degeneration.
The C. elegans genome contains one additional NXF member, NXF-2 (HEROLD et al.
2000; SEGREF et al. 1997; TAN et al. 2000). NXF-2 misses the NPC-binding domain, which is
essential for mRNA export (HEROLD et al. 2000). RNAi against NXF-2 did not result in
nuclear accumulation of mRNA or any other phenotype (TAN et al. 2000), indicating that
NXF-2 is probably not involved in mRNA export. We showed that nxf-1 is expressed in all
tissues and cells of C. elegans, and therefore it is likely that NXF-1 is responsible for all
mRNA export in C. elegans. The identification of mutations in NXF-1 that suppress heat-
shock promoter-induced phenotypes provides a mechanism to conditionally overexpress a
certain protein in a specific tissue. NXF-1 mutant animals that express wild type NXF-1 in a
specific tissue (by cloning wild type NXF-1 under a tissue-specific promoter) can only export
mRNA in the tissue with wild type NXF-1 during heat-shock. So, if a transgene with a gene
of interest under heat-shock promoter control is present, then mRNA of this gene (produced
during heat-shock) will only be exported from the nucleus in the tissue with wild type NXF-1.
In this way, a gene is conditionally (e.g. after heat-shock) expressed in a specific tissue.
In conclusion, we have identified mutations in the nuclear export factor NXF-1 that is
essential for mRNA export out of the nucleus in C. elegans. These mutations in NXF-1 are
likely to be temperature-sensitive and to suppress heat-shock promoter-induced phenotypes
by preventing the export of mRNAs that are produced during heat-shock.
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Hyperactivation of the G12-Mediated Signaling
Pathway in Caenorhabditis elegans Induces
a Developmental Growth Arrest via Protein Kinase C
pharyngeal pumping rate in gpa-12 mutants. Mutations
that affect pumping cause feeding behavior defects and
a delay in growth [9]. However, we observed no signifi-
cant difference in the rate of pumping (Figure 2A) or
growth rate (data not shown) of gpa-12 mutants com-
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Uppsalalaan 8, 3584 CT pared to wild-type. Furthermore, no disorganization of
the hypodermis is seen in gpa-12 mutants, as demon-Utrecht
The Netherlands strated by normal expression of a jam-1::gfp reporter
construct in hypodermal cells [10] (data not shown).
Because no phenotypic defects are observed in gpa-
12mutants, we analyzed the effect of gpa-12 gene dos-Summary
age on behavior. Therefore, we generated transgenic
animals that overexpress either wild-type or activatedThe G12 type of heterotrimeric G-proteins play an im-
portant role in development and behave as potent on- GPA-12. To construct the activated form of GPA-12, we
changed a glutamine (Q) at position 205 to a leucine (L),cogenes in cultured cells [1–5]. However, little is
known about the molecular nature of the components which is analogous to theQ229Lmutation inmammalian
activated G12. Overexpression was accomplished bythat act in the G12-signaling pathway in an organism.
We characterized a C. elegans G subunit gene, gpa- using transgenes that carry amulticopy array of the gpa-
12 wild-type gene or the constitutively active gpa-1212, which is a homolog of mammalian G12/G13, and
found that animals defective in gpa-12 are viable. Ex- mutant gene under control of its endogenous promoter
or a heat shock promoter (hsp). Interestingly, when wepression of activatedGPA-12 (G12QL) results in a devel-
opmental growth arrest caused by a feeding behavior heat shocked animals that carry a chromosomal inte-
grated transgene overexpressing activated GPA-12defect that is due to a dramatic reduction in pharyn-
geal pumping. To elucidate the molecular nature of (pkIs1330[hsp::gpa-12QL]) for 2 hr at an early larval stage,
we found that all animals arrest their developmentalthe signaling pathways in which G12 participates, we
screened for suppressors of the G12QL phenotype. We growth (Figure 2B) but eventually recover. Similar results
were found for another independently integrated trans-isolated 50 suppressors that contain mutations in
tpa-1, which encodes two protein kinase C isoforms, gene, pkIs1355[hsp::myc:gpa-12QL], which contains a
Myc-tag fused to the active form of GPA-12 (data notTPA-1A and TPA-1B, most similar to PKC/. TPA-1
mediates the action of the tumor promoter PMA [6]. shown). Also, animals carrying an extrachromosomal
array of the constitutively activated gpa-12 gene underExpression of G12QL and treatment of wild-type ani-
mals with PMA induce an identical growth arrest control of its endogenous promoter, pkEx1467, arrest
their growth (see the Supplemental Experimental Proce-caused by inhibition of larval feeding, which is depen-
dent on TPA-1A and TPA-1B function. These results dures available with this article online). In contrast to
pkIs1330 and pkIs1355 animals, these developmentallysuggest that TPA-1 is a downstream target of both G12
signaling and PMA in modulating feeding and growth arrested larvae could not recover to adulthood and ulti-
mately died. No growth arrest or reduced pumping (seein C. elegans. Taken together, our findings provide a
potential molecular mechanism for the transforming below; Figure 2C) was observed in animals overexpress-
ing wild-type GPA-12 from its endogenous promotercapability of G12 proteins.
(gpa-12::gpa-12WT) or a heat shock promoter (hsp::gpa-
12WT). Thus, while GPA-12 is not essential, overexpres-Results and Discussion
sion of activated GPA-12 causes an arrest of larval
growth.The C. elegans homolog of mammalian G12/G13, GPA-
12, is expressed throughout development in pharyngeal Based on the expression of GPA-12 in the pharynx,
we determined whether reduced pharyngeal pumpingmuscle cells that control pumping of the pharynx (Figure
causes the growth arrest induced by activated GPA-121A) and in hypodermal cells (Figure 1B). We isolated a
(G12QL). As shown in Figure 2C, heat-shocked pkIs1330loss-of-function gpa-12(pk322)mutant [7] in which 2 kb
[hsp::gpa-12QL] transgenic larvae exhibit slow and irreg-of the gpa-12 coding sequence is deleted. Since the
ular pumping, whereas wild-type larvae pump normallydeletion includes the regions needed for GTP binding
after heat shock. Slow pumping is not caused by struc-and hydrolysis, pk322 is likely a null allele. Unlike the
turally defective pharyngeal muscle, because theseG12/G13 homolog Concertina in Drosophila [4] and G13
pkIs1330 animals completely recover from the growthin mice [5], the inactivation of gpa-12 does not cause
arrest and do not show any pharyngeal defects. As aembryonic lethality. This raises the possibility that GPA-
result of slow pumping, almost no food is taken up by12 is redundant with other G subunits of C. elegans,
the pharynx in pkIs1330 larvae, as can be visualized byasdemonstrated forG12andGq inmice [8]. SinceGPA-
staining bacteria in the gut of these animals with the12 is highly expressed in the pharynx, we quantified the
lipophilic fluorescent dye (DiO) [11] (Figure S1). Taken
together, these data indicate that the arrest of larval*Correspondence: plasterk@niob.knaw.nl
1These authors contributed equally to this work. growth is caused by a feeding defect.
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also contain a mutation in the tpa-1 gene; most muta-
tions change conserved amino acid residues or result
in premature stops (Figure 3A; Table S1). tpa-1 encodes
two isoforms of protein kinase C (PKC), TPA-1A and
TPA-1B, which are most similar to the “novel” PKC/
[13]. All isolated mutations disrupt both isoforms of
TPA-1, whereas none are located in the first four exons
of tpa-1A. In a separate mutagenesis screen in which
shorter heat shock treatment (5 min) was used, we iso-
lated two alleles of tpa-1, pk1584 and pk1585, that have
a stop in tpa-1A, thereby disrupting TPA-1A, but not
TPA-1B (Figure 3A). These mutations only moderately
suppress the growth arrest inducedby2 hr of heat shock
(Table S1). Introduction of tpa-1 wild-type genomic se-
quence rescued tpa-1(pk1401) mutants, resulting again
in developmentally arrested animals after the heat
shock-induced G12QL expression of pkIs1330. More-
over, reduced pumping induced by G12QL is completely
suppressed by tpa-1(pk1401) mutants (Figure 2C). Im-
portantly, tpa-1mutations do not affect GPA-12 expres-
sion, but rather act onGPA-12 signaling (see theSupple-
mental Experimental Procedures). Together, these data
indicate that both TPA-1A and TPA-1B are involved in
the growth arrest induced by G12QL.
Mutations in tpa-1were first identified as suppressors
of the developmental growth arrest induced by the tu-
mor-promoting phorbol ester PMA [6]. To further investi-
gate whether the tpa-1 mutations isolated in this study
are able to suppress the growth arrest induced by PMA,
we analyzed all suppressors of the G12QL phenotype in
the presence of 0.1–1 g/ml PMA, a concentration range
commonly used to activate PKCs. Most homozygous
mutations in tpa-1 that disrupt both isoforms of TPA-1
cause resistance to the PMA-induced growth arrest
compared to wild-type and non-heat-shocked pkIs1330Figure 1. Expression of gpa-12 in C. elegans as Detected by Using
a Translational GFP Gene Fusion [hsp::gpa-12QL] control animals (Figure 4; Table S1). Only
(A and B) pRP2018 contains the full-length wild-type gpa-12 se- 2 tpa-1 alleles, pk1478 and pk1517, of the 48 isolated
quence fused to gfp. (A) The head region of an L2-staged larva tpa-1 suppressor mutations are sensitive to 1 g/ml
showing expression of GPA-12 in the pharyngeal muscle cells (ph). PMA but are resistant to lower PMA concentrations
(B) L1 larva showing expression in the cytoplasm and nuclei of the
compared to non-heat-shocked pkIs1330 control ani-hyp7 syncytium (sy), which comprises the main body hypodermis,
mals (Figure 4). Animals with mutations in tpa-1 thatand in additional cells, which are presumably the P cells (precursors
disrupt TPA-1A, but not TPA-1B (pk1584 and pk1585),of motorneurons in the ventral nerve cord). No expression is de-
tected in hypodermal seam cells (V1–V6 cells). The nuclear localiza- are moderately resistant to the developmental growth
tion of the gpa-12::gfp reporter construct (pRP2018) may reflect the arrest induced by 1 g/ml PMA (Table S1). These data
endogenous GPA-12 expression, since the gfp-reporter vector used suggest that both TPA-1A and TPA-1B are required for
does not contain a nuclear localization signal. We observed an iden-
the growth arrest induced by PMA.tical expression pattern of GPA-12 by using another gpa-12::gfp
We observed that both PMA and activated GPA-12reporter construct (pRP2015; see the Supplemental Experimental
(G12QL) induce a growth arrest that is mediated by TPA-Procedures), including nuclear localization.
1A and TPA-1B. After treatment with PMA for 6 hr, wild-
type larvae pump slowly (94 
 8 pumps/min), as they
To study the molecular nature of the components in- do following heat shock-induced expression of G12QL,
volved in G12-mediated signaling, we performed genetic and this is suppressed by tpa-1(pk1401) (206 
 9
screens to isolate extragenic mutations that suppress pumps/min). This suggests that both PMA and GPA-12
the activated GPA-12 (G12QL)-induced growth arrest. In act via TPA-1 in the pharynx to induce a growth arrest.
total, 50 independent mutations were isolated that sup- To test this hypothesis, we cloned tpa-1A and tpa-1B
press the G12QL-induced growth arrest after heat shock cDNA under the control of the myo-2 promoter; myo-2
treatment (2 hr at 33C); 44 mutations were caused by encodes a myosin heavy chain that is specifically ex-
the use of ethylmethane-sulfonate (EMS) as a mutagen, pressed in the pharyngeal muscle. Indeed, specific ex-
and 6 were caused by using a transposon insertion pression ofwild-type TPA-1A andTPA-1B in the pharynx
method [12]. By means of the latter approach, we found in a tpa-1 background results in the inhibition of larval
that four suppressors contained a Tc1 transposon inser- growth after heat shock-induced G12QL expression of
tion in the coding region of the tpa-1 gene. Sequence pkIs1330[hsp::gpa-12Ql] animals or treatment with PMA
(Table 1). Transgenic animals carrying tpa-1B cDNA un-analyses revealed that all EMS-derived suppressors
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Figure 2. TransgenicOverexpression of Acti-
vated GPA-12 Induces Severely Reduced
Pumping that Causes a Developmental
Growth Arrest
(A and B) (A) In the presence of a heat shock
treatment, growth of N2 (wild-type) animals
is not inhibited and all larvae reach adulthood,
(B) whereas pkIs1330 transgenic animals that
overexpress G12QL show a developmental
growth arrest, as indicated by the young lar-
vae (arrows). Animals were synchronized,
heat shocked for 2 hr at the L1 larval stage,
and photographed 3 days later. Pictures were
taken at the same magnification.
(C) The pharyngeal pumping rate is de-
creased to almost zero in animals after heat
shock-induced expression ofG12QLusing two
independently integrated transgenes:pkIs1330
[hsp::gpa-12QL] and pkIs1355[hsp::myc::gpa-
12QL]. Both pkIs1330 and pkIs1355 contain
multiple copies of the constitutive active gpa-
12gene under control of a heat shockpromoter
(hsp); pkIs1355 also contains aMyc-tag fused
to the active form of GPA-12. The pumping
activity is not affected in gpa-12(pk322) mu-
tants compared to N2 (wild-type) animals.
Normal pumping activity is also observed in
multiple transgenic lines that overexpress
wild-type GPA-12 from a transgene carrying
a multicopy array, either extrachromosomal
or integrated, of the wild-type gpa-12 gene
under control of its endogenous (gpa-12::gpa-
12WT) or heat shock promoter (hsp:::gpa-12WT);
in each case, data is shown for one trans-
genic line. Mutations in tpa-1 suppress the
pharyngeal pumping defect after heat shock treatment of pkIs1330 animals. The rate of pumps is quantified in at least 20 larvae with or
without heat shock treatment for each strain (see the Supplemental Experimental Procedures). The error bars indicate the 95% confidence
interval of the mean.
der control of a hypodermal promoter (dpy-7) did not affected in animals overexpressing activated GPA-12
(G12QL). In the absence of heat shock-induced expres-show a growth arrest, but resulted in cuticle defects
(data not shown). Thus, the growth arrest is caused sion of G12QL, two independent transgenic lines,
pkIs1330 and pkIs1355, are hypersensitive to PMA com-by activation of TPA-1 in the pharynx. This is further
confirmed by the fact that expression of G12QL from the pared to wild-type (Figure 4). This result can be explained
by a leaky expression of the heat shock promoter used.myo-2 promoter (myo-2::gpa-12QL) is also able to induce
a developmental growth arrest (see the Supplemental After heat shock-induced expression of G12QL, the sen-
sitivity of both transgenic lines toward PMA becomesExperimental Procedures). The growth arrest of myo-
2::gpa-12QL transgenic animals is restored in a tpa-1 even higher. As a consequence, these animals died at
an early larval stage (100%). However, when we testedsuppressor background. We found one homozygous
wild-type animal of the progeny of heterozygous tpa-1 several transgenic lines that overexpress wild-type
GPA-12 from its endogenous promoter or a heat shocksuppressor animals that contained themyo-2::gpa-12QL
transgenic array and survived to adulthood. Interest- promoter, no hypersensitivity toward PMA is observed
(data not shown). These findings suggest that excessiveingly, this mosaic transgenic animal did not express the
coinjected gpb-2::gfp reporter construct in the pharynx, activated GPA-12, and not loss or overexpression of
wild-typeGPA-12 function, affects thePMA-inducedde-where it is normally expressed [14], indicating that the
myo-2::gpa-12QL array has been lost in this lineage. Alto- velopmental sensitivity.
The genetic experiments presented here support agether, these data support a role for PMA and activated
GPA-12 in the pharynx in regulating feeding behavior model in which TPA-1, most similar to nPKC or  sub-
units, functions as a direct or indirect downstream ef-and therefore indirectly the growth of C. elegans.
Since the phorbol ester PMA directly interacts with fector of activated GPA-12. The two other subclasses
of PKC isoforms, the “conventional” and “atypical”andmediates the action of TPA-1, we examinedwhether
the effects of PMA require the function of GPA-12. How- PKCs, as well as another member of the nPKC class,
appear not to be involved in the activated GPA-12- andever, unlike tpa-1mutants, gpa-12mutants are sensitive
to the PMA-induced developmental growth arrest like PMA-induced growth arrest (Table S2). Our experiments
do not conclusively demonstrate that wild-type GPA-12wild-type animals (Figure 4), suggesting that wild-type
GPA-12 function is not required to cause PMA sensitiv- regulates TPA-1 activity, since wewere unable to detect
any phenotype (in particular a growth arrest) for eitherity. Therefore, we examined whether PMA sensitivity is
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Figure 3. The Gene Structure of tpa-1 and
the Expression Pattern of tpa-1A and tpa-1B
in C. elegans
(A) Structure of TPA-1 containing the pseudo-
substrate region (PS), the cysteine-rich do-
mains (C1A and C1B), and the kinase domain.
Shown are the different mutations in tpa-1A
and tpa-1B mentioned in the results section.
We found 15 independent mutations in tpa-1
that cause a premature termination of TPA-1,
including 3 that contain an identical mutation
(see Table S1 for the properties of all 50 tpa-1
alleles).
(B) Genomic organization of the tpa-1A and
tpa-1B gene. Solid boxes represent the cod-
ing sequence. gfp-reporter constructs of
tpa-1B that only show expression of TPA-1B
aremadeby using the intronic promoter pres-
ent in the fourth intron of tpa-1. pRP2016 in-
cludes 3.2 kb of the upstream tpa-1B se-
quence and contains most of the coding
sequence of tpa-1B, pRP2036 includes 3.2
kb of the upstream sequence of tpa-1B, and
pRP2040 includes 3 kb of the upstream se-
quence of tpa-1A.
(C) Expression of tpa-1A in various neurons
of the head, including AVA and ADE of an L1-
staged larva using the gfp-reporter construct
pRP2036.
(D and E) Animals that carry an integrated
tpa-1B::gfp transgene (pRP2016) show ex-
pression of tpa-1B in the pharyngeal muscle
cells (ph) (D), in neurons in the head (nr), in-
cluding RIA (D), and in the membrane surrounding the hypodermal seam cells (E). More intense expression of tpa-1B is seen at the boundary
between two seam cells ([E], arrow).
animals that overexpresswild-typeGPA-12 or lackGPA- it is an attractive model that the transforming capability
of activated G12 is due (at least in part) to their ability to12 function. This is, however, in agreement with data
on TPA-1 isoforms, because animals overexpressing activate PKCs. Several biochemical studies performed
in mammalian cells have shown that PKCs are activatedTPA-1A or TPA-1B also do not show a discernible phe-
notype (data not shown). In tpa-1 null mutants, the only by diacylglycerol (DAG) or other lipids (for review, see
[17, 18]). In line with these data, GPA-12 may activatedetectable phenotypes relate to tissues in which GPA-
12 is not expressed [15, 16]. Furthermore, the finding TPA-1 via lipid intermediates that can be generated by,
for instance, phospholipases. Mutations in egl-8 encod-that activated GPA-12 and PMA induce an identical ar-
rest of larval growth causedby their action in thepharynx ing a phospholipase C isoform (PLC) do not suppress
the growth arrest induced by G12QL or PMA (data notsuggests that the apparent activation of TPA-1 by acti-
vated GPA-12 reflects the actual signaling pathway nor- shown). This finding suggests that there should be other
lipid-mediated signal transducing proteins, like phos-mally used by wild-type GPA-12. In this pathway, PMA
can bypass GPA-12 function by directly interacting with pholipase D or A2, that activate TPA-1 through the pro-
duction of DAG. All 44 EMS-mutagenized mutants thatTPA-1, since animals lacking GPA-12 are not resistant
to the developmental defects induced by PMA. The data were identified as suppressors of the G12QL-induced
growth arrest by using 2 hr of heat shock havemutationsdo not support a model in which GPA-12 serves as a
substrate for TPA-1, such that GPA-12 is inactivated by in tpa-1. Components that act between GPA-12 and
TPA-1 may not be identified in our suppressor screen,TPA-1. This is emphasized by the finding that animals
overexpressing activated GPA-12 in the presence of because they are either redundant or essential. Initial
studies on suppressors isolated after 5 min of heatPMA show amore severe phenotype (lethality at an early
larval stage), which is probably due to an excessive shock suggest that loci other than tpa-1 are involved in
the G12QL-induced phenotype. Further characterizationactivation and recruitment of TPA-1. We also do not
believe that TPA-1 acts as positive regulator of GPA-12 of these loci should uncover more components in the
G12 pathway and give insight in the molecular mechanismin a feedback loop, since animals overexpressing wild-
type GPA-12 are not hypersensitive to PMA (data not with which activated G12 and TPA-1 induce a growth
arrest.shown).
The discovery that PKCs function as receptors for
phorbol ester tumor promoters established a key role
Supplemental Data
for PKCs in tumorigenesis. In addition, constitutively Supplemental Data including the Experimental Procedures as well
active mutants of members of the G12 family are capable as Figure S1 and Tables S1 and S2 are available at http://images.
cellpress.com/supmat/supmatin.htm.of malignant transformation of human cells. Therefore,
G12
QL induces a developmental growth arrest
69
Genetics Stock Center for providing some of the strains used in this
study.
Received: November 19, 2002
Revised: January 21, 2003
Accepted: January 23, 2003
Published: March 18, 2003
References
1. Chan, A.M., Fleming, T.P., McGovern, E.S., Chedid, M., Miki,
T., and Aaronson, S.A. (1993). Expression cDNA cloning of a
transforming gene encoding the wild-type G12 gene product.
Mol. Cell. Biol. 13, 762–768.
2. Voyno-Yasenetskaya, T.A., Pace, A.M., and Bourne, H.R. (1994).
Mutant -subunits of G12 and G13 proteins induce neoplastic
transformation of Rat-1 fibroblasts. Oncogene 9, 2559–2565.
3. Xu, N., Voyno-Yasenetskaya, T., and Gutkind, J.S. (1994). Potent
transforming activity of the G13 subunit defines a novel family
of oncogenes. Biochem. Biophys. Res. Commun. 201, 603–609.Figure 4. Developmental Growth Sensitivity in the Presence of the
4. Parks, S., andWieschaus, E. (1991). TheDrosophila gastrulationPhorbol Ester PMA
gene concertina encodes a G-like protein. Cell 64, 447–458.
Loss-of-function gpa-12(pk322) animals are sensitive to PMA like 5. Offermanns, S., Mancino, V., Revel, J.P., and Simon, M.I. (1997).
N2 (wild-type) animals. In the absence of a heat shock treatment, Vascular system defects and impaired cell chemokinesis as a
pkIs1330[hsp::gpa-12QL] and pkIs1355[hsp::myc::gpa-12QL] trans- result of G13 deficiency. Science 275, 533–536.
genic animals are hypersensitive to PMA, whereas they die when a 6. Tabuse, Y., Nishiwaki, K., and Miwa, J. (1989). Mutations in a
heat shock is applied (larvae showed pharyngeal defects and vacu- protein kinase C homolog confer phorbol ester resistance on
oles in their hypodermis). Both pkIs1330 and pkIs1355 animals bear Caenorhabditis elegans. Science 243, 1713–1716.
multiple copies of the constitutive active gpa-12 gene under control 7. Jansen, G., Thijssen, K.L., Werner, P., van der Horst, M., Hazen-
of a heat shock promoter (hsp); pkIs1355 also contains a Myc-tag donk, E., and Plasterk, R.H. (1999). The complete family of genes
fused to the active form of GPA-12. Three tpa-1 mutants (pk1401, encoding G proteins of Caenorhabditis elegans. Nat. Genet. 21,
pk1487, and pk1517) in a pkIs1330 background suppress the PMA- 414–419.
induced developmental sensitivity compared to non-heat-shocked 8. Gu, J.L., Muller, S., Mancino, V., Offermanns, S., and Simon, M.I.
pkIs1330 control animals. tpa-1(pk1401) is a putative null allele. tpa-1 (2002). Interaction of G12 with G13 and Gq signaling pathways.
(pk1478) contains a S247P amino acid substitution in the first C1A Proc. Natl. Acad. Sci. USA 99, 9352–9357.
region, which is responsible for binding of phorbol esters [19], indi- 9. Avery, L. (1993). The genetics of feeding in Caenorhabditis ele-
cating that this mutation in tpa-1 may lower its affinity for PMA. In gans. Genetics 133, 897–917.
tpa-1(pk1517), a conserved glutamic acid (E) at position 418 in the 10. Mohler, W.A., Simske, J.S., Williams-Masson, E.M., Hardin, J.D.,
kinase domain is changed into a lysine (K), which presumably lowers andWhite, J.G. (1998). Dynamics and ultrastructure of develop-
the catalytic activity of TPA-1. Inhibition of larval growth induced mental cell fusions in the Caenorhabditis elegans hypodermis.
by PMA is quantified by measuring the number of young adults at Curr. Biol. 8, 1087–1090.
different concentrations of PMA after 5 days (see the Supplemental 11. Hedgecock, E.M., Culotti, J.G., Thomson, J.N., and Perkins,
Experimental Procedures). L.A. (1985). Axonal guidancemutants ofCaenorhabditis elegans
identified by filling sensory neurons with fluorescein dyes. Dev.
Biol. 111, 158–170.
12. Wicks, S.R., de Vries, C.J., van Luenen, H.G., and Plasterk, R.H.Acknowledgments
(2000). CHE-3, a cytosolic dynein heavy chain, is required for
sensory cilia structure and function in Caenorhabditis elegans.This work was supported by the Netherlands Organization for Scien-
tific Research (NWO) grants 014-80-008 and 901-04-094. We thank Dev. Biol. 221, 295–307.
13. Sano, T., Tabuse, Y., Nishiwaki, K., and Miwa, J. (1995). TheRobin May for critically reading the manuscript, Yo Tabuse and Johji
Miwa for kindly providing the tpa-1A cDNA clone, Richard Zwaal and tpa-1 gene of Caenorhabditis elegans encodes two proteins
similar to Ca2-independent protein kinase Cs: evidence byLeon Avery for sharing unpublished results, and the Caenorhabditis
Table 1. Expression of tpa-1A and tpa-1B in the Pharyngeal Muscle Rescues the Activated GPA-12- and PMA-Induced Developmental
Growth Arrest
Growth after Expression Growth in the Presence
Noninduced Animals of G12QL (Percentage of PMA (Percentage of
(Percentage of the Total of the Total Number the Total Number
Genotype Transgene Number of Young Adults) of Young Adults) of Young Adults)
tpa-1(pk1397) none 99 (n  368) 98 (n  328) 94 (n  317)
tpa-1(pk1397); hsp::gpa-12QL none 95 (n  433) 96 (n  384) 95 (n  459)
tpa-1(pk1397) myo-2::tpa-1A 97 (n  413) 96 (n  392) 7 (n  229)
tpa-1(pk1397); hsp::gpa-12QL myo-2::tpa-1A 91 (n  280) 5 (n  193) 3 (n  177)
tpa-1(pk1397) myo-2::tpa-1B 98 (n  358) 95 (n  368) 8 (n  296)
tpa-1(pk1397); hsp::gpa-12QL myo-2::tpa-1B 82 (n  136) 2 (n  144) 4 (n  97)
Assays are described in the Supplemental Experimental Procedures. For each injected construct, we generated at least two extrachromosomal
transgenic lines and crossed these lines in a pkIs1330[hsp::gpa12QL] background. pkIs1330 contains multiple copies of the constitutive active
gpa-12 gene under control of a heat shock promoter (hsp). Growth after expression of G12QL (2 hr at 33C) or in the presence of PMA (1.0
g/ml) was determined by counting the number of animals (n) after 4 days and calculating the percentage of young adults.
Chapter 4
70
complete genomic and complementary DNA sequences of the
tpa-1 gene. J. Mol. Biol. 251, 477–485.
14. van der Linden, A.M., Simmer, F., Cuppen, E., and Plasterk,
R.H. (2001). The G-protein -subunit GPB-2 in Caenorhabditis
elegans regulates the Go-Gq signaling network through inter-
actions with the regulator of G-protein signaling proteins EGL-
10 and EAT-16. Genetics 158, 221–235.
15. Waggoner, L.E., Zhou, G.T., Schafer, R.W., and Schafer, W.R.
(1998). Control of alternative behavioral states by serotonin in
Caenorhabditis elegans. Neuron 21, 203–214.
16. Waggoner, L.E., Dickinson, K.A., Poole, D.S., Tabuse, Y., Miwa,
J., and Schafer, W.R. (2000). Long-term nicotine adaptation in
Caenorhabditis elegans involves PKC-dependent changes in
nicotinic receptor abundance. J. Neurosci. 20, 8802–8811.
17. Nishizuka, Y. (1992). Intracellular signaling by hydrolysis of
phospholipids and activation of protein kinase C. Science 258,
607–614.
18. Ron, D., and Kazanietz, M.G. (1999). New insights into the regu-
lation of protein kinase C and novel phorbol ester receptors.
FASEB J. 13, 1658–1676.
19. Ono, Y., Fujii, T., Igarashi, K., Kuno, T., Tanaka, C., Kikkawa,
U., and Nishizuka, Y. (1989). Phorbol ester binding to protein
kinase C requires a cysteine-rich zinc-finger-like sequence.
Proc. Natl. Acad. Sci. USA 86, 4868–4871.


Chapter 5
Characterization of Caenorhabditis elegans homologs of the
Down syndrome candidate gene DYRK1A
Reprinted from Genetics 163: 571-580 (2003).

75
Characterization of Caenorhabditis elegans Homologs of the
Down Syndrome Candidate Gene DYRK1A
William B. Raich,* Celine Moorman,† Clay O. Lacefield,* Jonah Lehrer,* Dusan Bartsch,*
Ronald H. A. Plasterk,† Eric R. Kandel*,‡ and Oliver Hobert*,1
*Department of Biochemistry and Molecular Biophysics, Center for Neurobiology and Behavior,
‡Howard Hughes Medical Institute, Columbia University College of Physicians and Surgeons,
New York, New York 10032 and †Hubrecht Laboratory, 3584 CT Utrecht, The Netherlands
Manuscript received June 18, 2002
Accepted for publication November 5, 2002
ABSTRACT
The pathology of trisomy 21/Down syndrome includes cognitive and memory deficits. Increased expres-
sion of the dual-specificity protein kinase DYRK1A kinase (DYRK1A) appears to play a significant role in
the neuropathology of Down syndrome. To shed light on the cellular role of DYRK1A and related genes
we identified three DYRK/minibrain-like genes in the genome sequence of Caenorhabditis elegans, termed
mbk-1, mbk-2, and hpk-1.We found these genes to be widely expressed and to localize to distinct subcellular
compartments. We isolated deletion alleles in all three genes and show that loss of mbk-1, the gene most
closely related to DYRK1A, causes no obvious defects, while another gene, mbk-2, is essential for viability.
The overexpression of DYRK1A in Down syndrome led us to examine the effects of overexpression of its
C. elegans ortholog mbk-1. We found that animals containing additional copies of the mbk-1 gene display
behavioral defects in chemotaxis toward volatile chemoattractants and that the extent of thesedefects correlates
with mbk-1 gene dosage. Using tissue-specific and inducible promoters, we show that additional copies of
mbk-1 can impair olfaction cell-autonomously in mature, fully differentiated neurons and that this impair-
ment is reversible. Our results suggest that increased gene dosage of human DYRK1A in trisomy 21 may
disrupt the function of fully differentiated neurons and that this disruption is reversible.
TRISOMY of chromosome 21, or Down syndrome, exhibit impairment in spatial learning and cognitiveflexibility (Altafaj et al. 2001). The cellular and molec-is the most frequent chromosomal abnormality in
human infants that come to term. Besides manifesting ular consequences of these DYRK1A perturbations are
unknown.a characteristic set of facial and physical features, heart
The first vertebrate member of the DYRK family wasdefects, and abnormalities in the immune and endo-
originally identified in a PCR screen for protein kinasescrine systems, patients with Down syndrome have defi-
(Kentrup et al. 1996) and subsequently shown to belongcits in spatial memory and difficulty in converting short-
to a larger family of related dual-specificity kinasesterm to long-term memories (Johannsen et al. 1996;
(Becker and Joost 1999) to which we refer here asTakashima 1997). Although the cognitive defects of
the DYRK/minibrain family. Members of this family areDown syndrome are likely to arise from increased dos-
localized to distinct subcellular compartments and phos-age of many genes, several lines of evidence suggest
phorylate various substrates in vitro (Becker and Joostthat increased expression of the dual-specificity pro-
1999). They share the unusual property of tyrosine-tein kinase DYRK1A plays a significant role. First, the
directed autophosphorylation as well as phosphoryla-DYRK1A locus maps to the Down syndrome candidate
tion of serine/threonine residues in exogenous sub-region (DSCR), a region of 70–100 genes (Shindoh et
strates (Becker and Joost 1999). Their precise cellularal. 1996). Rare patients with a partial trisomy of the
role, however, remains elusive. Insights into their physi-DSCR display defects in cognition, suggesting that the
ological relevance were provided by the finding that thegenes in this region are sufficient to produce the cogni-
Drosophila homolog of DYRK1A, termed minibrain, istive defects of Down syndrome. Second, a 180-kb region
involved in neuroblast proliferation in the fly brain (Tej-on human chromosome 21 containing the DYRK1A lo-
edor et al. 1995). A similar reduction in brain size hascus is sufficient to produce defects in learning andmem-
been recently observed in DYRK1A knockout miceory in transgenic mice (Smith et al. 1997). Third, trans-
(Fotaki et al. 2002). The sole Saccharomyces cerevisiaegenic mice overexpressing the full-length Dyrk1A cDNA
representative of the DYRK/minibrain family, Yak1p, acts
in parallel to a protein kinase A pathway to negatively
regulate cell-cycle progression (Garrett and Broach
1Corresponding author: Columbia University, College of Physicians
1989; Garrett et al. 1991).and Surgeons, 701 W. 168th St., HHSC 724, New York, NY 10032.
E-mail: or38@columbia.edu In metazoan animals, the only DYRK/minibrain family
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Mannheim) and cloned into pPD95.77 (from A. Fire), gener-member for which mutant alleles exist is the Drosophila
ating pBR126. To build mbk-2S::gfp, Expand long-templateminibrain gene. Here, we describe the expression pat-
PCR (Boehringer Mannheim) was used to amplify exons 7–11
tern and loss-of-function alleles of all three DYRK/mini- of the mbk-2 locus and fused in frame with gfp in pPD95.77
brain family members in the nematode Caenorhabditis (from A. Fire), generating pBR138. This construct uses intron
6 as the 5 noncoding sequence. pmbk-2L::gfp and mbk-2S doelegans. In contrast to Drosophila minibrain, we observe
not contain the full mbk-2 genomic locus, and this may resultno obvious morphological defects in mbk-1mutants, but
in an artifactual or incomplete expression pattern. To buildfind that another DYRK/minibrain family member, mbk-2,
phsp16-2::mbk-2L::gfp, full-length mbk-2L cDNA was fused with
is required for viability. In an attempt tomodel the cellular gfp and inserted into the heat-shock vector pPD49.79 (from
consequences of DYRK1A overexpression that are ob- A. Fire), generating pBR169.
hpk-1: To build a translational fusion between HPK-1 andserved in Down syndrome patients, we analyzed the effects
green fluorescent protein (GFP), the full-length hpk-1 geno-of providing extra copies of the wormortholog ofDYRK1A
mic locus, including 4 kb of 5 noncoding sequence and alland describe dosage-sensitive and reversible defects in
exons and introns, was amplified by Expand long-template
the processing of acute sensory information. PCR (Boehringer Mannheim) and cloned into the promot-
erless vector pPD95.77 (from A. Fire), generating pBR132.
Transgenic and mutant strains: The strains are as follows:
MATERIALS AND METHODS
EK224 cmIs6 [pBR104, pNC4.21] I; 6 outcrossed
cDNAs: A full-length mbk-1 cDNA was amplified with SL1 EK270 cmIs8 [pBR113, pNC4.21]; 2 outcrossed
and gene-specific primers. The structure of the cDNA is similar EK176 cmEx20 [pBR145, unc-122::gfp]
to the predicted T04C10.1 gene, with the exception of an EK179 cmEx21 [pBR147, unc-122::gfp]
incorrect first exon predicted in T04C10.1. The mbk-2 locus EK173 unc-4(e120) II; cmEx19 [pBR144, pNC4.21]
generates two messages, a long form (mbk-2L) and a short EK234 unc-4(e120) II; cmEx31 [pBR169, pNC4.21]
form (mbk-2S) that uses an internal start site from an alterna- EK123 cmEx6 [pBR126, pRF4]
tively spliced exon. Both splice forms are represented in ex- EK251 cmEx16 [pBR138, pRF4]
pressed sequence tag (EST) clones (a gift from Y. Kohara) EK135 cmEx11 [pBR132, pRF4]
that have been completely sequenced. Similarly, hpk-1 full- EK228 mbk-1(pk1389) X; 6 outcrossed
length cDNA clones are represented in Y. Kohara’s EST collec- EK264 cmEx36 [pBR177, pRF4]
tion. EK273 hpk-1(pk1393) X; 6 outcrossed
DNA constructs: Constructs are shown schematically in Fig- EK275 mbk-2(pk1427)/mgIs18 IV; 3 outcrossed
ure 1.
All expression constructs were injected at 50 ng/l. pNC4.21mbk-1: To build mbk-1::gfp, the mbk-1 genomic locus, includ-
[unc-4()] and unc-122::gfp were injected at 50 ng/l. pRF4ing 7 kb of 5 noncoding sequence and all exons and introns,
[rol-6(d)] was injected at 100 ng/l. Integrated lines were ob-was amplified by Expand long-template PCR (Boehringer
tained using a protocol described at http://cpmcnet.columbia.Mannheim, Indianapolis). The PCR product was cloned in
edu/dept/gsas/biochem/labs/hobert/integration_protocol.frame with gfp in the promoterless vector pPD95.75 (from A.
html.Fire), generating pBR104. To build mbk-1(YA)::gfp, the Quick-
Isolation of deletions in the mbk-1, mbk-2, and hpk-1 loci:Change kit (Stratagene, La Jolla, CA) was used to modify
PCR screening of a chemically induced deletion library waspBR104 with primers YAs (5-ctggacaccgaatcgcccaggccattcagt
done as previously described (Jansen et al. 1997). The relativecgagattctatcg) and YAas (5-cgatagaatctcgactgaatggcctgggcgat
position within the genomic loci of all three mutant alleles istcggtgtccag), generating pBR113. To build mbk-1(pk1389)::gfp,
schematically indicated in Figure 1. A 1658-bp deletionmutantthembk-1 locus was amplified from homozygousmbk-1(pk1389)
of mbk-1, pk1389, was isolated using primers MBK1A (5-gcaanimals by Expand long-template PCR (Boehringer Mann-
gacgtgcctgacaatcttc) and MBK1D (5-tgtaggtatggcggtatccgtc)heim). Following the cloning and sequencing of this PCR
and nested primers MBK1B (5-ctcaaatacccagcaacactcac) andproduct, a 4.0-kb BglII-Asp718 fragment was subcloned into
MBK1C (5-caatagtagatcccatcctcag). The deleted PCRproductpBR104, generating pBR177. To build pgcy-10::mbk-1, the gcy-
from pk1389 was sequenced and the deletion was confirmed10 promoter (Yu et al. 1997) was amplified from N2 genomic
by Southern analysis. The following sequence in capitals isDNA by Expand long-template PCR (Boehringer Mannheim)
deleted by pk1389 : 5-ataaaGCTTT-TTACGactat. The deletionand cloned in front of the full-length mbk-1 cDNA, generating
extends from the first intron into the sixth exon. If in thispBR145. To build pgcy-10::mbk-1(YA), the QuickChange kit
context exon 1 is spliced to exon 7 (the beginning of the(Stratagene) was used to modify pBR145 with primers YAs
kinase domain), a frameshift and a premature stop wouldand YAas, generating pBR147. To build phsp16-2::mbk-1::gfp,
result; splicing of exon 1 to more downstream exons wouldthe full-length mbk-1 cDNA was cloned into the heat-shock
also create frameshifts and/or delete the kinase domain. Thevector pPD49.78 (fromA. Fire), generating pBR144. To gener-
mbk-2 deletion, pk1427, spans 3398 bp in the genomic regionate a fusion with gfp, the promoter and cDNA were subse-
represented in cosmid F49E11 and deletes the capitalizedquently fused in frame with pBR104, generating pBR144.
sequence 5-tcgtcGTCCG-AAAACttgta. The hpk-1 deletion,mbk-2: To build pmbk-2L::gfp, 8 kb of 5 noncoding sequence
was amplified by Expand long-template PCR (Boehringer pk1393, spans 1457 bp in the genomic region represented in

Figure 1.—Reporter gene constructs and deletion alleles used to studyminibrain-like genes. Boxes denote exons of the respective
genes. Dark shaded bars above the genomic locus denote the location of the deletion in the respective mutant alleles (see
materials and methods for precise location). Kinase domains are lightly shaded. The kinase domain was predicted using
SMART (http://smart.embl-heidelberg.de/). The large size of the mbk-2 genomic locus prevented us from constructing a full-
length, translational gfp fusion construct. To monitor subcellular localization of mbk-2 we thus fused the cDNA of the mbk-2L
splice form to a heterologous promoter, phsp16-2 (Fire et al. 1990). The two alternatively spliced mbk-2 isoforms produced by
the mbk-2 locus were deduced by cDNA analysis (see materials and methods).
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cosmid F20B6 and deletes the capitalized sequence 5-caca previously described (Timmons et al. 2001). The effectiveness
of RNAi could be assessed by monitoring the decrease incATGCC-TGACAtaatg. All deletion alleles lead to a disruption
of the majority of the respective kinase domains and are pre- fluorescence of transgenic animals that expressed gfp-tagged
mbk-2.dicted to act as null alleles.
RNAi: mbk-2 dsRNA was delivered by bacterial feeding as Behavioral assays: Chemotaxis assays toward volatile odor-
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ants were performed as described (Bargmann et al. 1993). elegans genes with close homology to the DYRK/mini-
Chemotaxis index  (the number of animals attracted to the brain family, termed mbk-1 and mbk-2 (for minibrain-
odorant)  (the number of animals at the opposite end of kinase), and one gene, hpk-1 (named after its vertebrate
the plate)/(the total number of animals at both ends of the homologs, homeodomain-interacting protein kinase 1-3), withplate). When transgenic animals carrying extrachromsomal
a more distant homology (Figure 2A). mbk-1 and mbk-2arrays were scored, only those animals that carry the injection
both carry the characteristic DYRK family signature mo-marker were scored.
Scoring neuroanatomy: AWC morphology was observed by tifs in their kinase domain, as well as a DH-box, a con-
crossing kyIs140, a chromosomally integrated str-2::gfp con- served sequence motif preceding the catalytic domain
struct (Troemel et al. 1999), into the respective mutant back- (Becker and Joost 1999). mbk-1 is unique among theground. The generation, proliferation, and anatomy of several
C. elegans DYRK/minibrain family members in clusteringsensory neuron classes (ASK, ADL, ASI, AWB, ASH, ASJ, PHA,
in the DYRK1A subgroup (Figure 2A). In addition toand PHB) were visualized by filling exposed sensory neurons
with the lipophilic dye DiI, as previously described (Hedge- highest overall sequence similarity, MBK-1 and DYRK1A
cock et al. 1985). Briefly, amixed population of well-fed worms can also be distinguished from other DYRK family mem-
was washed with M9 buffer, incubated at room temperature bers by their sharing of an N-terminal nuclear localiza-with 10 g/ml DiI for 1 hr, washed several times with M9,
tion sequence, a leucine zipper in the kinase domain,and then mounted on a compound fluorescence microscope.
and stretches of homopolymeric amino acids at their CDAPI staining: 4,6-Diamidino-2-phenylindole (DAPI) stain-
ing on gfp-expressing transgenic lines was done by placing termini (Figure 2B). We thus consider MBK-1 the C.
animals in a drop of water on a coverslip, letting the water elegans ortholog of human DYRK1A.
evaporate, adding a drop of acetone, letting the drop evaporate, Expression and subcellular localization of DYRK/drying for 20 min, and then adding 1 g/ml DAPI in M9 me-
minibrain-like genes in C. elegans: To determine the sitesdium.
of expression and subcellular localization ofDYRK/mini-
brain-like genes, we fused gfp in framewith the respective
RESULTS genomic loci (Figure 1). The mbk-1::gfp construct in-
cluded 7 kb of 5 noncoding sequence and all of theIdentification of DYRK/minibrain-like genes in C. eleg-
exons and introns present in the endogenous mbk-1ans: Through sequence homology searching of the com-
locus. The mbk-1::gfp gene product is expressed in allplete C. elegans genome sequence, we identified two C.
somatic cells and primarily localizes to nuclei (Figure
3), similar to the reported expression and subcellular
localization of human DYRK1A (Song et al. 1997; Becker
et al. 1998). During development, mbk-1::gfp expression
can first be observed around the 300-min stage, when
Figure 2.—The DYRK/minibrain-like gene family in C. eleg-
ans. (A) Classification of the DYRK subfamily of protein ki-
nases. On the basis of BLAST- and PFAM-based similarity
searches of the complete genome sequence, C. elegans has two
members of the DYRK subfamily of protein kinases, MBK-1
(T04C10.1; LGX; GenBank accession no. AY064464) and
MBK-2 (F49E11.1; LGIV; GenBank accession no. AY090019),
as well as a related kinase called HPK-1 (F20B6.8; LGX). The
gene structures of mbk-1 and mbk-2 were confirmed by se-
quence analysis of EST clones. The alignment and dendro-
gramwere generated from the predicted kinase domains using
ClustalX and Align with default parameters. The DYRK1A
group is boxed by dark shading, the DYRK subfamily is boxed
by light shading, C. elegans proteins are in boldface type and
underlined, and the percentage identity between each kinase
domain and that of DYRK1A is listed to the right. (B) MBK-1
is the closest homolog to DYRK1A, whose overexpression is
implicated in Down syndrome. The relative positions of the
N-terminal nuclear localization sequence [NLS; amino acids
(aa) 120–127], the DH box, the kinase domain (aa 317–649),
leucine zipper (L-L; aa 443–464; contains four leucines each
spaced by 6 aa), and C-terminal homo-polymeric stretch of
amino acids (histidines in DYRK1A, glutamines in MBK-1)
sites are shown. DYRK kinases are regulated through the phos-
phorylation of two DYRK-specific tyrosines within the activa-
tion loop (Y-Y; aa 488 and 490). For a more detailed alignment
and more sequence features of DYRK kinases, see Becker and
Joost (1999).
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cell division ceases and morphogenesis begins (Figure (Becker et al. 1998), MBK-2::GFP was excluded from
the nucleus (Figure 4D).3A). Expression levels increase during later embryonic
A translational HPK-1::GFP reporter construct (Fig-stages and remain at comparable levels throughout lar-
ure 1) was broadly expressed during embryogenesis andval and adult stages (Figure 3).
localized to moving nuclear puncta (Figure 4, E–H). InIn contrast to mbk-1, mbk-2::gfp reporter constructs
adult animals, the number, intensity, and movement ofwere expressed in subsets of tissues, including the ner-
HPK-1-GFP puncta are greatly reduced. Although wevous system, body wall muscle, and the pharynx (Figure
have not further examined the identity of these puncta,4, A–C). To determine the subcellular localization of
the observation that the three vertebrate homologs ofMBK-2 protein, we fused a cDNA—encoding the longer
HPK-1, HIPK1–3, stably bind andphosphorylate nuclearsplice form of mbk-2 (see Figure 1 and materials and
transcription factors (Kim et al. 1998) suggests that thesemethods)—to gfp and expressed it under control of
dots may represent sites of active transcription.a ubiquitously expressed promoter (Figure 1). Unlike
Taken together, the distinctive subcellular localiza-MBK-1::GFP, but like its vertebrate ortholog DYRK2
tion patterns described here for the individual C. elegans
DYRK/minibrain family members reveal a striking simi-
larity to their presumptive vertebrate orthologs and,
together with the primary sequence similarity, suggests
that vertebrate and C. elegans DYRK/minibrain proteins
fulfill similar functions.
Providing extra copies of mbk-1 causes dosage-sensi-
tive olfactory defects: Because human DYRK1A overex-
pression has been implicated in the behavioral defects
of Down syndrome, we wanted to examine the conse-
quences of overexpression of the DYRK1A ortholog
mbk-1 on C. elegans behavior. Toward this end, a multi-
copy array derived from a subcloned amplicon of the
mbk-1 genomic locus was integrated into the genome of
wild-type worms, giving rise to multiple independent
lines that harbor additional copies of mbk-1 (see Figure
1 for constructs). An appended gfp tag allowed us to
monitor ectopic mbk-1 expression, which we observed
broadly throughout the whole animal (Figure 3). In
light of the multicopy nature of stably transmitted DNA
arrays in C. elegans (Mello et al. 1991), the level of
ectopic mbk-1 expression is possibly significantly greater
than the 1.5-foldDYRK1Aoverexpression resulting from
trisomy 21; however, as we have no means of assessing
expression of endogenous MBK-1 protein we cannot
conclusively state that we “overexpress” mbk-1, but we
can clearly state, on the basis of the appended gfp tag,
that we provided extra copies of the mbk-1 gene.
All of the transgenic lines that contain extra copies of
Figure 3.—Expression of the DYRK1A/minibrain ortholog
mbk-1 gene as assayed by reporter gene analysis. MBK-1::GFP
is expressed in all somatic tissues and primarily localizes to
nuclei in embryos (A), larvae (B), and adults (C). Nuclear
localization can be observed in all cells and is particularly
obvious in the enlarged nuclei of hypodermal cells (D, MBK-
1::GFP; E, DAPI staining; the dark center is the nucleolus).
Expression is monitored from a chromosomally integrated
array, cmIs6. (A) Embryos at different stages; the embryo at
the top is roughly at 300 min of development entering mor-
phogenesis and showing the first signs ofmbk-1::gfp expression;
the embryo on the lower left is at the comma stage with slightly
increased mbk-1::gfp expression. Maximal levels of mbk-1::gfp
expression are then observed around threefold stages (em-
bryos on left).
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Figure 4.—Expression of other DYRK1A/minibrain family members. (A–F) MBK-2::GFP is excluded from the nucleus and is
expressed in the nervous system. Expression constructs are shown in Figure 1. (A) In L1 larvae, the 5 noncoding sequence of
mbk-2L drives gfp expression widely in the nervous system, including head neurons (arrowhead) and the ventral nerve cord
(arrow). (B) In adult animals, gfp continues to be expressed in the nervous system (arrow) and is also expressed in body wall
muscle (arrowhead). (C) A translational fusion between mbk-2S and gfp is expressed at the periphery of the pharynx (arrow).
(D) Induced expression of a translational fusion protein between mbk-2L and gfp also localizes to the periphery of the pharynx
(arrow). In addition, the protein is clearly excluded from the nuclei of neurons in the head (inset, arrowheads); nuclear exclusion
was further corroborated by DAPI staining of an embryo (F) that expresses mbk-2::gfp (E). (G–K) HPK-1::GFP expression. The
expression construct is shown in Figure 1. To monitor GFP expression in living embryos, two-photon laser scanning microscopy
was used on mounted embryos. (G) A translational fusion protein between hpk-1 and gfp localizes to nuclei and is widely expressed
in cleavage stage embryos. (H) After 4 min, the number and location of HPK-1-GFP puncta within the embryo has dramatically
changed. (J) The boxed region is shown at 1-min intervals. The puncta within the highlighted nucleus rapidly rearrange
(arrowheads). (K) A fluorescence micrograph of HPK-1-GFP at postembryonic stages. In adult animals, the number, intensity,
and movement of HPK-1-GFP puncta (arrowhead) are greatly reduced.
mbk-1, here on referred to asmbk-1(gf) animals, appeared yielded comparable levels of protein expression as as-
sessed by the added GFP tag. The olfaction phenotypenormal in respect to overall morphology, life span,
dauer formation, thermotaxis, mechanosensation, and thus requires the kinase activity of mbk-1, is specific to
mbk-1, and is sensitive to gene dosage.chemotaxis toward water-soluble attractants (data not
shown). mbk-1(gf) animals display no defects in locomo- Attractive olfactory responses in C. elegans are largely
mediated by two bilaterally symmetric pairs of ciliatedtory rate or reversal behavior (data not shown). How-
ever, olfaction toward several volatile chemoattractants sensory neurons, called AWA and AWC (Bargmann et
al. 1993). These neurons are capable of sensing a widewas markedly disrupted in mbk-1(gf) animals (Figure 5).
Comparable defects were observed with chromosomally variety of discrete odorants. We found that extra copies
of mbk-1 strongly inhibited odortaxis toward AWC-integrated lines that contain extra copies of either wild-
type mbk-1 or a mutated version of mbk-1 in which the sensed odorants such as benzaldehyde, isoamylalcohol,
and 2-butanone across a wide range of concentrationskinase activity was potentially hyperactivated (Y-to-E
change in kinase domain; data not shown). mbk-1(gf) (Figure 5B). In contrast, extra copies of mbk-1 caused
only marginal defects in the response to AWA-senseddefects are apparent throughout a wide range of odor
concentrations. odorants such as diacetyl and pyrazine (Figure 5B).
The cellular specificity of odortaxis defects inducedThe olfactory-defective phenotype was sensitive to
gene dosage, since animals heterozygous for the inte- by extra copies ofmbk-1 agrees with our observation that
mbk-1(gf) animals are indistinguishable from wild-typegrated mbk-1 array display intermediate odortaxis de-
fects. As a control, we provided extra copies of mbk-1, animals in all other behaviors tested and suggests that
mbk-1 acts selectively within specific cellular contextsagain under the control of its own promoter and tagged
with gfp to monitor expression, but containing an inacti- rather than affecting neuronal signaling in a broad and
unspecific way.vated kinase domain (Figure 1). We found that worms
containing integrated copies of the mbk-1(YA) genomic mbk-1 can act autonomously in sensory neurons: To
elucidate the cellular context in which extra copies ofconstruct showed no defects in odortaxis (Figure 5A).
Additional copies of mbk-2 also produced no olfaction mbk-1 can affect olfactory behavior, we added extra cop-
ies of mbk-1 specifically in olfactory neurons using thedefect (Figure 6B). All ectopic expression constructs
DYRK/minibrain genes in C. elegans
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Figure 5.—Extra copies of mbk-1 pro-
duce defects in chemotaxis to volatile at-
tractants. (A) Odortaxis to benzaldehyde,
which is sensed mainly by AWC chemo-
sensory neurons. Representative odortaxis
plates are shown for wild type (N2) and
animals that are homozygous for an inte-
grated multicopy mbk-1 array (Is[mbk-1] 
cmIs6). Odortaxis results with wild-type ani-
mals and animals that are homozygous
(Is[mbk-1]) and heterozygous (/Is[mbk-1])
for extra copies of wild-type mbk-1 arrays and
homozygous for kinase-inactivated mbk-1 ar-
rays (Is[mbk-1(YA)]  cmIs8) are shown. Ty-
rosines 488 and 490 were mutated to ala-
nine in kinase-inactivated MBK-1, since
equivalent tyrosines in DYRK1A are essen-
tial for kinase activity (Kentrup et al. 1996;
Himpel et al. 2001). The mbk-1(YA) con-
struct was also tagged with gfp and expres-
sion levels were found to be indistinguish-
able from those of animals that express
extra copies of wild-type mbk-1. For a sum-
mary of expression constructs see Figure 1.
(B) The response to odorants sensed by the
AWC chemosensory neurons (isoamyl-
alcohol, 2-butanone) is affected more
strongly by providing extra copies of mbk-1
than the response to odorants sensed by
the AWA chemosensory neurons (pyrazine,
diacetyl) or by both AWC and AWA (2,4,5-
trimethylthiazole). N2 (open bars) and
Is[mbk-1] (shaded bars) are shown. Each bar
represents at least five independent assays;
error bars show SEM and an asterisk indi-
cates that the values differ significantly (P	
0.05) from controls.
gcy-10 promoter, which is active in the AWC and AWB disrupt the function not only of AWC but also of other
cells (such as, for example, in downstream inter-chemosensory neurons, as well as in the pharyngeal
interneuron I1 (Yu et al. 1997; Figure 1). As a control, neurons).
mbk-1 can act reversibly and acutely in differentiatedkinase-inactivated mbk-1 was also expressed under con-
trol of the gcy-10 promoter (Figure 6A). Transgenic lines neurons:Given that odortaxis defects arise from increas-
ing mbk-1 gene dosage, an important issue is determin-expressing wild-type mbk-1 in AWB/C/I1 showed im-
paired odortaxis toward benzaldehyde, sensed by AWC ing the temporal window of mbk-1 function: Is the in-
creased gene dosage altering development or the function(Figure 6A), but normal odortaxis toward diacetyl,
sensed by AWA(data not shown). In contrast, transgenic of already differentiated cells? To address this issue, we
followed several approaches: First, we tested whetherlines expressing kinase-inactivated mbk-1 in AWB/C/I1
displayed normal odortaxis toward both benzaldehyde AWC development is affected in mbk-1(gf) mutants by
assessingAWCgeneration, proliferation, or anatomyusingand diacetyl. Because AWB is dispensable for chemo-
taxis toward volatile attractants (Bargmann et al. 1993), str-2::gfp (Troemel et al. 1999) as an anatomical marker
(Figure 7). We observed no obvious abnormalities. More-and because the pharyngeal neuron I1 is primarily iso-
lated from the somatic nervous system (Albertson and over, the characteristic left/right asymmetric expression
of the str-2 marker, a sensitive indicator of function andThomson 1976), these results suggest thatmbk-1 overex-
pression can act cell-autonomously in AWC to disrupt development of the left/right AWC neuron pair (Troemel
et al. 1999), is unaffected in mbk-1(gf) animals. As a sec-neuronal function. The disruption in odortaxis is less
severe in animals expressing mbk-1 under control of the ond approach to delineate mbk-1 function, we used the
inducible heat-shock promoter hsp 16-2 (Fire et al. 1990)gcy-10 promoter than in animals expressingmbk-1 under
control of its own promoter or of the heat-shock pro- to drive expression of an mbk-1 cDNA fused to gfp. Adult
animals that received a dose of mbk-1 expression duringmoter. This may arise because gcy-10 is a relatively weak
promoter or because additional copies of mbk-1 pro- embryogenesis and the first larval stage, steps in which
the cells and structures essential for chemotaxis differ-vided under control of its own ubiquitous promoter
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Figure 7.—Decreases or increases in mbk-1 gene function
do not affect olfactory neuron proliferation or differentiation.
Figure 6.—mbk-1(gf) acts reversibly and acutely in differenti- str-2::gfp(kyIs140) was used to examine the morphology of the
ated neurons. (A) Odortaxis to benzaldehyde of wild-type AWC neurons in mbk-1(pk1389) and mbk-1(gf) animals. The
animals (N2) and animals that express mbk-1 (Ex[mbk-1]) and dendrites (arrows) and axons (arrowheads) showed no gross
kinase-inactivated mbk-1 (Ex[mbk-1(YA)]) under control of the morphological abnormalities following mbk-1 perturbation. In
gcy-10 promoter. (B) Odortaxis to benzaldehyde. mbk-1 or addition, the left/right asymmetrical expression of str-2::gfp
mbk-2 was fused with gfp and expressed using the inducible was preserved. Other neurons also show no proliferation de-
promoter hsp 16-2 (Fire et al. 1990). To developmentally stage fects (data not shown).
the heat shocks, gravid hermaphrodites were collected and
treated with alkaline hypochlorite to physically separate the
embryos. For the developmental heat shocks (devo. heat shock),
with the acute function, but not with the formation orthese embryos were immediately placed at 33 for 1 hr, re-
turned to 20 for 12 hr, heat-shocked again for 1 hr, and differentiation, of the olfactory neurons and that the
allowed to grow to adulthood at 20 prior to the assay. For phenotypes resulting from overexpressed mbk-1 can be
adult expression, young adult animals were heat-shocked at reversed by reducing mbk-1 levels.33 for 1 hr, returned to 20 for 2 hr, and assayed either
Loss-of-function analysis ofmbk-1:The defects causedimmediately (acute heat shock) or following 24 hr (recovered).
by providing additional copies of mbk-1 prompted usOn the basis of GFP fluorescence, MBK-1::GFP or MBK-2::GFP
were expressed for 12 hr but 	24 hr following 1 hr at 33 to elucidate the mbk-1 loss-of-function phenotype. We
and both were expressed at approximately similar levels. Each isolated a mbk-1 loss-of-function allele, pk1389, through
bar represents at least five independent assays; error bars show PCR screening of a C. elegans deletion library. pk1389 isSEM and an asterisk indicates that the values differ signifi-
a likely null allele since it eliminates exons 2–6 of mbk-1.cantly (P 	 0.05) from controls.
Exon splicing around this deletion would lead to a
frameshift and to a premature stop in the message or
to a deletion of the entire kinase domain (Figure 1 andentiate, showed a normal response to the AWC-sensed
materials and methods). To confirm this notion, weodorant benzaldehyde (Figure 6B and data not shown).
introduced the pk1389 deletion into the context of theIn contrast, adult animals in which mbk-1 expression
translational mbk-1::gfp construct (Figure 1) and foundwas induced 2 hr before the assay showed a significant
that transgenic animals expressing this construct showdecrease in odortaxis toward benzaldehyde. Extra cop-
no gfp expression (data not shown).ies of mbk-2, whose expression was also monitored with
mbk-1(pk1389) homozygous mutant animals are viablean attached gfp tag (Figure 1), produced no defects
and show no obvious morphological abnormalities. We(Figure 6B).
examined several aspects of nervous system function inIntriguingly, the effects of providing extra copies of
mbk-1mutants, including the behavior of mbk-1mutantsmbk-1 overexpression were reversible, since adult ani-
in response to various sensory inputs (mechano- andmals tested 24 hr aftermbk-1 induction displayed normal
chemosensory), and detailed aspects of its locomotoryolfaction (Figure 6B; note that decrease inmbk-1 expres-
behavior. We observed no obvious defects under stan-sion could be monitored with the attached gfp tag).
These results indicate that extra copies ofmbk-1 interfere dard conditions (data not shown). We observed slight
DYRK/minibrain genes in C. elegans
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but significant defects in attraction to low doses of olfac- terns of similarity in expression and subcellular localiza-
tion of these proteins across phylogeny. Like their verte-tory cues, but since we were not able to rescue this
phenotype through expression ofmbk-1 from extrachro- brate orthologs, all three DYRK/minibrain-like genes are
broadly expressed. MBK-1, like its vertebrate orthologmosomal arrays, we could not conclude that these defects
are indeed due to loss of mbk-1 (data not shown; these DYRK1A, localizes to the nucleus while the closely re-
lated MBK-2, like its vertebrate ortholog DYRK2, is pre-rescue experimentsmay have failed because of an inabil-
ity to supply precisely the right amount of mbk-1). dominantly cytoplasmic and excluded from the nucleus.
HPK-1, like its vertebrate homolog HIPK2, is localizedWe examined nervous system architecture of mbk-1
mutant animals in more detail. We visualized a total of to subnuclear puncta. However, interspecies compari-
sons in mutant phenotypes reveal a strong dissimilarity.18 individual head and tail sensory neurons and their
axonal anatomy in the main head ganglia of C. elegans While the Drosophila minibrain locus affects neuroblast
proliferation and hence brain size (Fischbach andboth with gfp reporter genes that label individual cells
and with the fluorescent dye DiI (Hedgecock et al. Heisenberg 1984; Tejedor et al. 1995), a physiological
function apparently conserved in mice (Fotaki et al.1985) and found no morphological defects or aberrant
cell numbers in mbk-1(lf) mutants (Figure 7 and data 2002), we observed no apparent cellular proliferation
defects in the nervous system of mbk-1 mutant animals.not shown). Since most of these 18 visualized neurons
derive nonclonally from different embryonic precursors Our mutant analysis of the other two DYRK/minibrain-
like genes, none of which have been knocked out in(ABalp, ABpla, ABplp, Abpra, and ABprp), their visual-
ization allowed us to ascertain the integrity of various any other species, revealed that one of them, mbk-2, is
essential for viability, due to a function of the gene inlineage branches in mbk-1 mutants. The absence of any
defects in cell generation and number is significant in cytokinesis in the early embryo (J. Pellettieri and
G. Seydoux, personal communication); perhaps thislight of the widespread neuroblast proliferation defects
that lead to a significantly reduced brain size observed defect relates to the neuroblast proliferation defects in
Drosophila minibrain mutants. However, mbk-1, and notin Drosophila minibrain mutants (Tejedor et al. 1995).
Isolation of loss-of-function alleles in other DYRK1A/ mbk-2, represents the Drosophila sequence ortholog of
minibrain and Drosophila has a separate mbk-2-ortholo-minibrain family members: Since mbk-1 may act redun-
dantly with other DYRK1A/minibrain family members to gous gene (Figure 2).
The most important conclusions from our functionalaffect C. elegans nervous system development or function,
we isolated mutations in the only other two DYRK1A/ analysis of DYRK1/minibrain family genes derive from
providing extra copies of thembk-1 gene. First, increasesminibrain-related genes in the C. elegans genome, namely
mbk-2 and hpk-1 (Figures 1 and 2). Due to their deletion inmbk-1 expression produce functional olfactory defects
without apparently interfering with either neuronal pro-of the respective kinase domains, the mbk-2 and hpk-1
mutant alleles constitute likely null alleles (Figure 1). liferation or neuronal differentiation. Second, the phe-
notypes resulting from providing extra copies of mbk-1While hpk-1nullmutant animals are viable and appear
indistinguishable from wild type (data not shown), mbk- can be specifically induced in adult animals and are
thus acute rather than developmental defects. Third,2(pk1427) homozygous animals display 100% penetrant
maternal-effect embryonic lethality. Thematernal-effect the defects can be reversed by restoringmbk-1 to normal
levels of expression. Fourth, extra copies of the ubiqui-lethality is caused by defects in spindle positioning and
cytokinesis in the early embryo (J. Pellettieri and G. tously expressedmbk-1 gene specifically disrupt olfactory
behavior but no other behaviors tested. This apparentSeydoux, personal communication). In addition, mbk-2
homozygous animals derived from a heterozygous par- specificity suggests that additional copies of mbk-1 do
not cause an unspecific disruption of signaling or sick-ent appear sick and grow poorly. To independently con-
firm the linkage of the lethality with the mbk-2 locus, ening of a neuron, but act in a cellular-context-depen-
dent manner.we inactivated mbk-2 by RNAi (Fire et al. 1998) and
observed 100% embryonic lethality in the progeny of 7 We conclude that aberrant expression levels of mbk-1
interfere with acute sensory processing in olfactory neu-out of 10 adult mbk-2(RNAi) animals and 80% embry-
onic lethality in the progeny of the remaining 3 animals. rons. This finding is relevant since it is the additional
copy of the vertebrate mbk-1 ortholog DYRK1A that causesThe survivors display vulval defects at low penetrance
(11%; data not shown). The embryonic lethality and neurological defects either in humans or in mouse mod-
els. Our experiments with the temporal regulation andoverall sickness of maternally rescued mbk-2mutant ani-
mals did not allow us to test whether mbk-1 and mbk-2 reversibility of mbk-1 expression phenotypes may be
taken as an indication that human DYRK1A overexpres-have redundant functions in nervous system function.
sion disrupts the function of terminally differentiated
neurons. Moreover, the reversibility of defects observed
DISCUSSION
upon the reversion of mbk-1 expression levels back to
normal suggests that therapies aimed at the reductionOur analysis of the C. elegans homologs of the DYRK/
minibrain family of protein kinases reveals strong pat- of DYRK1A expression or activity may provide a viable
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Summary
Signal transduction allows cells to respond to signals from their environment and is
therefore important for most biological processes. The binding of an extracellular
signalling molecule to a cell-surface receptor is the first step in most signal transduction
pathways. Cell-surface receptors transduce the extracellular signals by generating a
cascade of intracellular signals that alter the behaviour of the cell. The proteins involved
in signal transduction include, besides the receptors, GTP-binding proteins (or G
proteins), protein kinases, phospolipases and ion channels, and these proteins are
conserved between multicellular organisms. In this study, we used the nematode
Caenorhabditis elegans, which is a simple and well-described organism that is very well
suited to perform genetic experiments, to analyse conserved signal transduction
pathways.
Chapter two of this thesis describes the genetic analysis of an important signal-
transducing molecule, the adenylyl cyclase SGS-1. Adenylyl cyclases act downstream of
certain heterotrimeric G proteins and convert ATP into the second messenger cyclic AMP.
In C. elegans, SGS-1 can be activated by the homologue of mammalian Gas, GSA-1, since
mutations in sgs-1 suppress the neuronal degeneration induced by expression of
constitutively active GSA-1 from its own or heat-shock promoter. We show that SGS-1 is
essential for viability and that it is involved in behaviours as diverse as pharyngeal
pumping and locomotion. To regulate this latter behaviour SGS-1 needs to be activated by
GSA-1.
In chapter three, nxf-1, another suppressor of the neuronal degeneration induced by
expression of constitutively active GSA-1 from a heat-shock promoter, is characterized.
nxf-1 encodes a nuclear export factor that is involved in transport of mRNA out of the
nucleus. Mutations in nxf-1 also suppress other heat-shock promoter-induced phenotypes,
indicating that this locus is not a specific downstream target of Gas, but rather a general
suppressor of heat-shock promoter-induced phenotypes. We postulate that the mutations in
nxf-1 make the protein inactive during heat-shock, resulting in reduced transport of the
activated Gas and other mRNAs out of the nucleus and thus the absence of the activated
Gas phenotype after heat-shock.
Chapter four reports the analysis of the C. elegans homologue of Ga12/13, GPA-12.
Loss of GPA-12 does not result in any obvious defect in development or behaviour of the
animal. However, overexpression of constitutively active GPA-12 from its own or heat-
shock promoter results in a developmental growth arrest that is caused by a feeding defect.
Mutations in tpa-1, which encodes two PKC isoforms, suppress the developmental growth
arrest induced by activated GPA-12, indicating that TPA-1 acts downstream of GPA-12.
Activation of TPA-1 by the tumour-promoting phorbol ester TPA (or PMA) results in an
identical developmental growth arrest, showing that activated GPA-12 and PMA use the
same PKC signalling pathway.
In chapter five of this thesis, the DYRK family of protein kinases is described. A
human DYRK kinase is implicated in the cognitive defects caused by trisomy of
chromosome 21/Down syndrome, and we demonstrate that in Caenorhabditis elegans
overexpression of a DYRK family member, mbk-1, results in signal transduction defects
in olfactory neurons. mbk-1 knockout animals do not show any obvious defects. Loss of
hpk-1, another member of the DYRK family in C. elegans, does also not result in any
obvious phenotype. However, a third member, mbk-2, is essential for viability.
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Samenvatting
Signaal transductie is een belangrijk mechanisme, gebruikt in verschillende biologische
processen, waarmee cellen kunnen reageren op signalen vanuit hun omgeving. Defecten in
signaal transductie moleculen leiden tot het ontstaan van verschillende ziektes, zoals
bijvoorbeeld kanker, en daarom worden signaal transductie paden veelvuldig bestudeerd. De
eerste stap in veel signaal transductie paden is het binden van een signaalstof, bijvoorbeeld
een hormoon, aan een receptor op de cel. Receptoren kunnen vervolgens in de cel een cascade
van moleculen activeren die uiteindelijk zorgen voor een respons. De meeste eiwitten die
betrokken zijn bij signaal transductie zijn geconserveerd gedurende de evolutie en hebben
dezelfde functies in verschillende organismes. Hierdoor kan signaal transductie uitstekend
bestudeerd worden in modelorganismes, zoals het rondwormpje Caenorhabditis elegans. Dit
rondwormpje is een simpel en goed beschreven organisme, dat vooral geschikt is voor
genetisch onderzoek. Zo is het mogelijk om genen gericht uit te schakelen of te muteren in C.
elegans. Door een gen uit te schakelen dat codeert voor een signaal transductie eiwit kan de
functie van zo´n eiwit in een signaal transductie pad worden achterhaald. Daarnaast is het
mogelijk om andere genen die een rol spelen in dat signaal transductie pad op te sporen in C.
elegans.
In hoofdstuk twee van dit proefschrift wordt een belangrijk signaal transductie eiwit
bestudeerd, namelijk de adenylyl cyclase SGS-1. Adenylyl cyclases worden geactiveerd door
bepaalde heterotrimere G eiwitten en produceren het signaal molecuul cyclisch AMP. SGS-1
wordt geactiveerd door het Gas eiwit van C. elegans, GSA-1. Overexpressie van een actieve
versie van GSA-1 leidt tot de dood van specifieke zenuwcellen, zowel bij expressie
geïnduceerd door zijn eigen promoter als bij expressie geïnduceerd door de heat-shock
promoter. Deze zogenaamde neuronale degeneratie wordt veroorzaakt doordat GSA-1 te veel
signaleert naar SGS-1, want mutaties die de activiteit van SGS-1 verminderen onderdrukken
de neuronale degeneratie. We laten zien dat SGS-1 ook wordt geactiveerd door GSA-1 om
beweging te reguleren. Daarnaast is SGS-1 essentieel voor de levensvatbaarheid van C.
elegans, omdat bij complete uitschakeling van dit eiwit wormen in een larvaal stadium blijven
en niet kunnen uitgroeien tot volwassenen.
Hoofdstuk drie beschrijft een ander gen dat, als het wordt gemuteerd, de neuronale
degeneratie geïnduceerd door expressie van actief GSA-1 vanaf de heat-shock promoter
onderdrukt, namelijk nxf-1. nxf-1 codeert voor een eiwit dat messenger RNA (mRNA) uit de
kern transporteert. Mutaties in nxf-1 onderdrukken ook phenotypes die geïnduceerd worden
door expressie van andere eiwitten vanaf de heat-shock promoter, en dus is het waarschijnlijk
dat NXF-1 niet specifiek betrokken is bij signaal transductie via GSA-1. Waarschijnlijk
maken de mutaties in nxf-1 het eiwit inactief gedurende de heat-shock, waardoor het transport
van geactiveerd Gas en andere mRNAs uit de kern sterk gereduceerd is, wat resulteert in een
verwaarloosbare hoeveelheid geactiveerd GSA-1 in de cel en dus in afwezigheid van
neuronale degeneratie.
In hoofdstuk vier wordt de genetische analyse van het Ga12/13 eiwit van C. elegans,
GPA-12, beschreven. Verlies van GPA-12 leidt niet tot een zichtbaar defect in de
ontwikkeling of het gedrag van C. elegans. Echter, overexpressie van actief GPA-12 resulteert
in een groei stilstand die veroorzaakt wordt door een gereduceerde opname van voedsel.
Mutaties in het gen tpa-1, dat codeert voor twee verschillende protein kinase C (PKC)
eiwitten, onderdrukken deze groei stilstand, wat suggereert dat TPA-1 wordt geactiveerd door
actief GPA-12. Activatie van TPA-1 door de tumor-inducerende stof TPA, oftewel PMA,
resulteert in een identieke groei stilstand, zodat het waarschijnlijk is dat actief GPA-12 en
PMA hetzelfde PKC signaal transductie pad gebruiken.
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In hoofdstuk vijf van dit proefschrift wordt de DYRK familie van protein kinases
besproken. Een humaan DYRK kinase, DYRK1A, is betrokken bij de cognitieve defecten in
Down syndroom dat veroorzaakt wordt door de aanwezigheid van een extra kopie van
chromosoom 21.  Expressie van extra kopiën van een DYRK familielid, mbk-1, in C. elegans
resulteert in defecten in zenuwcellen die betrokken zijn bij reuk. Verlies van MBK-1 heeft
geen duidelijk effect op het phenotype van de worm, evenals verlies van een ander lid van de
DYRK familie, HPK-1. Het derde lid van de familie, MBK-2, is echter nodig voor
levensvatbaarheid.
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Abbreviations
ACY adenylyl cyclase
aPKC atypical protein kinase C
ATP adenosine triphosphate
cAMP cyclic-3’,5’-adenosine monophosphate
CAN canal-associated neuron
cPKC conventional protein kinase C
DAG diacylglycerol
GFP green fluorescent protein
GDP guanosine diphosphate
GGL Gg-like
GTP guanosine triphosphate
HPK homeodomain interacting protein kinase
IP3 inositol 1,4,5-triphosphate
MBK minibrain kinase
nPKC novel protein kinase C
NXF nuclear export factor
PAR partitioning abnormal
PINS partner of inscuteable
PKA protein kinase A
PKC protein kinase C
PLC phospholipase C
PMA phorbol 12-myristate13-acetate
RGS regulator of G protein signalling
RNAi RNA interference
SGS suppressor of activated Gas
TPA 12-O-tetradecanoylphorbol-13-acetate
YAC yeast artificial chromosome
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